Clinical Trials - SNY

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT07184944A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseRECRUITINGPHASE32026-01-292034-03-202029-08-13
NCT07185009A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisRECRUITINGPHASE32026-01-072033-04-282028-09-21
NCT07116031A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)NOT_YET_RECRUITINGPHASE22025-10-152031-02-282031-02-28
NCT07170917Brivekimig for the Treatment of Moderate to Severe Hidradenitis SuppurativaNOT_YET_RECRUITINGPHASE22025-10-142028-04-272027-08-01
NCT07184931An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseRECRUITINGPHASE32025-10-012029-05-142029-05-14
NCT07184996An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative ColitisRECRUITINGPHASE32025-10-012028-05-092028-05-09
NCT07007962Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line TreatmentNOT_YET_RECRUITINGPHASE32025-10-012028-12-302027-11-05
NCT07135986Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in ChinaNOT_YET_RECRUITINGPHASE32025-09-262026-06-292026-01-28
NCT07053423A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.RECRUITINGPHASE42025-09-222029-02-152028-12-23
NCT07190222Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic PhenotypeNOT_YET_RECRUITINGPHASE32025-09-182030-01-222029-11-27
NCT07190196A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related DiseaseNOT_YET_RECRUITINGPHASE32025-09-182030-12-252028-06-28
NCT07190209Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic PhenotypeNOT_YET_RECRUITINGPHASE32025-09-182030-01-222029-11-27
NCT07156175A Study to Investigate the Efficacy and Safety of SAR444336 in Adults With Microscopic Colitis in Clinical RemissionNOT_YET_RECRUITINGPHASE22025-09-152027-05-062027-04-08
NCT06984627A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' DiseaseRECRUITINGPHASE22025-09-022026-09-232026-08-25
NCT07038473Early Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)NOT_YET_RECRUITINGNA2025-08-312026-09-012026-07-31
NCT07135973A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD)NOT_YET_RECRUITINGPHASE42025-08-292028-03-172027-08-30
NCT07146750A Bioequivalence Study of Amlitelimab Delivered by 2 Different Devices in Healthy Adult ParticipantsRECRUITINGPHASE12025-08-252026-04-082026-03-25
NCT07086976A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune Hemolytic AnemiaRECRUITINGPHASE32025-08-182029-12-262028-05-31
NCT07088068A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 DiabetesRECRUITINGPHASE32025-08-062028-12-122028-06-06
NCT07109297Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in IndiaRECRUITINGPHASE42025-07-312026-11-302026-11-30
NCT06791291Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 DiabetesRECRUITINGPHASE22025-07-252028-03-062028-03-06
NCT06844214A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 50 Years of Age With Non-congenital Myotonic Dystrophy Type 1RECRUITINGPHASE1, PHASE22025-07-232030-02-282029-02-28
NCT07071558Study to Evaluate the Safety and Immunogenicity of Investigational Vaccines Using the RSV (Respiratory Syncytial Virus) Monovalent Antigen in Healthy Participants 18 to 49 Years of AgeACTIVE_NOT_RECRUITINGPHASE12025-07-142026-02-262026-02-26
NCT07103148A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric PopulationRECRUITINGPHASE32025-07-112029-10-112026-08-08
NCT06975722A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative ColitisRECRUITINGPHASE22025-07-072029-10-172026-12-17
NCT06975865The Efficacy and Safety of Rilzabrutinib in Patients Aged 10 to 65 Years With Sickle-cell DiseaseRECRUITINGPHASE32025-07-072028-12-292027-07-23
NCT07013747Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild AcneRECRUITINGPHASE1, PHASE22025-07-032029-06-192029-06-19
NCT05567406Safety and Efficacy of Oral Belumosudil in Black or African American, American Indian or Alaska Native, and Native Hawaiian or Other Pacific Islander Male and Female Participants Aged 12 Years and Above With Chronic Graft Versus Host Disease (cGVHD) After At Least 2 Prior Lines of Systemic TherapyRECRUITINGPHASE22025-06-162026-08-312026-08-31
NCT05720455Study to Assess Safety and Efficacy of Fexofenadine Hydrochloride (HCL) + Pseudoephedrine HCL Fixed Dose Combination in Indian Male and Female Participants With Allergic Rhinitis (AR) Who Are 12 Years and AboveNOT_YET_RECRUITINGPHASE42025-06-062025-10-302025-10-30
NCT06958536A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's DiseaseRECRUITINGPHASE22025-06-032029-10-172026-12-17
NCT06941870Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial HypertrophyNOT_YET_RECRUITINGPHASE42025-05-302027-06-152027-03-16
NCT07002060Phase 3 Randomized, Modified Double-blind, Active-controlled Safety Study on vYF in AdultsACTIVE_NOT_RECRUITINGPHASE32025-05-222026-01-082026-01-08
NCT06975878Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of AgeRECRUITINGPHASE32025-05-222027-08-182027-08-18
NCT06914908Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP StudyRECRUITINGPHASE22025-05-122031-01-292031-01-29
NCT06666413China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With IOPDRECRUITINGPHASE42025-05-072028-05-022028-05-02
NCT06907511Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and OlderACTIVE_NOT_RECRUITINGPHASE1, PHASE22025-04-172026-05-282026-05-28
NCT06859099Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDPRECRUITINGPHASE32025-04-012029-10-032029-10-03
NCT06867094A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative ColitisRECRUITINGPHASE22025-03-282028-05-112027-07-29
NCT06891417Phase 1/2 Study of Chlamydia Trachomatis mRNA Vaccine in Adults Aged 18 to 29 YearsACTIVE_NOT_RECRUITINGPHASE1, PHASE22025-03-272028-01-032028-01-03
NCT06850051A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.ACTIVE_NOT_RECRUITINGPHASE12025-03-192025-12-312025-12-31
NCT06356571A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple MyelomaRECRUITINGPHASE22025-03-172027-07-152027-01-08
NCT06812988Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® MoleculeRECRUITINGPHASE22025-02-282028-09-132027-08-09
NCT06838000Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and AdolescentsACTIVE_NOT_RECRUITINGPHASE32025-02-282026-12-012026-12-01
NCT06824181Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of AgeRECRUITINGPHASE32025-02-272027-08-262027-08-26
NCT06824194Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of AgeRECRUITINGPHASE32025-02-182027-05-122027-05-12
NCT06834347A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal PolypsRECRUITINGPHASE32025-02-122027-12-132027-01-08
NCT06834360A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal PolypsRECRUITINGPHASE32025-02-062027-12-132027-01-08
NCT06790121A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic DermatitisACTIVE_NOT_RECRUITINGPHASE22025-02-032026-04-132025-12-31
NCT06805513Actual Use Trial of Tadalafil 5 mgRECRUITINGPHASE32025-01-302026-02-282026-01-31
NCT06716424A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes MellitusRECRUITINGPHASE42025-01-062026-04-032026-04-03
NCT06744205A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and OlderACTIVE_NOT_RECRUITINGPHASE1, PHASE22025-01-062026-04-162026-04-16
NCT06500702A Study to Evaluate the Efficacy and Safety of Frexalimab, SAR442970, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change DiseaseRECRUITINGPHASE22024-12-192028-02-162026-12-23
NCT06736041Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of AgeRECRUITINGPHASE32024-12-182027-05-172027-05-17
NCT06691113A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal PolypsRECRUITINGPHASE22024-12-162027-02-092026-08-07
NCT06637631A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.RECRUITINGPHASE22024-12-102029-05-232027-07-21
NCT06671587iGlarLixi CGM Study in Chinese T2D Individuals After OADsRECRUITINGPHASE42024-12-102026-09-182026-09-18
NCT06727058Study to Evaluate Safety and Immunogenicity of a Pandemic Flu H5 mRNA Vaccine in Healthy Adults Aged 18 Years and OlderACTIVE_NOT_RECRUITINGPHASE1, PHASE22024-12-092026-10-132025-12-11
NCT06616415A Clinical Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Belumosudil in Chinese Adolescents With cGVHD Who Have Had an Inadequate Response to Glucocorticoids or Other Systemic TherapiesACTIVE_NOT_RECRUITINGPHASE42024-12-042026-05-132026-05-13
NCT06687967A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1)RECRUITINGPHASE32024-11-282027-07-052027-04-12
NCT06687980A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2)RECRUITINGPHASE32024-11-252027-07-052027-04-12
NCT06705140A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and ToddlersACTIVE_NOT_RECRUITINGPHASE32024-11-252026-04-172026-04-17
NCT06660667A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular DegenerationRECRUITINGPHASE1, PHASE22024-11-212031-06-302027-05-18
NCT06704932A First-in-human Study to Investigate Safety and Tolerability of SAR446959 in Participants With Osteoarthritis of the KneeACTIVE_NOT_RECRUITINGPHASE12024-11-202025-12-192025-12-19
NCT06686628An Open-label, DDI Study to Investigate the Effects of Amlitelimab on the PK of Selected Cytochrome P450 SubstratesACTIVE_NOT_RECRUITINGPHASE12024-11-202026-04-032025-11-23
NCT06695117Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and OlderACTIVE_NOT_RECRUITINGPHASE1, PHASE22024-11-192026-04-012026-04-01
NCT06695130Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and Recombinant Influenza Vaccine in Adult Participants 50 Years of Age and OlderACTIVE_NOT_RECRUITINGPHASE1, PHASE22024-11-182026-04-032026-04-03
NCT06686654Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and OlderACTIVE_NOT_RECRUITINGPHASE1, PHASE22024-11-112027-09-022027-07-19
NCT06676319Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk AsthmaRECRUITINGPHASE22024-11-072027-11-122027-10-12
NCT06647407Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and InfantsRECRUITINGPHASE1, PHASE22024-11-052027-05-172027-04-21
NCT06641180Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of AgeCOMPLETEDPHASE32024-11-042025-06-242025-01-28
NCT06630806A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory MyelomaRECRUITINGPHASE12024-10-302029-05-142028-11-13
NCT06583031Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 YearsACTIVE_NOT_RECRUITINGPHASE12024-10-092025-09-282025-09-28
NCT06582056Study on Biomarkers of Periodontitis and Type 2 Diabetes Mellitus in Males and Females 30 - 70 Years of AgeRECRUITINGNA2024-10-092025-10-302025-10-30
NCT05726682A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)WITHDRAWNPHASE22024-10-082027-10-112027-02-12
NCT06609239Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma.RECRUITINGPHASE22024-09-302031-01-202031-01-20
NCT06604767Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and OlderACTIVE_NOT_RECRUITINGPHASE12024-09-172026-03-052026-03-05
NCT06557772A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac DiseaseRECRUITINGPHASE22024-08-292029-04-102026-08-04
NCT06290141A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)RECRUITINGPHASE32024-08-212027-11-192025-11-05
NCT06508489A Study to Investigate Natural Killer Cell Engager (SAR443579) With Different Agents in Participants With Hematological MalignanciesTERMINATEDPHASE1, PHASE22024-08-132025-08-082025-08-08
NCT06507553Study of Influenza Vaccines Containing an Additional H3 Antigen in Healthy Adult Participants 18 to 49 Years of Age and 60 Years of Age and OlderCOMPLETEDPHASE12024-08-122025-03-042025-03-04
NCT06454240A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal PolypsACTIVE_NOT_RECRUITINGPHASE22024-07-172027-04-092027-01-15
NCT06290128A Study to Test the Effects and Safety of Riliprubart in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) for Which the Usual Treatments do Not WorkRECRUITINGPHASE32024-07-122027-10-122026-02-03
NCT06386211Bioavailability Study of Magne-B6 New FormulationCOMPLETEDPHASE12024-07-032024-08-242024-08-24
NCT05897424Long-term, Open-label Study of SAR447537 (INBRX-101) in Adults With Alpha-1 Antitrypsin Deficiency EmphysemaRECRUITINGPHASE22024-06-202028-09-302028-06-30
NCT06444451A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia AreataACTIVE_NOT_RECRUITINGPHASE22024-06-062028-01-052025-09-17
NCT06293053A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo NodularisRECRUITINGPHASE32024-05-152027-11-032027-10-28
NCT06397768Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and ToddlersACTIVE_NOT_RECRUITINGPHASE32024-05-132025-09-302025-09-30
NCT06407934A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic DermatitisRECRUITINGPHASE32024-05-082027-04-052026-06-29
NCT06372145A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.RECRUITINGPHASE32024-04-162029-04-302029-04-30
NCT06316297Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe AcneRECRUITINGPHASE1, PHASE22024-04-052028-08-312028-08-31
NCT06251024Study of a Respiratory Syncytial Virus Candidate Formulation in Adults Aged 60 Years and OlderCOMPLETEDPHASE22024-04-022025-03-112025-03-11
NCT05908656Implementation and Evaluation of a Rare Disease Algorithm to Identify Persons at Risk of Gaucher Disease Using Data From Electronic Health Records (EHRs) in the United States (Project Searchlight)COMPLETEDNA2024-04-022024-08-262024-08-26
NCT06361875A Study to Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and AboveCOMPLETEDPHASE1, PHASE22024-04-012025-06-092025-06-09
NCT06342700A Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy ParticipantsCOMPLETEDPHASE12024-03-252024-04-232024-04-23
NCT06284915Study on Immunogenicity and Safety of a Meningococcal ACYW Conjugate Vaccine in Healthy Infants and ToddlersACTIVE_NOT_RECRUITINGPHASE32024-03-192025-10-032025-10-03
NCT06145373A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With EmicizumabRECRUITINGPHASE42024-03-012029-11-302026-09-19
NCT06241118A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK InhibitorRECRUITINGPHASE32024-02-292026-09-142026-05-25
NCT06284902Bioavailability Study of Fexofenadine HCl New Formulation TabletCOMPLETEDPHASE12024-02-232024-05-232024-05-08
NCT05983068A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic DermatitisACTIVE_NOT_RECRUITINGPHASE42024-02-222026-08-072026-05-29
NCT06280391A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis BronchiectasisACTIVE_NOT_RECRUITINGPHASE22024-02-202026-08-112026-03-24
NCT06252285Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and ToddlersACTIVE_NOT_RECRUITINGPHASE32024-02-062027-12-072026-05-27
NCT06237296Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and OlderCOMPLETEDPHASE12024-01-232025-02-112025-02-11
NCT06143891A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.ACTIVE_NOT_RECRUITINGPHASE32024-01-232028-09-292028-09-29
NCT06224348A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical CorticosteroidsACTIVE_NOT_RECRUITINGPHASE32024-01-182025-12-112025-08-21
NCT06228586Study on a MenACYW Conjugate Vaccine Administered as a Single Dose in Participants Aged 12 Months and Older in VietnamCOMPLETEDPHASE32024-01-182024-03-312024-03-31
NCT06208306A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPDACTIVE_NOT_RECRUITINGPHASE32024-01-112026-12-012026-12-01
NCT06191315Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)RECRUITINGPHASE32024-01-032028-12-212028-12-21
NCT06141486Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple SclerosisRECRUITINGPHASE32023-12-272028-03-242026-12-23
NCT06181435A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)ACTIVE_NOT_RECRUITINGPHASE32023-12-212026-03-172025-11-26
NCT06141473Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple SclerosisRECRUITINGPHASE32023-12-132027-05-062027-05-06
NCT06111586FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)RECRUITINGPHASE22023-12-112028-10-272027-04-30
NCT06101095A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial)ACTIVE_NOT_RECRUITINGPHASE42023-11-292028-02-012025-11-11
NCT06019728A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of FabrazymeCOMPLETEDPHASE42023-11-102024-10-252024-10-25
NCT06058156Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic DermatitisACTIVE_NOT_RECRUITINGPHASE22023-11-092026-08-182026-07-21
NCT06130566A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic DermatitisACTIVE_NOT_RECRUITINGPHASE32023-11-082025-11-122025-07-23
NCT06073093A Study to Evaluate SAR441566 Efficacy and Safety in Adults With Rheumatoid ArthritisCOMPLETEDPHASE22023-11-072025-07-022025-06-18
NCT06118099Proof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidradenitis SuppurativaACTIVE_NOT_RECRUITINGPHASE22023-11-012027-01-142025-02-06
NCT06134648Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine CandidateACTIVE_NOT_RECRUITINGPHASE1, PHASE22023-11-012026-03-102026-03-10
NCT06128733Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and AdolescentsCOMPLETEDPHASE1, PHASE22023-10-312025-07-212025-07-21
NCT06073119A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque PsoriasisCOMPLETEDPHASE22023-10-262024-12-112024-11-13
NCT06102005Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe AsthmaACTIVE_NOT_RECRUITINGPHASE22023-10-162026-03-232026-03-23
NCT05856331Study of SAR447537 (INBRX-101) Compared to Plasma-derived A1PI Therapy in Adults With AATD EmphysemaCOMPLETEDPHASE22023-10-122025-08-062025-08-06
NCT06082037A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft DysfunctionRECRUITINGPHASE32023-10-102028-06-022026-09-17
NCT06067425Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of SAR442501 in Pediatric Participants With AchondroplasiaTERMINATEDPHASE22023-10-102025-02-122025-02-12
NCT06015308A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With PlaceboACTIVE_NOT_RECRUITINGPHASE22023-10-062025-12-312025-09-10
NCT06028230A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis SuppurativaACTIVE_NOT_RECRUITINGPHASE22023-09-292026-07-172026-06-19
NCT05929651Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in InfancyCOMPLETEDPHASE42023-09-072024-09-092024-09-09
NCT06033833Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical StudyACTIVE_NOT_RECRUITINGPHASE22023-09-052029-06-252029-06-25
NCT05972629A Phase 1/Phase 2 Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Intravenous Administration of SAR444836 in Adult Participants With PhenylketonuriaACTIVE_NOT_RECRUITINGPHASE1, PHASE22023-08-072030-04-022030-04-02
NCT05757713Teplizumab in Pediatric Stage 2 Type 1 DiabetesACTIVE_NOT_RECRUITINGPHASE42023-07-252026-08-272026-08-27
NCT05712278A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid LeukemiaTERMINATEDPHASE12023-06-162024-03-122024-02-23
NCT05849922A Study to Test the Efficacy and Safety of SAR442970 in Adults With Hidradenitis SuppurativaCOMPLETEDPHASE22023-06-062025-01-092024-08-22
NCT05844735A Randomized Placebo- and Active Comparator-controlled Study to Evaluate the Photosafety of SAR441566COMPLETEDPHASE12023-05-222023-10-232023-10-15
NCT05878093Dupilumab in Chinese Adult Participants With CRSwNPCOMPLETEDPHASE32023-05-162024-11-282024-09-06
NCT05858788A Single Ascending Dose Study to Characterize the Pharmacokinetics, Safety, and Tolerability of SAR441566 in Healthy Adult Japanese Male Participants.COMPLETEDPHASE12023-05-152023-07-172023-07-17
NCT05839626A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA)TERMINATEDPHASE1, PHASE22023-05-152025-05-262025-05-26
NCT05829356Substudy 01 - Safety and Immunogenicity of One Monovalent Modified mRNA Vaccine Encoding Influenza Hemagglutinin With LNP, in Adult Participants Aged 18 to 49 Years and 60 Years and AboveCOMPLETEDPHASE12023-04-122024-03-142024-03-14
NCT05704049A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple MyelomaRECRUITINGPHASE22023-04-052028-05-182026-02-20
NCT05669989International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From IsatuximabACTIVE_NOT_RECRUITINGPHASE22023-04-052026-11-302026-11-30
NCT05769777Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic DermatitisRECRUITINGPHASE22023-04-032031-06-112031-06-11
NCT05794230Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South AfricaACTIVE_NOT_RECRUITINGPHASE32023-03-272025-12-022025-12-02
NCT04242147A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of KD033 (SAR445710) in Subjects With Metastatic or Locally Advanced Solid TumorsTERMINATEDPHASE12023-03-062023-12-012023-12-01
NCT05680298Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in ChinaCOMPLETEDPHASE42023-02-222024-03-152023-12-22
NCT05684341A Randomized Controlled Trial to Compare the Glycemic Control, With or Without the Connected Solution, of Adult Type 2 Diabetic Participants on Basal Insulin in TaiwanCOMPLETEDNA2023-02-172024-06-182024-06-18
NCT05687279Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA)COMPLETEDPHASE1, PHASE22023-02-062024-12-272024-12-27
NCT05662319A Study to Test a Medicine (Fitusiran) Injected Under the Skin for Preventing Bleeding Episodes in Male Adolescent or Adult Participants With Severe HemophiliaACTIVE_NOT_RECRUITINGPHASE32023-02-012028-06-012026-09-12
NCT05692154A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic RhinitisCOMPLETEDPHASE32023-01-232023-03-142023-03-14
NCT05607173A Pharmacokinetic and Tolerability Study of Fexinidazole in a Single Oral Dose in Adult Participants With Mild and Moderate Hepatic ImpairmentCOMPLETEDPHASE12023-01-182023-05-032023-05-03
NCT05718258A Study in Adults to Investigate the Impact of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Venglustat Compared to Participants With Normal Hepatic FunctionCOMPLETEDPHASE12023-01-182024-01-292024-01-29
NCT05731128A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))RECRUITINGPHASE22023-01-122027-03-242026-06-17
NCT05630547A Study to Evaluate the Effect of SAR443820 on Serum Neurofilament Levels in Male and Female Adult Participants With Multiple SclerosisTERMINATEDPHASE22022-12-192024-11-212024-11-21
NCT05650554Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adult Participants18 Years of Age and OlderCOMPLETEDPHASE1, PHASE22022-12-122024-04-022024-04-02
NCT05552859Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal ImpairmentTERMINATEDPHASE42022-12-052023-08-042023-07-28
NCT05584670A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid TumorsRECRUITINGPHASE1, PHASE22022-11-292028-11-072027-01-19
NCT05624606Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and OlderCOMPLETEDPHASE1, PHASE22022-11-282024-03-282024-03-28
NCT05624112Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in ChinaCOMPLETEDPHASE42022-11-252024-01-252024-01-25
NCT05588843Dose-finding Study of SAR443122 in Adult Participants With Ulcerative ColitisRECRUITINGPHASE22022-11-252026-12-162026-02-25
NCT05468320Caplacizumab and Immunosuppressive Therapy Without Firstline Therapeutic Plasma Exchange in Adults With Immune-mediated Thrombotic Thrombocytopenic PurpuraCOMPLETEDPHASE32022-11-212024-12-262024-12-26
NCT05639894Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and OlderCOMPLETEDPHASE1, PHASE22022-11-172025-05-022025-05-02
NCT05513391Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) Compared With Egg-Based Quadrivalent Influenza Vaccine (IIV4) in Participants Aged 3 to 8 YearsTERMINATEDPHASE32022-11-102023-10-032023-10-03
NCT05608005Study on Two Adjuvanted Dose Levels of Panblok H7+MF59 Compared for Immunogenicity and Safety With an Unadjuvanted Dose of Panblok H7 in Participants 18 Years of Age and OlderCOMPLETEDPHASE1, PHASE22022-11-032024-02-132023-02-18
NCT05513053Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) in Participants 9 Through 49 Years of Age.COMPLETEDPHASE32022-10-272023-10-272023-10-27
NCT05429762Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid TumorsTERMINATEDPHASE12022-10-032024-04-102023-08-01
NCT05553301Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and OlderCOMPLETEDPHASE1, PHASE22022-10-032024-01-192024-01-19
NCT05450562Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITINGPHASE1, PHASE22022-09-202025-12-252025-12-25
NCT05231668Single Ascending Dose Study of SAR439459 in Adults With Osteogenesis Imperfecta (OI)TERMINATEDPHASE12022-08-252024-11-122024-11-12
NCT05526521A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥2 Years to <12 Years of Age With Uncontrolled Chronic Spontaneous Urticaria (CSU) (LIBERTY-CSU CUPIDKids)COMPLETEDPHASE32022-08-252025-02-032024-11-11
NCT04936685Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5- and/or 10-year Booster Doses in Children and Adolescents Vaccinated 5 or 10 Years Earlier as ToddlersACTIVE_NOT_RECRUITINGPHASE32022-08-232027-12-262023-03-09
NCT05492578Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical TrialsRECRUITINGPHASE2, PHASE32022-08-222028-12-132028-12-13
NCT05437510Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of LifeCOMPLETEDPHASE32022-08-082025-04-092024-03-27
NCT05806567A Study to Assess the Effect of Oral Belumosudil on Inhibition of Various Proteins in the Fed State in Healthy Male SubjectsCOMPLETEDPHASE12022-07-272022-10-282022-10-20
NCT05453942A Study to Investigate Safety, Tolerability and Clinical Response With SAR441566 Compared With Placebo in Participants With Mild to Moderate PsoriasisCOMPLETEDPHASE12022-07-122023-02-092023-02-09
NCT05164055Avalglucosidase Alfa French Post-trial Access for Participants With Pompe Disease (PTA Avalglucosidase)ACTIVE_NOT_RECRUITINGPHASE42022-07-112025-12-312025-12-31
NCT05413369iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)COMPLETEDPHASE32022-07-072023-10-202023-10-20
NCT05421598Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe AsthmaCOMPLETEDPHASE22022-06-302025-03-202024-10-11
NCT05405166SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMMACTIVE_NOT_RECRUITINGPHASE32022-06-232027-03-232024-11-06
NCT05426174Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and OlderCOMPLETEDPHASE12022-06-092024-01-032024-01-03
NCT05156710BIVV020 (SAR445088) n Prevention and Treatment of Antibody-mediated Rejection (AMR)ACTIVE_NOT_RECRUITINGPHASE22022-06-092026-11-172025-10-27
NCT05366764First-in-human Study of SAR443765 in Healthy Participants and in Asthmatic ParticipantsCOMPLETEDPHASE12022-06-082023-02-242023-02-24
NCT05245071Tusamitamab Ravtansine in NSQ NSCLC Participants With Negative or Moderate CEACAM5 Expression Tumors and High Circulating CEATERMINATEDPHASE22022-06-012024-11-202024-03-06
NCT05326412Mechanistic Study of the Effect of Itepekimab on Airway Inflammation in Patients With COPDCOMPLETEDPHASE22022-05-192025-07-252025-03-05
NCT05280548A Study to Evaluate the Effect of Venglustat Tablets on Left Ventricular Mass Index in Male and Female Adult Participants With Fabry DiseaseACTIVE_NOT_RECRUITINGPHASE32022-05-032027-12-062026-05-15
NCT05796479A PK Comparability Study of Two Different Amlitelimab Drug Products in Healthy ParticipantsCOMPLETEDPHASE12022-04-282023-05-222023-05-22
NCT05222906Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3ACTIVE_NOT_RECRUITINGPHASE32022-04-182026-10-302025-09-30
NCT05237284Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS)TERMINATEDPHASE22022-04-132024-03-072024-03-07
NCT06118151Safety and Immunogenicity of a Monovalent mRNA Vaccine Encoding Influenza Hemagglutinin in Adult Participants 18 Years of Age and OlderCOMPLETEDPHASE12022-04-112023-02-172023-02-17
NCT05283915Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Mild Hepatic Impairment Compared to Participants With Normal Hepatic FunctionCOMPLETEDPHASE12022-03-182022-05-242022-05-24
NCT05206773A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry DiseaseACTIVE_NOT_RECRUITINGPHASE32022-03-112027-01-042025-12-07
NCT05282030Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Renal Impairment Compared to Healthy Participants.COMPLETEDPHASE12022-03-102022-08-022022-08-02
NCT05305989Extended Treatment and Follow-up of Subjects Treated With Belumosudil in Study KD025-208 or Study KD025-213COMPLETEDPHASE22022-02-232024-06-062024-06-06
NCT05797753A Study to Assess the Effect of Erythromycin on the Test Medicine (SAR443820) When Given Orally as Tablets to Healthy Adult Male and Female Participants (Part A); and the Effect of Itraconazole on the Test Medicine (SAR443820) When Given Orally as Capsules to Healthy Adult Male Participants (Part B)COMPLETEDPHASE12022-02-182022-07-012022-07-01
NCT05128773Study of Amcenestrant (SAR439859) Versus Tamoxifen for Patients With Hormone Receptor-positive (HR+) Early Breast Cancer, Who Have Discontinued Adjuvant Aromatase Inhibitor Therapy Due to Treatment-related ToxicityTERMINATEDPHASE32022-02-172022-10-132022-10-13
NCT05263206Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)RECRUITINGPHASE32022-02-152027-08-252027-06-02
NCT05114590Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Very Uncontrolled Type 2 Diabetes MellitusCOMPLETEDPHASE42022-01-272023-04-142023-03-28
NCT05087628PRV-3279-2a Trial in Systemic LupusTERMINATEDPHASE22022-01-242024-06-242024-05-14
NCT05097287Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe AsthmaRECRUITINGPHASE42021-12-162030-01-222029-10-31
NCT05104892Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe AsthmaCOMPLETEDPHASE22021-12-122024-02-282024-02-06
NCT05104567A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)COMPLETEDPHASE22021-12-092024-09-092023-07-26
NCT05086315First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)TERMINATEDPHASE1, PHASE22021-12-082025-06-132025-06-13
NCT05144945Study Describing the Immunogenicity and Safety of Quadrivalent Recombinant Influenza Vaccine (RIV4) Versus a Licensed Quadrivalent-inactivated Influenza Vaccine (IIV4) (Fluarix® Quadrivalent) in Participants 18 Years of Age and Older in South KoreaCOMPLETEDPHASE32021-12-072022-09-012022-09-01
NCT05179603A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205]TERMINATEDPHASE22021-12-072024-09-062023-09-14
NCT05002777Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA)ACTIVE_NOT_RECRUITINGPHASE22021-12-072029-12-312024-05-23
NCT05132569Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia GravisTERMINATEDPHASE32021-12-032023-02-212023-02-21
NCT05107115Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 AntihistamineCOMPLETEDPHASE22021-11-242024-04-232023-07-19
NCT06949358A Study to Evaluate Safety and Tolerability of Olipudase Alfa in Pediatric and Adult Participants With Acid Sphingomyelinase Deficiency (ASMD) Who Completed the DFI12712 or the LTS13632 Study in FranceCOMPLETEDPHASE22021-11-182025-04-082025-04-08
NCT05071053Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab in Pretreated Participants With Gastric CancerTERMINATEDPHASE22021-11-162024-11-052023-06-23
NCT05126329Pharmacokinetics of Amcenestrant in Female Hepatic Impaired Participants as Compared to Participants With Normal Hepatic FunctionTERMINATEDPHASE12021-11-152022-05-162022-05-16
NCT05132127Sutimlimab (BIVV009) for the Adult Participants With Cold Agglutinin Disease (CAD) Who Have Completed Phase 3 Studies (CARDINAL or CADENZA) in JapanCOMPLETEDPHASE32021-11-112022-11-152022-11-15
NCT05039840Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus ErythematosusRECRUITINGPHASE22021-11-102026-10-022026-07-10
NCT05137041Efficacy and Safety of FIRTECH in Patients With Mild to Moderate Acute Low Back PainCOMPLETEDPHASE32021-11-042022-11-222022-11-22
NCT05134571China Post-marketing Surveillance (PMS) Study of Aldurazyme®COMPLETEDPHASE42021-10-282023-07-262023-07-26
NCT05087212Mobilization of Stem Cells With AMD3100 (Plerixafor) in Combination With G-CSF in Multiple Myeloma PatientsCOMPLETEDPHASE42021-10-222022-12-302022-12-06
NCT05049122Dupilumab in Japanese Patients With Chronic Rhinosinusitis With Nasal Polyp (SINUS-M52)COMPLETEDPHASE42021-10-222023-07-052022-12-21
NCT05876767Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single and Repeated Doses of SAR444336 in Healthy Adult ParticipantsCOMPLETEDPHASE12021-10-152023-12-122023-12-12
NCT05054387China Post-marketing Surveillance (PMS) Study of Fabrazyme®COMPLETEDPHASE42021-10-132023-03-092023-03-09
NCT06326814A Study to Test if SAR443809 is Tolerated and Safe When Taken as a Single Dose in Healthy AdultsCOMPLETEDPHASE12021-10-112023-05-052023-05-05
NCT05061420A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) (Pegathor Head and Neck 204)TERMINATEDPHASE22021-10-082024-11-262023-07-21
NCT05011123Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and AsiaACTIVE_NOT_RECRUITINGPHASE22021-10-072027-04-232022-05-23
NCT05131373Safety, Tolerability, and Immunogenicity of ORI-A-ce001 for the Treatment of Acne VulgarisCOMPLETEDPHASE12021-09-282023-11-272023-11-27
NCT04998604EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 PatientsCOMPLETEDPHASE42021-09-272024-12-272024-10-16
NCT04914897A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202)TERMINATEDPHASE22021-09-232024-10-172023-07-18
NCT06114238Pharmacokinetic Study to Compare Itepekimab Exposure When Administered With an Autoinjector Versus Prefilled SyringeCOMPLETEDPHASE12021-09-162022-03-082022-03-08
NCT04661033Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia (wAIHA)TERMINATEDPHASE22021-09-092023-06-262023-06-26
NCT05018806Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic DermatitisCOMPLETEDPHASE22021-09-092023-06-232023-06-23
NCT05050318Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, RespectivelyCOMPLETEDPHASE42021-09-082021-11-102021-11-10
NCT04910776Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase AlfaACTIVE_NOT_RECRUITINGPHASE32021-09-012027-08-102026-03-06
NCT05013554Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid TumorsTERMINATEDPHASE12021-08-162024-01-152024-01-15
NCT04992546Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic DermatitisCOMPLETEDPHASE22021-08-132022-12-282022-12-28
NCT05042440Pharmacokinetic Assessment of Standard Half-Life (SHL) FVIII, Extended Half-Life (EHL) FVIII, and Efanesoctocog Alfa (BIVV001) in Severe Hemophilia ACOMPLETEDPHASE12021-08-112021-11-242021-11-24
NCT04982991Single Ascending Dose Study of SAR443820 in Healthy Adult Chinese and Japanese Female and Male ParticipantsCOMPLETEDPHASE12021-08-052021-10-112021-10-11
NCT05797701A Study in Healthy Adult Male & Female Participants to Assess the Amount of the Study Medicine (SAR443820) Absorbed by the Body, When Given Orally in Fasted Condition as a Tablet Versus as a Capsule (Part 1) and When Given Orally as a Tablet in Fasted Condition Versus as a Tablet After Food (Part 2)COMPLETEDPHASE12021-07-282021-09-062021-09-06
NCT04969276Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 VaccineCOMPLETEDPHASE22021-07-162022-02-082022-02-08
NCT04913220A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201)TERMINATEDPHASE1, PHASE22021-07-152025-02-182023-08-22
NCT04942210Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USAACTIVE_NOT_RECRUITINGPHASE22021-07-012027-06-292022-06-24
NCT04940026Study to Determine Absorption, Metabolism, and Excretion of [14C]-SAR439859, and to Assess Absolute Oral Bioavailability of Amcenestrant (SAR439859), in Healthy Post-menopausal WomenCOMPLETEDPHASE12021-06-152021-08-192021-08-19
NCT05976386Single Dose Comparability Study of New and Current Dupilumab Drug Products Subcutaneously Administered in Healthy AdultsCOMPLETEDPHASE12021-06-082021-09-242021-09-24
NCT04980027Evaluation of the Safety and Efficacy of Insulin Glargine 300 U/ml (Gla-300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus Uncontrolled on Oral Antihyperglycemic DrugsCOMPLETEDPHASE42021-06-072022-12-232022-12-23
NCT04879628Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple SclerosisACTIVE_NOT_RECRUITINGPHASE22021-06-072027-08-232022-09-21
NCT05002933A Clinical Efficacy and Safety Study of Insulin Glargine U300 in Chinese Adult Patients With Uncontrolled Type 2 Diabetes Mellitus With a 3-month Extension PeriodCOMPLETEDPHASE42021-05-202023-02-242023-02-24
NCT04770935To Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD)COMPLETEDPHASE12021-05-032022-12-202022-12-01
NCT04658472Proof-of-concept Study for SAR445088 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)ACTIVE_NOT_RECRUITINGPHASE22021-04-282025-09-302025-09-30
NCT04823130Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic DermatitisCOMPLETEDPHASE42021-04-222022-08-302022-06-30
NCT04717375Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid TumorsTERMINATEDPHASE1, PHASE22021-04-112025-07-022025-07-02
NCT04748926Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy ParticipantsCOMPLETEDPHASE12021-04-072021-05-212021-05-21
NCT04781816Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus ErythematosusCOMPLETEDPHASE22021-04-012023-06-262023-05-25
NCT04825223Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and InfantsTERMINATEDPHASE1, PHASE22021-03-292022-07-222022-07-22
NCT04659603Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid TumorsTERMINATEDPHASE22021-03-292025-01-192024-02-16
NCT04802057Safety and Tolerability Study in Adults With Cold Agglutinin Disease Previously Treated With SAR445088 or Never Treated With SAR445088TERMINATEDPHASE12021-03-222025-03-042025-03-04
NCT04490018Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy AdolescentsCOMPLETEDPHASE32021-03-162022-05-112022-05-11
NCT04798027Study of mRNA Vaccine Formulation Against COVID-19 in Healthy Adults 18 Years of Age and OlderTERMINATEDPHASE1, PHASE22021-03-122022-06-272022-06-27
NCT04676373Study to Evaluate Efficacy and Safety in Chinese Patients With Late Onset Pompe Disease With Alglucosidase Alfa TreatmenCOMPLETEDPHASE42021-03-102024-07-252024-07-25
NCT04680975Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic SclerosisTERMINATEDPHASE22021-03-032022-12-192022-05-10
NCT04656600Study to Evaluate Efficacy and Safety of Imiglucerase Treatment in Chinese Patients With Gaucher Disease Type ⅢCOMPLETEDPHASE42021-03-022023-10-122023-10-12
NCT04762680Study of Recombinant Protein Vaccines With Adjuvant as a Primary Series and as a Booster Dose Against COVID-19 in Adults 18 Years of Age and OlderCOMPLETEDPHASE2, PHASE32021-02-242023-06-292023-06-29
NCT04644575Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia AACTIVE_NOT_RECRUITINGPHASE32021-02-232027-01-152027-01-15
NCT04759131Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia ACOMPLETEDPHASE32021-02-192023-01-182023-01-18
NCT04718870Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic DermatitisCOMPLETEDPHASE42021-02-192022-11-302022-09-07
NCT04751487Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)COMPLETEDPHASE32021-02-122025-08-282025-04-21
NCT04705051Long-term Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) With VenglustatTERMINATEDPHASE32021-02-092021-07-132021-07-13
NCT04669600A Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)COMPLETEDPHASE22021-02-042023-02-072022-02-15
NCT04300192Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary Vaccine Regimens in Republic of South AfricaCOMPLETEDPHASE42021-01-272023-01-112023-01-11
NCT04643002Isatuximab in Combination With Novel Agents in RRMM - Master ProtocolRECRUITINGPHASE1, PHASE22021-01-252028-04-202027-09-13
NCT04678882Dupilumab in Japanese Patients With Atopic DermatitisCOMPLETEDPHASE32021-01-152023-10-282021-12-14
NCT06444191Pharmacokinetics (PK) of Rilzabrutinib (PRN1008) in Healthy Japanese and Caucasian SubjectsCOMPLETEDPHASE12021-01-042021-04-122021-04-12
NCT04701983Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)COMPLETEDPHASE32020-12-162025-08-272025-04-11
NCT04562766Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)ACTIVE_NOT_RECRUITINGPHASE32020-12-142026-08-262025-01-15
NCT04681729Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)COMPLETEDPHASE32020-12-102023-04-202023-02-02
NCT04669041A Study to Evaluate the Efficacy and the Safety of Single Pill Combination (SPC) Ezetimibe/Rosuvastatin in Chinese Adult Patients With Primary Hypercholesterolemia Not Adequately Controlled on Statin TherapyCOMPLETEDPHASE32020-12-082022-06-152022-06-15
NCT04678856Dupilumab in CRSsNPCOMPLETEDPHASE32020-12-022024-01-292023-11-14
NCT04684524Dupilumab in Allergic Fungal Rhinosinusitis (AFRS) (LIBERTY-AFRS-AI)COMPLETEDPHASE32020-12-012025-03-072024-12-14
NCT05795907Single & Multiple Ascending Dose Study of SAR443820 in Healthy Adult ParticipantsCOMPLETEDPHASE12020-11-302021-07-202021-07-20
NCT05846009A First-in-human Single and Repeated Dose Escalation Study of SAR442501 in Healthy Adults SubjectsCOMPLETEDPHASE12020-11-182022-01-122022-01-12
NCT04572841Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS)COMPLETEDPHASE22020-11-122024-02-092023-11-08
NCT04537234Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Taiwanese Adults 65 Years of Age and OlderCOMPLETEDPHASE32020-11-102021-02-092021-02-09
NCT06444204A Study to Evaluate the Effect of Mild and Moderate Hepatic Impairment on the Single-Dose Pharmacokinetics of Rilzabrutinib (PRN1008)COMPLETEDPHASE12020-11-022021-03-232021-03-23
NCT04524689Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed in Patients With NSQ NSCLCTERMINATEDPHASE22020-10-262024-12-242024-03-12
NCT04498832Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Japanese Adults 60 Years of Age and OlderCOMPLETEDPHASE32020-10-212021-01-142021-01-14
NCT04478266Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast CancerTERMINATEDPHASE32020-10-142023-05-262022-06-28
NCT04594551Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adults in ThaïlandCOMPLETEDPHASE32020-10-112021-06-232021-06-23
NCT04583618Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years.COMPLETEDPHASE22020-10-082022-01-202021-08-09
NCT04411641Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES)COMPLETEDPHASE32020-09-242024-08-292024-08-29
NCT04491877Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and ToddlersCOMPLETEDPHASE1, PHASE22020-09-172023-04-132023-04-13
NCT04551677Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2020-2021 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, RespectivelyCOMPLETEDPHASE42020-09-162020-12-182020-12-18
NCT04544267Study on a High-Dose Quadrivalent Influenza Vaccine Compared With Standard-Dose Quadrivalent Influenza Vaccine in Children 6 Months Through 35 Months of AgeSUSPENDEDPHASE32020-09-152026-072026-07
NCT04537208Study of Recombinant Protein Vaccine Formulations Against COVID-19 in Healthy Adults 18 Years of Age and OlderCOMPLETEDPHASE1, PHASE22020-09-032021-11-192021-11-19
NCT04143958To Assess the Glycosphingolipid Clearance and Clinical Effects of Switching to Agalsidase Beta (Fabrazyme) Versus Continuing on Agalsidase Alfa (Replagal) in Male Patients With Classic Fabry DiseaseWITHDRAWNPHASE42020-092023-112023-11
NCT04394624Tusamitamab Ravtansine (SAR408701) in Combination With Ramucirumab or Ramucirumab and Pembrolizumab in Pretreated Patients With NSQ NSCLC (CARMEN-LC04)TERMINATEDPHASE22020-08-312024-10-242023-03-06
NCT04424927PRV-015 in Gluten-free Diet Non-responsive Celiac DiseaseCOMPLETEDPHASE22020-08-242024-07-302024-07-30
NCT04520451Open Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease ParticipantsCOMPLETEDPHASE22020-08-222024-10-152024-10-15
NCT04904549Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and OlderCOMPLETEDPHASE32020-08-202024-08-312024-08-31
NCT04458051Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)ACTIVE_NOT_RECRUITINGPHASE32020-08-132025-11-142025-11-14
NCT04502862A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent AsthmaCOMPLETEDPHASE42020-08-102023-11-102023-10-03
NCT06106074Study of the Tolerability and Pharmacokinetics of Oral Doses of SAR442168 With a Food Effect Investigation in Healthy Adult ParticipantsCOMPLETEDPHASE12020-08-102022-05-232022-05-23
NCT04478084Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adult and Pediatric Population in ThaïlandCOMPLETEDPHASE32020-08-042022-07-212022-03-19
NCT04401020First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHLACTIVE_NOT_RECRUITINGPHASE12020-07-242026-03-172024-03-02
NCT04469621A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19COMPLETEDPHASE12020-07-172020-10-232020-10-23
NCT04447417Dupilumab Skin Barrier Function Study in Atopic DermatitisCOMPLETEDPHASE42020-07-162021-06-172021-06-17
NCT04456673Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 InflammationCOMPLETEDPHASE32020-07-062024-05-272024-02-28
NCT04451954Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult SubjectsCOMPLETEDPHASE12020-07-022021-09-202021-09-20
NCT04410978Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 1)COMPLETEDPHASE32020-06-302024-07-152024-07-15
NCT04221451A Multinational, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, and Safety of Venglustat in Late-onset GM2TERMINATEDPHASE32020-06-292024-12-262024-12-26
NCT04429295Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in ThailandCOMPLETEDPHASE32020-06-282021-11-202021-02-26
NCT06418607A Study of the Safety, Tolerability, and Bioequivalence of Orally Administered Venglustat in Healthy Adult ParticipantsCOMPLETEDPHASE12020-06-232020-07-132020-07-13
NCT04400318The Effect of Dupilumab on Lung Inflammation and Related Changes in Airway Volumes Detectable by Functional Respiratory Imaging in Patients With Moderate-severe AsthmaCOMPLETEDPHASE42020-06-202023-08-212023-06-26
NCT04294459Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney TransplantationTERMINATEDPHASE1, PHASE22020-06-182022-05-022022-05-02
NCT06418620A Study of the Safety, Tolerability, and Bioavailability of Orally Administered Venglustat in Healthy Adult ParticipantsCOMPLETEDPHASE12020-06-182020-08-072020-08-07
NCT04270409Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple MyelomaACTIVE_NOT_RECRUITINGPHASE32020-06-162033-10-212030-10-14
NCT04269551A Safety and Tolerability Study of BIVV020 in Adults With Cold Agglutinin DiseaseCOMPLETEDPHASE12020-06-152022-01-062022-01-06
NCT04410991Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2)COMPLETEDPHASE32020-06-112024-07-162024-07-16
NCT04418661Safety and Efficacy Study of Vociprotafib (SAR442720) in Combination With Other Agents in Advanced MalignanciesTERMINATEDPHASE1, PHASE22020-06-092024-04-042024-04-04
NCT05238714Excretion Balance, Pharmacokinetics, and Metabolism Following of [14C]-Venglustat Administration in Healthy Male SubjectsCOMPLETEDPHASE12020-05-262020-06-262020-06-26
NCT04398706Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and InfantsCOMPLETEDPHASE22020-05-222023-08-102023-08-10
NCT04368429Study of a Quadrivalent Meningococcal Conjugate Vaccine as a Single Dose Compared With a Single Dose of a Meningococcal Reference Vaccine in Children, Adolescents, and Adults 2 to 55 Years of AgeCOMPLETEDPHASE32020-05-222020-11-072020-11-07
NCT04410965Evaluation of the Relationship Between ABCG2 Mutation and Teriflunomide Exposure and Safety in Chinese RMS Patients Treated With Teriflunomide 14 mg Once Daily for 24 WeeksCOMPLETEDPHASE42020-05-202021-07-122021-07-12
NCT06064539Study of Drug-drug Interaction of the Effects of Gemfibrozil and Rifampicin on SAR442168 in Healthy Adult SubjectsCOMPLETEDPHASE12020-05-182020-07-082020-07-08
NCT04003818Efficacy and Safety of Teicoplanin in CDADTERMINATEDPHASE42020-05-152021-03-102021-01-21
NCT04349306Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute LeukemiaCOMPLETEDPHASE42020-05-142021-03-122021-03-12
NCT04333654Hydroxychloroquine in Outpatient Adults With COVID-19TERMINATEDPHASE12020-04-122020-05-262020-05-26
NCT04327388Sarilumab COVID-19COMPLETEDPHASE32020-03-282020-09-022020-07-31
NCT04270942At-Risk for Type 1 Diabetes Extension Study (TN-10 Extension)COMPLETEDPHASE22020-02-262024-01-222024-01-22
NCT04222985Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2TERMINATEDPHASE12020-02-182021-05-192021-05-19
NCT04154956SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer PatientsACTIVE_NOT_RECRUITINGPHASE32020-02-062026-03-312023-09-22
NCT04191382Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast CancerTERMINATEDPHASE22020-02-042021-05-282021-04-30
NCT03974113Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or BACTIVE_NOT_RECRUITINGPHASE32020-01-282026-12-152026-08-15
NCT04202679Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (PRIME2)COMPLETEDPHASE32020-01-162021-11-222021-08-30
NCT04142086Dose-ranging Study of an Investigational Yellow Fever Candidate Vaccine in AdultsCOMPLETEDPHASE12020-01-152021-06-242021-06-24
NCT04210349Study of Shenzhen Quadrivalent Inactivated Influenza Vaccine Versus the Shenzhen Trivalent Inactivated Influenza Vaccine in Chinese Subjects From 6 Months of AgeCOMPLETEDPHASE32020-01-092020-12-012020-12-01
NCT04143061Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, Children, and Toddlers in India and Healthy Adolescents and Children in the Republic of South AfricaCOMPLETEDPHASE32019-12-302023-01-282023-01-28
NCT04183335Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME)COMPLETEDPHASE32019-12-122022-02-032021-11-12
NCT04180488Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID)COMPLETEDPHASE32019-12-112024-10-252024-08-01
NCT04166942KD025 Hepatic Impairment Study With Normal Hepatic Function and Subjects With Varying Degrees of Hepatic ImpairmentCOMPLETEDPHASE12019-12-112022-06-062022-06-06
NCT04161495A Phase 3 Open-label Interventional Study of Intravenous Recombinant Coagulation Factor VIII Fc-von Willebrand Factor-XTEN Fusion Protein, Efanesoctocog Alfa (BIVV001), in Patients With Severe Hemophilia ACOMPLETEDPHASE32019-11-192022-02-032022-02-03
NCT04171310Study of Excretion Balance and Pharmacokinetics of [14C]-SAR442168 in Healthy Male SubjectsCOMPLETEDPHASE12019-11-132019-12-302019-12-30
NCT04144179Safety and Immunogenicity of Quadrivalent Recombinant Influenza Vaccine Formulations Containing Different H3 Hemagglutinin Antigens in Healthy Adult Subjects 18 to 30 Years of AgeCOMPLETEDPHASE12019-11-062020-02-242020-02-24
NCT02741128Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive AdultsCOMPLETEDPHASE22019-11-062023-01-192023-01-19
NCT04137887Study to Evaluate the Effectiveness of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Adults 65 Years of Age and OlderTERMINATEDPHASE32019-11-042020-05-312020-05-31
NCT02855268Study of Lademirsen (SAR339375) in Patients With Alport SyndromeTERMINATEDPHASE22019-11-022022-09-222022-09-22
NCT04024228Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Europeans Adults 60 Years of Age and OlderCOMPLETEDPHASE32019-10-282020-06-052020-01-09
NCT04059484Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast CancerTERMINATEDPHASE22019-10-222025-01-022022-02-15
NCT04074187A Trial of Caplacizumab in Japanese Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)COMPLETEDPHASE2, PHASE32019-10-212021-05-192021-05-19
NCT04127786Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines, Given in a Pre-exposure Regimen to Children and Adults and as Single Booster Dose to a Subset of AdultsCOMPLETEDPHASE32019-10-212025-04-242020-03-25
NCT04075513Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes PatientsCOMPLETEDPHASE42019-10-092021-09-162021-09-16
NCT04142242Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49COMPLETEDPHASE32019-10-042022-05-252020-04-01
NCT04109222Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, RespectivelyCOMPLETEDPHASE42019-09-302019-12-102019-12-10
NCT04106544A Prospective and Retrospective Cohort Study in Patients With Chronic Forms of Acid Sphingomyelinase Deficiency (ASMD)COMPLETEDNA2019-09-272023-05-152023-05-15
NCT03996291Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple SclerosisCOMPLETEDPHASE22019-09-232024-11-262024-11-26
NCT03890367Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to Two Meningococcal Reference Vaccines in European ToddlersCOMPLETEDPHASE32019-09-122020-10-142020-10-14
NCT04084769Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4)COMPLETEDPHASE32019-09-032020-09-142020-09-14
NCT04033367SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"COMPLETEDPHASE42019-08-222021-10-062021-10-06
NCT04000282First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE12019-08-192023-09-042022-08-29
NCT04045795Multi-center, Open-label, Phase 1b Study in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)COMPLETEDPHASE12019-08-062024-03-272024-03-27
NCT03860844Isatuximab in Combination With Chemotherapy in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid LeukemiaTERMINATEDPHASE22019-08-062023-05-262022-09-12
NCT03770728Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With SulfonylureaTERMINATEDPHASE32019-08-012020-12-272020-11-28
NCT03965962Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines in a Simulated Post-Exposure Regimen in AdultsCOMPLETEDPHASE32019-07-012021-07-012020-12-22
NCT03794336Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High CV Risk or CHD Treated With Aspirin and Inadequately Controlled With Metformin Monotherapy or Drug NaiveCOMPLETEDPHASE42019-06-292020-12-142020-12-14
NCT03919799KD025 in Subjects With Diffuse Cutaneous Systemic SclerosisTERMINATEDPHASE22019-06-262023-02-172022-08-09
NCT03958799A Study to Describe the Safety Profile and Compare the Immune Response of 4 Different Formulations of an Investigational Tdap Vaccine When Compared to Licensed Tdap Vaccine in Young Adults in CanadaCOMPLETEDPHASE12019-06-262021-04-062021-04-06
NCT04009681A Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)ACTIVE_NOT_RECRUITINGPHASE1, PHASE22019-06-202025-112025-11
NCT03437720Assessment of the Safety and Effect of SAR425899 Versus Placebo for the Treatment of Non-alcoholic Fatty Liver DiseaseWITHDRAWNPHASE22019-05-232021-08-252021-08-25
NCT03909451Sotagliflozin Multiple-dose Study in Healthy Chinese SubjectsCOMPLETEDPHASE12019-04-282019-08-192019-08-19
NCT04521738First-in-human Study to Assess Safety and Tolerability of a Single Subcutaneous Dose of SAR441255 in Lean to Overweight SubjectsCOMPLETEDPHASE12019-04-252019-09-262019-09-26
NCT03930732Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate-to-severe COPD With Type 2 InflammationCOMPLETEDPHASE32019-04-152023-05-022023-02-08
NCT03869866Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) in Older Adults in Turkey and LebanonCOMPLETEDPHASE32019-04-092022-03-182022-03-18
NCT03889639Dose-finding Study for SAR442168 in Relapsing Multiple SclerosisCOMPLETEDPHASE22019-03-292020-01-022020-01-02
NCT03856619To Evaluate the Safety and Efficacy of Teriflunomide in Patients With Relapsing Forms of Multiple SclerosisCOMPLETEDPHASE42019-03-272022-05-132022-05-13
NCT03903016A Bioequivalence Study Comparing Two Different Strengths Formulations of Insulin Lispro in Patients With Type 1 DiabetesCOMPLETEDPHASE12019-03-262019-08-192019-08-19
NCT03816839Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2)TERMINATEDPHASE12019-03-252024-12-262020-10-27
NCT03874715Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin GlargineCOMPLETEDPHASE32019-03-112020-07-082020-07-08
NCT03767543Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)COMPLETEDPHASE32019-03-112020-10-232020-10-23
NCT03430089Safety of a Single Dose or Two Doses of Shenzhen Quadrivalent Influenza VaccineCOMPLETEDPHASE12019-02-222019-06-062019-06-06
NCT03798080Comparison of the Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Ratio Combination to Insulin Glargine in Patients With Type 2 Diabetes Insufficiently Controlled on Basal InsulinCOMPLETEDPHASE32019-02-192020-12-012020-12-01
NCT03798054Evaluation of Insulin Glargine/Lixisenatide Fixed Ratio Combination in Patients With Type 2 Diabetes Insufficiently Controlled With Oral Antidiabetic Drug(s)COMPLETEDPHASE32019-02-152021-03-012021-03-01
NCT03784898Collection of Blood Samples From Patients With Relapsing MS Who Developed ITP After Receiving LemtradaCOMPLETEDPHASE42019-02-082019-12-112019-12-11
NCT03468829Efficacy and Safety of ALX-0171 in Adult Hematopoietic Stem Cell Transplant (HSCT) Recipients Who Present With Respiratory Syncytial Virus (RSV) InfectionWITHDRAWNPHASE22019-022020-052020-05
NCT03782532Efficacy and Safety Study of Dupilumab in Patients With Persistent AsthmaCOMPLETEDPHASE32019-01-252022-05-212022-05-21
NCT03776227A Bioequivalence Study Testing Two Formulations of Sotagliflozin in Healthy Male and Female Subjects Under Fasted ConditionsCOMPLETEDPHASE12019-01-252019-04-222019-04-22
NCT03765437Safety of a Quadrivalent Influenza Vaccine (VaxigripTetra™) in Subjects Aged 6 Months and Older in VietnamCOMPLETEDPHASE32019-01-152019-03-172019-03-17
NCT03802487Study To Determine Bioavailability of Sotagliflozin in Healthy Male and Female SubjectsCOMPLETEDPHASE12019-01-142019-03-282019-03-28
NCT03754790Long-term Safety and Efficacy Study of Fitusiran in Patients With Hemophilia A or B, With or Without Inhibitory Antibodies to Factor VIII or IXACTIVE_NOT_RECRUITINGPHASE32019-01-092026-11-052026-11-05
NCT03762265A Study of PRN1008 in Patients With PemphigusTERMINATEDPHASE32019-01-082021-12-172021-07-30
NCT03871348A First-in-Human Dose Escalation and Expansion Study to Evaluate Intratumoral Administration of SAR441000 as Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsTERMINATEDPHASE12019-01-032024-02-212022-07-25
NCT03912259Evaluation of Dupilumab in Chinese Adult Patients With Moderate to Severe Atopic DermatitisCOMPLETEDPHASE32018-12-192020-02-142020-02-14
NCT03760991Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus Uncontrolled on Other Kinds of InsulinCOMPLETEDPHASE42018-12-182020-09-232020-09-23
NCT03757351Study to Evaluate DNL747 in Subjects With Amyotrophic Lateral SclerosisTERMINATEDPHASE12018-12-142020-06-182020-06-18
NCT03547271Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in EuropeCOMPLETEDPHASE32018-12-142023-05-242023-05-17
NCT03769181A Study of Isatuximab-based Therapy in Participants With LymphomaTERMINATEDPHASE1, PHASE22018-12-112022-11-082022-11-08
NCT03687333Evaluate Efficacy and Safety in Chinese Patients With Infantile-Onset Pompe Disease With One Year Alglucosidase Alfa TreatmentCOMPLETEDPHASE42018-12-042020-12-302020-12-30
NCT06698198Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine Candidate in Healthy Adults (19-49 Years)COMPLETEDPHASE12018-12-032019-09-302019-09-30
NCT03761134Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Metformin With or Without SulfonylureaTERMINATEDPHASE32018-11-302020-04-292020-04-29
NCT03760965Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Diet and ExerciseTERMINATEDPHASE32018-11-272020-04-242020-04-24
NCT03600805Evaluation of Efficacy and Safety of Sarilumab in Patients With GCATERMINATEDPHASE32018-11-202020-11-242020-11-24
NCT03713684Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)TERMINATEDPHASE32018-11-092021-01-042020-11-20
NCT05845996Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous and Subcutaneous Single and Repeated Doses of SAR441344 in Healthy Adult SubjectsCOMPLETEDPHASE12018-11-082020-04-102020-04-10
NCT03594955First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic SyndromeTERMINATEDPHASE1, PHASE22018-10-242021-02-062021-02-06
NCT03733717Evaluation of Pharmacokinetics, Safety, and Preliminary Efficacy of Isatuximab in Chinese Patients With Relapsed and/or Refractory Multiple MyelomaCOMPLETEDPHASE12018-10-222023-08-252020-09-06
NCT03630705Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and MexicoCOMPLETEDPHASE32018-10-172022-02-182022-02-18
NCT03640481Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic TherapyTERMINATEDPHASE22018-10-112023-12-112023-12-11
NCT03632720Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United KingdomCOMPLETEDPHASE32018-10-102022-12-052022-12-05
NCT03600818Evaluation of the Efficacy and Safety of Sarilumab in Patients With Polymyalgia RheumaticaTERMINATEDPHASE32018-10-092021-05-192021-05-19
NCT03698279Safety and Immunogenicity of Different Dosages of High-Dose Quadrivalent Influenza Vaccine in Children 6 Months to 17 Years of AgeCOMPLETEDPHASE22018-10-092019-10-162019-10-16
NCT03681158Study of Excretion Balance and Pharmacokinetics of [14C]-Sodium Valproate (3.7 MBq) in Healthy Postmenopausal or Permanently Sterile Female SubjectsCOMPLETEDPHASE12018-10-052019-04-112019-04-11
NCT03687554Effect of Venglustat in Patients With Renal ImpairmentCOMPLETEDPHASE12018-10-052019-02-272019-02-27
NCT03691610Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and ToddlersCOMPLETEDPHASE32018-10-042023-10-202023-10-20
NCT03523728A Medical Research Study Designed to Determine if Venglustat Can be a Future Treatment for ADPKD PatientsTERMINATEDPHASE2, PHASE32018-10-042021-08-032021-08-03
NCT03700242Imovax® Rabies and VERORAB® Immunogenicity and Safety After One Week 2-sites Intradermal or 1-site Intramuscular Pre-Exposure Prophylaxis Regimens, Followed by a Simulated Post-Exposure Prophylaxis Regimen at One YearCOMPLETEDPHASE32018-09-262020-04-082019-01-19
NCT03684642Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With MetforminTERMINATEDPHASE32018-09-262020-11-172020-10-13
NCT03673462Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and ToddlersCOMPLETEDPHASE32018-09-172023-03-162023-03-16
NCT03664882Study Evaluating the Efficacy and Safety of Fexofenadine in Subjects Suffering From Seasonal Allergic Rhinitis in Presence of PollutantsCOMPLETEDPHASE32018-09-172019-01-032019-01-03
NCT03660839Study to Investigate the Clinical and Parasiticidal Activity and Pharmacokinetics of Different Doses of Artefenomel and Ferroquine in Patients With Uncomplicated Plasmodium Falciparum MalariaCOMPLETEDPHASE22018-09-112019-11-062019-11-06
NCT03617523Safety and Immunogenicity of Fluzone® Quadrivalent, Flublok® Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2018-2019 FormulationsCOMPLETEDPHASE42018-09-102018-11-122018-11-12
NCT03510715An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Homozygous Familial HypercholesterolemiaCOMPLETEDPHASE32018-08-312020-02-172020-02-17
NCT03620747Continuation of TRAVERSE- LTS12551 Evaluating Dupilumab Safety in Patients With Asthma (Long-Term Follow-Up)COMPLETEDPHASE32018-08-302022-02-182022-02-18
NCT06421714A Study of the Safety, Tolerability, and Pharmacokinetics of Orally Administered Venglustat and Itraconazole in Healthy Adult Male ParticipantsCOMPLETEDPHASE12018-08-162018-10-142018-10-14
NCT02991469A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)RECRUITINGPHASE22018-08-092029-02-192026-04-01
NCT03637764Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced MalignanciesTERMINATEDPHASE1, PHASE22018-08-062022-05-112022-05-11
NCT03549871A Study of Fitusiran in Severe Hemophilia A and B Patients Previously Receiving Factor or Bypassing Agent ProphylaxisCOMPLETEDPHASE32018-07-252022-03-252022-01-20
NCT03546907Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)COMPLETEDPHASE22018-07-162020-02-212019-10-03
NCT03583658Efficacy and Safety Study of New Ambroxol Hardboiled Lozenges in Acute PharyngitisCOMPLETEDPHASE32018-06-302018-09-022018-09-02
NCT03560466Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)COMPLETEDPHASE32018-06-212025-04-012025-04-01
NCT03529123Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 Diabetes (LixiLan-India)COMPLETEDPHASE32018-06-192019-11-252019-11-25
NCT03510884An Efficacy and Safety Study of Alirocumab in Children and Adolescents With Heterozygous Familial HypercholesterolemiaCOMPLETEDPHASE32018-05-312022-08-052021-01-14
NCT03436498Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus PatientsCOMPLETEDPHASE12018-05-102018-10-062018-10-06
NCT03463135A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent PatientsCOMPLETEDPHASE12018-05-072020-03-102019-05-08
NCT03496298Effect of Efpeglenatide on Cardiovascular OutcomesTERMINATEDPHASE32018-04-272020-12-102020-12-10
NCT03537508Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the USCOMPLETEDPHASE32018-04-252023-09-222023-09-22
NCT03376802A Clinical Study to Investigate the Effect of SAR425899 on Energy Expenditure in Obese SubjectsCOMPLETEDPHASE12018-04-182018-12-272018-12-27
NCT03485677Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3ACTIVE_NOT_RECRUITINGPHASE32018-04-112025-11-202025-11-20
NCT03415178Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying TherapyCOMPLETEDPHASE32018-03-292018-08-092018-08-09
NCT03395210A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP)ACTIVE_NOT_RECRUITINGPHASE22018-03-222025-12-312023-01-31
NCT03347422A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Without A Recent History of Blood TransfusionCOMPLETEDPHASE32018-03-172021-12-032021-12-03
NCT03387852Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma ParticipantsCOMPLETEDPHASE22018-03-122019-08-072019-03-21
NCT03462069Comparison of Pharmacodynamic Effects of Sotagliflozin and Empagliflozin in T2DM Patients With Mild to Moderate HypertensionCOMPLETEDPHASE22018-03-122019-04-182019-04-18
NCT03462017Pharmacodynamic Study to Assess the Effects of Repeated Dosing of SAR247799 on Endothelial Function in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE12018-03-072018-12-222018-12-22
NCT03347396A Study to Assess the Efficacy and Safety of BIVV009 (Sutimlimab) in Participants With Primary Cold Agglutinin Disease Who Have a Recent History of Blood Transfusion (Cardinal Study)COMPLETEDPHASE32018-03-052021-10-052021-10-05
NCT03449758Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid ArthritisCOMPLETEDPHASE42018-03-052019-07-312019-07-31
NCT03417245A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without InhibitorsCOMPLETEDPHASE32018-03-012021-07-142021-01-26
NCT03418571Evaluation of ALX-0171 in Japanese Children Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract InfectionTERMINATEDPHASE22018-03-012018-10-242018-10-24
NCT03476135Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine in ChildrenCOMPLETEDPHASE32018-02-272018-09-102018-09-10
NCT03194867Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) PatientsCOMPLETEDPHASE1, PHASE22018-02-212023-04-052023-04-05
NCT03434119Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic AgentsTERMINATEDPHASE32018-02-202019-01-072019-01-07
NCT03417102A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With InhibitorsCOMPLETEDPHASE32018-02-142021-06-232020-11-25
NCT03406000Phase 4 Study to Evaluate Treatment Optimization With Once-daily Insulin Glargine 300 U/mLCOMPLETEDPHASE42018-01-222019-02-042019-02-04
NCT03359837Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin TherapyCOMPLETEDPHASE42018-01-202020-06-292020-06-29
NCT03414736A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension PeriodCOMPLETEDPHASE12018-01-192018-10-052018-10-05
NCT03414723A Drug-Drug Interaction Study Between Sotagliflozin and RamiprilCOMPLETEDPHASE12018-01-152018-03-102018-03-10
NCT03367819Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced MalignanciesTERMINATEDPHASE1, PHASE22018-01-042021-03-102021-03-10
NCT03387657A Drug to Drug Interaction Study of Sotagliflozin With HydrochlorothiazideCOMPLETEDPHASE12018-01-032018-03-022018-03-02
NCT06188325A Study to Evaluate Pharmacokinetic Parameters of Eliglustat in Healthy Volunteers Who Are CYP2D6 Extensive or Poor MetabolizersCOMPLETEDPHASE12018-01-012018-03-262018-03-26
NCT03373786A Study of RG-012 in Subjects With Alport SyndromeCOMPLETEDPHASE12017-12-222019-05-202019-05-20
NCT03350191A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus PatientsCOMPLETEDPHASE12017-12-202018-06-072018-06-07
NCT03391193Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza VaccineCOMPLETEDPHASE32017-12-192018-08-252018-03-28
NCT03916601Comparison of Exposure and Activity of SAR341402 Mix 70/30 to NovoLog Mix 70/30, NovoMix 30 and SAR341402 Rapid-acting Solution in Patients With Type 1 Diabetes MellitusCOMPLETEDPHASE12017-12-132018-03-222018-03-22
NCT03093480A Study to Evaluate Efficacy of rFVIIIFc for Immune Tolerance Induction (ITI) in Severe Hemophilia A Participants With Inhibitors Undergoing the First ITI Treatment (verITI-8 Study)COMPLETEDPHASE42017-12-082021-02-162020-05-04
NCT03319667A Study to Investigate the Clinical Benefit of Isatuximab in Combination With Bortezomib, Lenalidomide and Dexamethasone in Adults With Newly Diagnosed Multiple Myeloma Not Eligible for TransplantACTIVE_NOT_RECRUITINGPHASE32017-12-072027-06-302026-04-05
NCT03344029Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 YearsCOMPLETEDPHASE42017-11-032018-05-222018-05-22
NCT03275285Multinational Clinical Study Comparing Isatuximab, Carfilzomib And Dexamethasone To Carfilzomib And Dexamethasone In Relapse And/Or Refractory Multiple Myeloma PatientsCOMPLETEDPHASE32017-10-252025-01-032022-01-14
NCT03368664A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMTACTIVE_NOT_RECRUITINGPHASE32017-10-242025-122021-05-04
NCT03310944Comparison of Sotagliflozin Prototype Tablets With Reference Tablet in Healthy SubjectsCOMPLETEDPHASE12017-10-182017-12-082017-12-08
NCT03324113Evaluation of SAR408701 in Japanese Patients With Advanced Malignant Solid TumorsCOMPLETEDPHASE12017-10-172022-12-262022-11-18
NCT03312478Association of Type 1 Diabetes Mellitus in Offsprings With Positive Parental History of DiabetesCOMPLETEDPHASE42017-10-132018-08-192018-08-19
NCT03019406A Study to Assess Safety and Efficacy of Avalglucosidase Alfa Administered Every Other Week in Pediatric Patients With Infantile-onset Pompe Disease Previously Treated With Alglucosidase AlfaACTIVE_NOT_RECRUITINGPHASE22017-10-122026-12-302019-09-30
NCT03203642Study of the Efficacy and Safety of Tesevatinib in Subjects With ADPKDCOMPLETEDPHASE22017-10-122022-01-252022-01-25
NCT03236311A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCITERMINATEDPHASE22017-10-122018-07-232018-07-23
NCT03284957Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast CancerTERMINATEDPHASE1, PHASE22017-09-202024-11-082024-11-08
NCT03260868Evaluation of Virtual Versus Traditional Study Conducted in a Group Pilot Study in Adult Patients With Type 1 Diabetes Mellitus (eStudy)TERMINATEDPHASE42017-09-192018-11-222018-11-22
NCT03233217Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Patients ≥65 YearsCOMPLETEDPHASE1, PHASE22017-09-152017-11-282017-11-28
NCT03308825Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza VaccinesCOMPLETEDPHASE42017-09-112017-11-222017-11-22
NCT03282240Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the USCOMPLETEDPHASE32017-09-082018-04-192017-11-02
NCT03205163A Safety, Tolerability, and Pharmacokinetics Study of a Single Intravenous Injection of Recombinant Coagulation Factor VIII Fc - Von Willebrand Factor - XTEN Fusion Protein (rFVIIIFc-VWF-XTEN) (BIVV001) in Previously Treated Adults With Severe Hemophilia A (EXTEN-A)COMPLETEDPHASE1, PHASE22017-08-282018-11-122018-11-12
NCT03190369Randomized Study of the Efficacy and Safety of a Single Dose of Synvisc-One® in Chinese Patients With Symptomatic Osteoarthritis of the KneeCOMPLETEDPHASE32017-08-212019-01-282019-01-28
NCT03099122A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney TransplantCOMPLETEDPHASE42017-08-162019-11-122019-11-12
NCT03275454A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple- Dose BIVV009 in Participants With Chronic Immune Thrombocytopenia (ITP)COMPLETEDPHASE12017-08-142021-02-162021-02-16
NCT03211858Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin GlargineCOMPLETEDPHASE32017-08-022019-01-122018-07-16
NCT03211195Sotagliflozin Bioequivalence StudyCOMPLETEDPHASE12017-06-292017-08-222017-08-22
NCT03174548A Study to Evaluate the Effect of Food on the Pharmacokinetics of Sotagliflozin and to Explore the Relative Bioavailability in Healthy SubjectsCOMPLETEDPHASE12017-06-122017-09-152017-09-15
NCT03192345A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and Cemiplimab in Patients With Advanced Solid TumorsCOMPLETEDPHASE12017-06-092022-01-172021-12-21
NCT03001011Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In ChinaCOMPLETEDPHASE32017-06-072019-08-162019-08-16
NCT03172208Caplacizumab Single and Multiple Dose Study in Healthy Japanese and White Subjects.COMPLETEDPHASE12017-06-052017-10-192017-10-19
NCT02803918A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)COMPLETEDPHASE12017-05-172020-01-272020-01-27
NCT02948959Evaluation of Dupilumab in Children With Uncontrolled AsthmaCOMPLETEDPHASE32017-04-212020-08-262020-08-26
NCT03145766Immunogenicity and Safety of a Purified Vero Rabies VaccineCOMPLETEDPHASE22017-04-172018-01-082018-01-08
NCT02984683Study Evaluating Efficacy and Safety of SAR566658 Treatment in Patients With CA6 Positive Metastatic Triple Negative Breast CancerTERMINATEDPHASE22017-03-232018-09-072018-09-07
NCT03514732Study to Evaluate Improvements of the Quality of Sleep With NOVANUIT® Triple Action in Healthy Volunteers With Sleep DisordersCOMPLETEDPHASE12017-03-172017-07-052017-07-05
NCT03070678Interaction Study to Evaluate the Effects of Mefenamic Acid on the Pharmacokinetics and Pharmacodynamics of Sotagliflozin in Healthy Male and Female SubjectsCOMPLETEDPHASE12017-03-142017-04-182017-04-18
NCT02999633Safety and Efficacy of Isatuximab in Lymphoblastic LeukemiaTERMINATEDPHASE22017-03-082017-11-142017-11-14
NCT03063580Effect of Rifampicin on the Pharmacokinetics and Pharmacodynamics of SotagliflozinCOMPLETEDPHASE12017-02-272017-05-122017-05-12
NCT02955797Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in ToddlersCOMPLETEDPHASE32017-02-242017-10-262017-10-26
NCT03069963PH Metry Study to Compare the Antacid Activity of Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult SubjectsCOMPLETEDPHASE12017-02-242017-04-232017-04-23
NCT02941367Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During RamadanCOMPLETEDPHASE42017-02-232017-08-042017-08-04
NCT02910518A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes MellitusCOMPLETEDPHASE12017-02-172017-05-032017-05-03
NCT03077438Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 YearsCOMPLETEDPHASE32017-02-172017-10-102017-10-10
NCT03065816Scintigraphy Study to Compare the Antireflux Activity of the Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult SubjectsCOMPLETEDPHASE12017-02-092017-05-022017-05-02
NCT02520102Open Label Study of Sargramostim Among Patients Receiving Myelosuppressive Induction Chemotherapy for Acute Myelogenous LeukemiaWITHDRAWNPHASE22017-022017-02-282017-02-28
NCT02859896Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on DialysisTERMINATEDPHASE32017-01-192025-06-112025-06-11
NCT02979431Dose Ranging Study of ALX-0171 in Infants Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract InfectionCOMPLETEDPHASE22017-01-112018-05-252018-05-25
NCT02843035Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 With Venglustat Monotherapy ExtensionACTIVE_NOT_RECRUITINGPHASE22017-01-042026-10-302026-10-30
NCT02990338Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma PatientsCOMPLETEDPHASE32016-12-222023-11-012018-11-22
NCT02921971Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic SclerosisCOMPLETEDPHASE22016-12-212019-04-012019-01-14
NCT02992418Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy SubjectsTERMINATEDPHASE32016-12-192019-12-102019-12-10
NCT02906020A Global Study to Assess the Drug Dynamics, Efficacy, and Safety of Venglustat (GZ/SAR402671) in Parkinson's Disease Patients Carrying a Glucocerebrosidase (GBA) Gene MutationTERMINATEDPHASE22016-12-152021-05-272020-12-18
NCT02912468A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal PolypsCOMPLETEDPHASE32016-12-052018-07-052018-07-05
NCT02973321A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE22016-12-022017-12-272017-12-27
NCT02977533A Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple SclerosisCOMPLETEDPHASE12016-12-012018-05-162018-05-16
NCT02993757Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®COMPLETEDPHASE32016-12-012019-05-272019-05-27
NCT03317015A Study to Assess Efficacy and Safety of Nasacort® Nasal Spray in Comparison With Flixonase® Nasal Spray in Adults Suffering From Perennial Allergic Rhinitis (PAR)COMPLETEDPHASE32016-11-302017-07-102017-07-10
NCT02954692A Study to Evaluate the Effectiveness and Safety Initiation and Titration of Insulin Glargine (U300) in Insulin-naïve Patients With Type 2 Diabetes Mellitus (T2DM) Controlled on Oral Antidiabetic Drug Treatment in TurkeyCOMPLETEDPHASE42016-11-302017-12-222017-12-22
NCT02979015A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous (SC) Administered Alirocumab in Healthy Chinese SubjectsCOMPLETEDPHASE12016-11-292017-11-272017-11-27
NCT02898454Controlled Clinical Study of Dupilumab in Patients With Nasal PolypsCOMPLETEDPHASE32016-11-282018-11-162018-08-27
NCT02979535Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix®COMPLETEDPHASE32016-11-162019-03-252019-03-25
NCT02984982Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With HypercholesterolemiaCOMPLETEDPHASE42016-11-152018-07-272018-07-27
NCT03205371Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in ToddlersCOMPLETEDPHASE32016-11-072018-07-192018-07-19
NCT02782741Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies Avalglucosidase Alfa and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe DiseaseCOMPLETEDPHASE32016-11-022023-05-312020-03-19
NCT02667496Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's DiseaseWITHDRAWNPHASE22016-112017-03-312017-03-31
NCT02878603Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)COMPLETEDPHASE32016-10-062020-10-232020-10-23
NCT02940379A Drug to Drug Interaction Study of Sotagliflozin With Midazolam and MetoprololCOMPLETEDPHASE12016-102016-122016-12
NCT02915302Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy ChildrenCOMPLETEDPHASE42016-09-232017-03-062017-03-06
NCT02841995A Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Chronic Graft Versus Host DiseaseCOMPLETEDPHASE22016-09-152022-05-122022-05-12
NCT02908269Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 FormulationsCOMPLETEDPHASE42016-09-152016-12-092016-12-09
NCT02890992An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial HypercholesterolemiaCOMPLETEDPHASE22016-09-152019-02-222018-09-13
NCT02836704Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)COMPLETEDPHASE42016-09-092018-04-262018-04-26
NCT02776735An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)COMPLETEDPHASE22016-09-062023-12-272022-04-08
NCT02812706Isatuximab Single Agent Study in Japanese Relapsed AND Refractory Multiple Myeloma PatientsCOMPLETEDPHASE1, PHASE22016-09-052022-09-282018-07-31
NCT02855684Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic TherapyCOMPLETEDPHASE32016-08-242018-08-062018-08-06
NCT02842359Evaluation of the Fixed-dose Combination of Irbesartan/Atorvastatin in Type 2 Diabetic Patients Diagnosed With Hyperlipidemia and HypertensionCOMPLETEDPHASE42016-08-232018-04-192018-04-19
NCT02715726Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With HypercholesterolemiaCOMPLETEDPHASE32016-07-272018-08-062018-08-06
NCT02864927Postmarketing Surveillance Study for Use of Menactra® in the Republic of KoreaCOMPLETEDPHASE42016-07-212019-06-122019-06-12
NCT02845271Proof-of-concept Study to Assess the Efficacy, Tolerability and Safety of a Single Intraarticular Dose of GZ389988 Versus Placebo in Patients With Painful Osteoarthritis of the KneeCOMPLETEDPHASE22016-07-212017-09-132017-06-28
NCT02842866Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and OlderCOMPLETEDPHASE32016-07-152017-02-132017-02-13
NCT02842853Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate VaccineCOMPLETEDPHASE32016-07-152017-02-282017-02-28
NCT02817451DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected InfantsCOMPLETEDPHASE32016-07-142019-02-222019-02-22
NCT02787551Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension PeriodCOMPLETEDPHASE32016-07-062018-11-172018-05-25
NCT02824198Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose ScheduleCOMPLETEDPHASE22016-07-012019-01-182017-03-18
NCT02640404Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in VietnamCOMPLETEDPHASE22016-06-062016-12-052016-12-05
NCT02752828Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in JapanCOMPLETEDPHASE32016-05-232018-03-122018-03-12
NCT02738151Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor AgonistCOMPLETEDPHASE42016-05-192017-08-152017-08-15
NCT02752412Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic DrugsCOMPLETEDPHASE32016-05-172018-10-042018-10-04
NCT02749890Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Lixisenatide on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in JapanCOMPLETEDPHASE32016-05-092018-052018-05
NCT02688933A Study Comparing the Efficacy and Safety of the Morning Injection of Toujeo Versus Lantus in Patients With Type 1 Diabetes MellitusCOMPLETEDPHASE42016-05-052017-06-192017-06-19
NCT02628444Immunogenicity and Safety of Different Vaccination Schedules of Tetravalent Dengue Vaccine in Healthy Subjects 9 to 50 Years of AgeCOMPLETEDPHASE22016-05-022020-04-292020-04-29
NCT02752906Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate VaccineCOMPLETEDPHASE32016-04-152016-12-192016-12-19
NCT02623725Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose ScheduleCOMPLETEDPHASE22016-04-142018-10-282016-11-23
NCT02735044Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Children and Adolescents With Type 1 Diabetes MellitusCOMPLETEDPHASE32016-04-142018-12-202018-05-31
NCT02635243A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced HypoglycemiaWITHDRAWNPHASE12016-042016-112016-11
NCT02331810Pharmacodynamics Assessment Study After Single Subcutaneous Dose Of SAR113244 Versus Placebo In Lupus Male And Female PatientsWITHDRAWNPHASE12016-042017-052017-05
NCT02713477Postprandial Glucodynamic Response to Insulin Glargine/Lixisenatide Fixed Ratio Combination in Japanese Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE12016-042016-062016-06
NCT02642159Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)COMPLETEDPHASE42016-03-152017-05-152017-03-22
NCT02697474Anti-Hep B Antibodies at Age 9 to 10 Years After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine.COMPLETEDPHASE32016-022017-012016-06
NCT02573233Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With AsthmaCOMPLETEDPHASE22016-01-272018-01-032018-01-03
NCT02664103Study of Capecitabine and Cyclophosphamide Administered as a Single Pill in Patients With Advanced Breast CancerCOMPLETEDPHASE22016-01-232017-11-062017-11-06
NCT02704429A Study of PRN1008 in Adult Patients With Pemphigus VulgarisCOMPLETEDPHASE22016-01-222020-01-102019-12-18
NCT02967237Evaluation of Toujeo Insulin in Type 2 Diabetes Patients Inadequately Control With Their Basal Insulin TreatmentCOMPLETEDPHASE42016-01-042017-07-242017-07-24
NCT02967211A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulin in Patients Already Using Basal InsulinCOMPLETEDPHASE42015-12-212017-10-202017-10-20
NCT02004691Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase DeficiencyCOMPLETEDPHASE2, PHASE32015-12-182023-10-192021-03-15
NCT02583594A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple SclerosisCOMPLETEDPHASE12015-12-062021-03-012016-03
NCT02585674Comparison of MyStar DoseCoach to Routine Titration in Adult Patients With Type 2 Diabetes Mellitus Using ToujeoCOMPLETEDPHASE32015-122016-112016-11
NCT02633787Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately 4 Years EarlierCOMPLETEDPHASE42015-122016-032016-02
NCT02625636A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Doses of SAR438544 in Comparison to Placebo and Glucagon in Healthy Subjects and Type 1 Diabetes Mellitus PatientsCOMPLETEDPHASE12015-122016-022016-02
NCT02584504Efficacy and Safety of Alirocumab in Patients With Hypercholesterolemia Not Adequately Controlled With Non-statin Lipid Modifying Therapy or the Lowest Strength of StatinCOMPLETEDPHASE32015-11-302018-01-092017-04-05
NCT02606357Treatment of Type 2 Diabetes With Long Acting Basal Insulin in JordanCOMPLETEDPHASE42015-11-222017-11-272017-11-27
NCT02485691Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted AgentCOMPLETEDPHASE42015-11-092021-03-152019-03-27
NCT02967224A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo Compared to "Standard of Care" Basal Insulins in Insulin Naïve Patients Initiating InsulinCOMPLETEDPHASE42015-11-052017-10-162017-10-16
NCT02553317Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic PurpuraCOMPLETEDPHASE32015-112017-082017-08
NCT02610348Anti-Hep B Antibodies at Age 12 to 18 Months After Hep B Vaccine at Birth and DTaP-IPV-Hep B-PRP-T Hexavalent Vaccine Concomitantly With Prevnar® at 2, 4 and 6 Months of AgeCOMPLETEDNA2015-112016-032015-12
NCT02603510Assessment of the Safety of SAR342434 and Humalog® When Administered as Continuous Subcutaneous Insulin InfusionCOMPLETEDPHASE12015-112016-042016-04
NCT02435121A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET AmplificationCOMPLETEDPHASE22015-112016-012016-01
NCT02608125A Dose Escalation Study in Solid Tumors and a Dose Expansion Study of PRN1371 in Adult Patients With Metastatic Urothelial CarcinomaTERMINATEDPHASE12015-10-282020-06-232020-06-23
NCT02536755Phase 3b Study to Evaluate Skeletal Response to Eliglustat in Adult Patients Who Completed Phase 2 or Phase 3 StudiesCOMPLETEDPHASE32015-10-272021-06-242021-06-24
NCT02585778Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)COMPLETEDPHASE32015-10-232017-04-032017-04-03
NCT02587520Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy SubjectsCOMPLETEDPHASE1, PHASE22015-10-222017-02-212017-02-21
NCT02591290Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult SubjectsCOMPLETEDPHASE42015-10-202016-03-162016-03-16
NCT02528214Evaluation of Dupilumab in Patients With Severe Steroid Dependent AsthmaCOMPLETEDPHASE32015-10-152017-11-132017-09-20
NCT02575781A Study of SAR428926 in Patients With Advanced Solid TumorsCOMPLETEDPHASE12015-10-052018-062018-06
NCT02513186Study of Isatuximab Combined With Bortezomib + Cyclophosphamide + Dexamethasone (VCD) and Bortezomib + Lenalidomide + Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) Non Eligible for Transplant or No Intent for Immediate TransplantationCOMPLETEDPHASE12015-09-302024-01-222022-01-28
NCT02554773An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or BCOMPLETEDPHASE1, PHASE22015-09-182023-03-212023-03-21
NCT02545842Assessment Study of Three Different Fasting Plasma Glucose Targets in Chinese Patients With Type 2 Diabetes Mellitus (BEYOND III/FPG GOAL)COMPLETEDPHASE42015-09-072018-04-202018-04-20
NCT02514668A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple MyelomaCOMPLETEDPHASE12015-09-012021-12-022021-12-02
NCT02550197Immunogenicity and Safety of a Quadrivalent Influenza Vaccine Given by Intramuscular Route in Subjects Aged 18 to 60 YearsCOMPLETEDPHASE32015-092016-072016-04
NCT02553343A Study of the Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Subjects Aged 65 Years and OlderCOMPLETEDPHASE22015-092016-04-042016-04-04
NCT02536937A Study of the Effects of Renal Impairment on the Pharmacokinetics and Tolerability of Eliglustat TartrateCOMPLETEDPHASE12015-092017-012017-01
NCT02536911A Study of the Effects of Hepatic Impairment on the Pharmacokinetics and Tolerability of Eliglustat TartrateCOMPLETEDPHASE12015-092016-122016-12
NCT02563093Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in AdultsCOMPLETEDPHASE42015-092016-072015-12
NCT0253115228-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular HypertensionCOMPLETEDPHASE12015-092016-042016-04
NCT02502149Pharmacokinetics and Safety of rFVIIIFc Manufactured at 15,000 L (15K) ScaleCOMPLETEDPHASE32015-082017-062017-04
NCT02539108Safety and Immunogenicity of the 2015-2016 Formulation of Fluzone® Quadrivalent (Influenza Vaccine) Among Healthy ChildrenCOMPLETEDPHASE42015-082016-072015-12
NCT02517385Essentiale® Paste in Patients With Gastrointestinal Symptoms in Acute or Chronic Liver DiseasesCOMPLETEDPHASE32015-082016-062016-06
NCT02451358Study of a Single Dose or Two Doses of a Quadrivalent Influenza Vaccine in Subjects Aged 6 Months or Older in IndiaCOMPLETEDPHASE32015-07-272017-01-282017-01-28
NCT02497612To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine and Artefenomel in Adults and Children With Uncomplicated Plasmodium Falciparum MalariaTERMINATEDPHASE22015-07-252019-09-232019-09-23
NCT02502903Safety, Tolerability and Activity of BIVV009 in Healthy Volunteers and Patients With Complement Mediated DisordersCOMPLETEDPHASE12015-07-132021-03-312021-03-31
NCT02489344Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry DiseaseCOMPLETEDPHASE22015-07-072018-11-202018-11-20
NCT02518620An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumatoid ArthritisCOMPLETEDPHASE22015-072018-082018-08
NCT02437890A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus ErythematosusCOMPLETEDPHASE22015-072018-012018-01
NCT02503306Efficacy and Tolerability Study of Avanafil in RussiaCOMPLETEDPHASE32015-072016-032016-03
NCT02476006Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)COMPLETEDPHASE32015-06-232019-04-122019-04-12
NCT03546192Immunogenicity and Safety of Fluzone® Quadrivalent, Southern Hemisphere 2015 Formulation (Intramuscular Route)COMPLETEDPHASE42015-06-172015-07-172015-07-17
NCT02379390Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or EnzalutamideTERMINATEDPHASE22015-06-172018-05-102018-05-10
NCT02451137A "Real World" Trial to Determine Efficacy and Health Outcomes of Toujeo (ACHIEVE CONTROL REAL LIFE STUDY PROGRAM)COMPLETEDPHASE42015-06-162018-08-092018-03-02
NCT02492165Study of a Single Primary Dose Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV®) in Healthy SubjectsCOMPLETEDPHASE32015-062016-062016-03
NCT02283775SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM PatientsCOMPLETEDPHASE12015-05-152021-05-262021-05-26
NCT02345070Efficacy and Safety of SAR156597 in the Treatment of Idiopathic Pulmonary FibrosisCOMPLETEDPHASE22015-05-012017-08-142017-05-22
NCT02292654Safety, Tolerability, PK, and Efficacy Evaluation of Repeat Ascending Doses of Olipudase Alfa in Pediatric Patients <18 Years of Age With Acid Sphingomyelinase DeficiencyCOMPLETEDPHASE1, PHASE22015-05-012019-12-092019-12-09
NCT02404558Single-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid ArthritisCOMPLETEDPHASE12015-052016-032016-03
NCT02332577Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired PneumoniaTERMINATEDPHASE42015-04-302023-02-202023-02-20
NCT02414854Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest)COMPLETEDPHASE32015-04-272017-11-232017-07-29
NCT02428491Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After BirthCOMPLETEDPHASE32015-04-202017-01-112017-01-11
NCT02434822A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican RepublicCOMPLETEDPHASE32015-042016-072015-09
NCT02274740Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic PatientsTERMINATEDPHASE22015-042015-082015-08
NCT02441894Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate CancerCOMPLETEDPHASE42015-042016-112016-02
NCT02424942First-in-human Study With Ascending Single Intra-articular Doses of GZ389988 in Patients With Painful Osteoarthritis of the KneeCOMPLETEDPHASE12015-042016-072016-07
NCT02422654Taste Evaluation of Different Liquid Formulations With EliglustatCOMPLETEDPHASE12015-042015-052015-05
NCT03205358Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy ToddlersCOMPLETEDPHASE22015-03-312015-08-192015-08-19
NCT02287922A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid ArthritisCOMPLETEDPHASE22015-032016-072016-07
NCT02411825Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) PatientsCOMPLETEDPHASE12015-032016-012016-01
NCT02401243Study of Two Titration Algorithms With Insulin Glargine 300 Units/mL in Type 2 Diabetes Mellitus PatientsCOMPLETEDPHASE32015-032016-022016-02
NCT02401191A Study Assessing the Safety and Effectiveness of FEX60/PE10 Fixed Combination Tablet in Patients With Allergic RhinitisCOMPLETEDPHASE32015-032015-072015-07
NCT02373202A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)COMPLETEDPHASE32015-022016-112016-11
NCT02306811Efficacy and Safety of Vatelizumab in Patients Who Completed Treatment in Study DRI13839TERMINATEDPHASE22015-022016-072016-04
NCT02332590Efficacy and Safety of Sarilumab and Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (SARIL-RA-MONARCH)COMPLETEDPHASE32015-01-282020-12-292016-01-20
NCT02234323An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Previously Untreated Males With Severe Hemophilia ACOMPLETEDPHASE32015-01-122019-09-232019-09-23
NCT02255656Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409COMPLETEDPHASE42015-01-072020-07-152020-07-15
NCT05976373A Study to Investigate the Pharmacokinetics (PK), Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants.COMPLETEDPHASE12015-01-052015-03-302015-03-30
NCT02320721Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic MedicationsCOMPLETEDPHASE32015-012016-052016-05
NCT02309359A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid ArthritisCOMPLETEDPHASE22015-012016-082016-08
NCT02294474Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin GlargineCOMPLETEDPHASE32015-012016-022016-02
NCT02289963Evaluation of Alirocumab in Addition to Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia in South Korea and TaiwanCOMPLETEDPHASE32015-012016-042016-04
NCT02309320A Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171COMPLETEDPHASE1, PHASE22014-122016-022016-02
NCT02343926Phase 3 Study to Compare the Efficacy and Safety of Gemigliptin and Vildagliptin as Add-on Therapy to Metformin in People With Type 2 Diabetes Inadequately Controlled With MetforminCOMPLETEDPHASE32014-122016-042016-04
NCT02234310Study to Determine the Safety and Efficacy of rFIXFc in Previously Untreated Males With Severe Hemophilia BCOMPLETEDPHASE32014-11-132019-08-202019-08-20
NCT01410890Pharmacokinetics of Alglucosidase Alfa in Patients With Pompe DiseaseCOMPLETEDPHASE42014-11-032020-11-202020-11-20
NCT05976360A Study to Investigate the Pharmacokinetics, Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy ParticipantsCOMPLETEDPHASE12014-11-022015-01-172015-01-17
NCT02293902A Study Assessing the Efficacy and Safety of Sarilumab Added to MTX in Japanese Patients With Moderately to Severely Active Rheumatoid Arthritis (SARIL-RA-KAKEHASI)COMPLETEDPHASE32014-112016-102016-10
NCT02228460Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-naïve Adult Male Patients With Fabry DiseaseCOMPLETEDPHASE22014-112016-092016-09
NCT02321709Multiple Ascending Dose Study To Assess The Safety Profile Of SAR113244 Versus Placebo In Lupus Male And Female PatientsCOMPLETEDPHASE12014-112016-032016-03
NCT02221492Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin LymphomaCOMPLETEDPHASE22014-112016-032016-03
NCT02274285DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese InfantsCOMPLETEDPHASE32014-102016-05-282016-05-28
NCT02273180Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin GlargineCOMPLETEDPHASE32014-102016-072015-12
NCT02205489Management Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADACOMPLETEDPHASE42014-102016-042016-04
NCT02282826A First-in-human, Single Ascending Dose Study of GZ402668 in Patients With Progressive Multiple SclerosisCOMPLETEDPHASE12014-102016-032016-03
NCT02258334Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in AdultsCOMPLETEDPHASE42014-102014-122014-11
NCT02221479Plerixafor Plus Granulocyte Colony-stimulating Factor (G-CSF) For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Multiple MyelomaCOMPLETEDPHASE22014-102015-072015-07
NCT02222948Efficacy and Safety of Vatelizumab in Patients With Relapsing-Remitting Multiple SclerosisTERMINATEDPHASE22014-092016-072016-04
NCT02228980Study of a Single Dose or Two Doses of a Trivalent Inactivated Influenza Vaccine Produced at Shenzhen, ChinaCOMPLETEDPHASE42014-092015-102014-12
NCT06193304A Study to Evaluate Pharmacokinetic Parameters and Safety of Eliglustat Absorption Through the MouthCOMPLETEDPHASE12014-08-252014-09-212014-09-21
NCT02134028Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE)COMPLETEDPHASE32014-08-052019-10-112019-10-11
NCT02200991Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin GlargineCOMPLETEDPHASE42014-082015-112015-11
NCT02222870Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent, Influenza VaccineCOMPLETEDPHASE42014-082015-062014-12
NCT02201199Single Dose Clamp Study To Compare Concentration/Time Profile And Metabolic Activity Profile Of 2 New Formulations Of Insulin Glargine With LantusCOMPLETEDPHASE12014-082014-112014-11
NCT02227212Ease of Use and Safety of the New U300 Pen Injector in Insulin-Naïve Patients With T2DMCOMPLETEDPHASE32014-082014-112014-11
NCT02187848Evaluation of SAR408701 in Patients With Advanced Solid TumorsTERMINATEDPHASE12014-07-232024-11-192020-11-10
NCT02199691Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy AdolescentsCOMPLETEDPHASE22014-07-222015-10-022015-10-02
NCT02201108Efficacy, Safety and Pharmacokinetics of Teriflunomide in Pediatric Patients With Relapsing Forms of Multiple SclerosisCOMPLETEDPHASE32014-07-162024-07-292019-10-25
NCT02074137Evaluation of Safety of Cabazitaxel (Jevtana) in Patients With Metastatic Hormone Refractory Prostate CancerCOMPLETEDPHASE42014-072016-032016-03
NCT02169817Evaluation Of Bacillus Clausii In Treatment Of Acute Diarrhea In Latin American ChildrenCOMPLETEDPHASE42014-072016-012016-01
NCT02189733Bioequivalence of Liquid and Reconstituted Lyophilized Subcutaneous Formulations of Caplacizumab.COMPLETEDPHASE12014-072014-09
NCT02201004TOFO Insulin Combination TrialCOMPLETEDPHASE42014-062016-102016-01
NCT02121210To Evaluate the Immunogenicity and Safety of Sarilumab Administered as Monotherapy in Patients With Rheumatoid Arthritis (RA)COMPLETEDPHASE32014-062015-052015-05
NCT02175485Evaluation of Efficacy of Dellegra in Exposure UnitCOMPLETEDPHASE42014-062014-062014-06
NCT02061631Study to Evaluate the Response Rate to Therapy With Docetaxel and Cisplatin in Unresectable Locally Advanced Squamous Cell Carcinoma of Head and NeckCOMPLETEDPHASE22014-052015-102015-07
NCT02046629A Study to Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese VolunteersCOMPLETEDPHASE12014-052014-072014-07
NCT02101073ALX-0061 Phase I Bioavailability Study in Healthy VolunteersCOMPLETEDPHASE12014-03-312014-07-312014-07-31
NCT05918614A Study to Determine the Effect of 500 mg Oral Dose of KD025 in Healthy Male and Post-menopausal Female SubjectsCOMPLETEDPHASE12014-03-282014-06-072014-06-07
NCT01288573A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens AloneCOMPLETEDPHASE1, PHASE22014-03-032017-05-092017-05-09
NCT01949675A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the PhilippinesCOMPLETEDPHASE42014-032015-082015-02
NCT02057250To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid ArthritisCOMPLETEDPHASE32014-032016-032015-02
NCT02083965Pharmacokinetics of rFVIIIFc at Two Vial StrengthsCOMPLETEDPHASE12014-032015-052014-10
NCT02089347Study of SP306 Given Intramuscularly Compared to DT Given Subcutaneously in Japanese Adolescents 11 - 12 Years OldCOMPLETEDPHASE32014-032015-032014-09
NCT02094833DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed InfantsCOMPLETEDPHASE32014-032016-112016-04
NCT02107898Efficacy and Safety Evaluation of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia or High Cardiovascular Risk Patients With Hypercholesterolemia on Lipid Modifying Therapy (ODYSSEY JAPAN)COMPLETEDPHASE32014-032015-092015-01
NCT02085005Capecitabine Plus Aflibercept as Maintenance Therapy Following Capecitabine Plus Oxaliplatin Plus Aflibercept in Patients With Metastatic Colorectal CancerWITHDRAWNPHASE22014-032016-082016-08
NCT02032524Avalglucosidase Alfa Extension StudyCOMPLETEDPHASE22014-02-272022-12-122022-12-12
NCT02058147Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DMCOMPLETEDPHASE32014-022015-062015-06
NCT01948193Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine in Indian Infants Previously Given a Dose of Hepatitis B Vaccine at BirthCOMPLETEDPHASE32014-022015-062014-12
NCT02035605A Phase 1 Study of an Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B PatientsCOMPLETEDPHASE12014-01-202017-07-202017-07-20
NCT02012998Study of the Immunogenicity and Safety of a Challenge Dose of HBVAXPRO in Healthy Children Vaccinated 10 Years Ago With 3 Doses of HEXAVAC or INFANRIX HEXACOMPLETEDPHASE32014-012015-022015-02
NCT02058160Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination Versus Insulin Glargine in Patients With Type 2 DiabetesCOMPLETEDPHASE32014-012015-072015-07
NCT02017639Sarilumab Effect on the Pharmacokinetics of SimvastatinCOMPLETEDPHASE12014-012016-032016-03
NCT01954394Open Label Study of Long Term Safety Evaluation of AlirocumabCOMPLETEDPHASE32013-12-172017-06-302017-06-30
NCT02023879Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II)COMPLETEDPHASE32013-12-162017-06-302014-10-27
NCT02004704A Long-Term Study of Olipudase Alfa in Patients With Acid Sphingomyelinase DeficiencyCOMPLETEDPHASE22013-12-042023-09-062023-09-06
NCT01959971Effect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-CholesterolCOMPLETEDPHASE12013-122015-052015-05
NCT01955629Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer PatientTERMINATEDPHASE1, PHASE22013-122015-032015-03
NCT02011763Safety of Two Doses of Avaxim® 80U Pediatric (Inactivated Hepatitis A Vaccine) in Toddlers, Children and AdolescentsCOMPLETEDPHASE42013-122015-082014-09
NCT02027753Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor TherapyCOMPLETEDPHASE42013-122015-042015-04
NCT02005536Study of IMOVAX POLIO® Subcutaneous as a Booster Vaccine in Pre-school Age Children in JapanCOMPLETEDPHASE42013-122014-102014-09
NCT05918588A Study to Determine the Effect of Multiple Oral Doses and Regimens of KD025 in Healthy Male and Post-menopausal Female SubjectsCOMPLETEDPHASE12013-11-212014-03-062014-03-06
NCT01943825Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue VaccineCOMPLETEDPHASE22013-11-052015-11-252015-11-25
NCT01981967Post-licensure Safety Study of IMOJEV® in ThailandCOMPLETEDPHASE42013-112015-102015-04
NCT01985191A Safety and Efficacy Study of SAR405838 and Pimasertib in Cancer PatientsCOMPLETEDPHASE12013-112016-022016-02
NCT01993173Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China.COMPLETEDPHASE32013-112015-042014-02
NCT01960179Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 DiabetesCOMPLETEDPHASE32013-112015-032015-03
NCT01900431Phase II Study to Analyze Sarilumab in Non-Infectious UveitisCOMPLETEDPHASE22013-102016-042015-07
NCT02332811An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic CKD PatientsCOMPLETEDPHASE32013-102014-072014-07
NCT01943838A Study of the Safety and Pharmacokinetics of SAR245408 Tablets in Patients With Solid Tumors or LymphomaCOMPLETEDPHASE12013-102015-022015-02
NCT01983540Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa VaccinationCOMPLETEDPHASE32013-102015-122015-06
NCT01967784Study of a Quadrivalent Influenza Vaccine Administered Via the Intramuscular Route in Children and Adolescents in TaiwanCOMPLETEDPHASE32013-102014-072014-04
NCT01863888Effect of Teriflunomide on Immune Cell Subsets in the Blood of Patients With Multiple SclerosisCOMPLETEDPHASE32013-102015-012015-01
NCT01876784Evaluation of Efficacy, Safety of Vandetanib in Patients With Differentiated Thyroid CancerCOMPLETEDPHASE32013-09-172022-01-222015-08-30
NCT02065011A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of SAR421869 in Patients With Usher Syndrome Type 1BACTIVE_NOT_RECRUITINGPHASE22013-09-122031-06-132031-06-13
NCT01930357Purified Vero Rabies Vaccine-Serum Free Compared to Human Diploid Cell Vaccine in a Pre-exposure Prophylaxis RegimenCOMPLETEDPHASE22013-092015-062014-08
NCT01940965Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 DiabetesCOMPLETEDPHASE32013-092015-072015-07
NCT01930552A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid MalignanciesCOMPLETEDPHASE12013-092014-122014-12
NCT01946425Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus VaccineCOMPLETEDPHASE42013-092014-072013-12
NCT01946438Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose Influenza Virus Vaccines in AdultsCOMPLETEDPHASE42013-092014-072013-12
NCT01898364Safety and Efficacy Evaluation of Repeat neoGAA Dosing in Late Onset Pompe Disease Patients.COMPLETEDPHASE12013-08-192015-02-252015-02-25
NCT01920893An Evaluation of Dupilumab in Patients With Nasal Polyposis And Chronic Symptoms Of SinusitisCOMPLETEDPHASE22013-082014-112014-11
NCT01933776Study of the Tdap Combined Vaccine (ADACEL™) as a Booster Dose in Healthy Adults and Children in ChinaCOMPLETEDPHASE12013-082014-012013-11
NCT01887912Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile InfectionTERMINATEDPHASE32013-07-302018-06-122018-06-12
NCT01900444Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South KoreaCOMPLETEDPHASE32013-07-112014-03-112014-03-11
NCT01896830Study of a Candidate Clostridium Difficile Toxoid Vaccine in Healthy Adult Subjects Aged 40 to 75 Years in JapanCOMPLETEDPHASE1, PHASE22013-072014-062013-10
NCT01909843ALX-0171 Safety Study in Adults With Hyperresponsive AirwaysCOMPLETEDPHASE12013-072013-122013-12
NCT01882868A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in JapanCOMPLETEDPHASE22013-072015-082015-08
NCT01861249Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)TERMINATEDPHASE22013-072016-042014-05
NCT01890759Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian FederationCOMPLETEDPHASE32013-06-252016-04-122016-04-12
NCT01753453An Exploratory Safety Study to Investigate the Extent of Tumor Cell Mobilization (TCM) After Use of G-CSF Alone or G-CSF Plus Plerixafor in Multiple Myeloma (MM) Patients Who May be Poor Mobilizers of Stem CellsCOMPLETEDPHASE22013-062016-092016-09
NCT01854047An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled AsthmaCOMPLETEDPHASE22013-062015-042014-11
NCT01798706Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic PatientsCOMPLETEDPHASE32013-062015-022015-02
NCT01895335Using Patient Reported Outcomes (PROs) to Evaluate Teriflunomide Treatment in Relapsing Multiple Sclerosis (RMS) PatientsCOMPLETEDPHASE42013-062015-112015-11
NCT01877395Study of Purified Vero Rabies Vaccine and Rabies Human Diploid Cell Vaccine in a Simulated Rabies Post-exposure RegimenCOMPLETEDPHASE22013-062014-092014-05
NCT01875926ALX-0171 Phase I Pharmacokinetic Study in Healthy Male VolunteersCOMPLETEDPHASE12013-052013-102013-10
NCT01839526A Study of Renal Function in Treatment-naïve, Young Male Patients With Fabry DiseaseTERMINATEDPHASE12013-052016-092016-09
NCT01839175Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster VaccinationCOMPLETEDPHASE32013-042015-022014-07
NCT01764997An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus MethotrexateTERMINATEDPHASE32013-042015-012015-01
NCT01767714Evaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5×10^6CD34+ Cells/kg in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous TransplantationCOMPLETEDPHASE32013-042014-112014-11
NCT01850680Single Ascending Dose Study of Safety and Tolerability of Sarilumab and Methotrexate in Japanese Patients With Rheumatoid ArthritisCOMPLETEDPHASE12013-042013-122013-12
NCT01838083Euglycemic Clamp Study Comparing Two New Insulin Glargine Formulations in Subjects With Type 1 Diabetes MellitusCOMPLETEDPHASE12013-042013-082013-08
NCT01768572To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)COMPLETEDPHASE32013-032014-102014-10
NCT01718353Early Switch From First-Line Docetaxel/Prednisone to Cabazitaxel/Prednisone and the Opposite Sequence, Exploring Molecular Markers in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)COMPLETEDPHASE22013-032015-082015-08
NCT01812707Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy in JapanCOMPLETEDPHASE22013-032014-012014-01
NCT01722526Tolerability and Safety Study of Recombinant Human Acid Sphingomyelinase in Acid Sphingomyelinase Deficiency PatientsCOMPLETEDPHASE12013-032014-012014-01
NCT02273258A Study to Compare Pharmacokinetics and Pharmacodynamics of SAR342434 to Insulin Lispro in Subjects With Type 1 DiabetesCOMPLETEDPHASE12013-032013-072013-07
NCT01749969SAR650984 (Isatuximab), Lenalidomide, and Dexamethasone in Combination in RRMM PatientsCOMPLETEDPHASE12013-02-062023-06-202023-06-20
NCT01784874Comparison of Purified Vero Rabies Vaccine, Serum Free With Human Diploid Cell Vaccine in Pre-exposure UseCOMPLETEDPHASE22013-022015-122014-04
NCT01751308Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System TumorsCOMPLETEDPHASE1, PHASE22013-022016-022015-07
NCT01785329Pharmacokinetic of Alirocumab SAR236553 (REGN727) Administered Subcutaneously at 3 Different Injection Sites in Healthy SubjectsCOMPLETEDPHASE12013-022013-072013-07
NCT01768559Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic PatientsCOMPLETEDPHASE32013-012014-122014-12
NCT01651143Proof of Biological Activity of SAR100842 in Systemic SclerosisCOMPLETEDPHASE22013-012014-042013-11
NCT01736592Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular DegenerationACTIVE_NOT_RECRUITINGPHASE22012-12-142033-08-292033-08-29
NCT01234597Evaluation of the Prandial Treatment Adjustment Effect Via Continuous Glucose Monitoring on Type 2 Diabetes Mellitus (DM) Patients Uncontrolled With a Basal Insulin or Premix Once a DayCOMPLETEDPHASE42012-122015-042015-04
NCT01690403Interaction Study to Assess the Pharmacokinetic Interaction of Oral Administration of Rifapentine on ATRIPLA™ in HIV PatientsCOMPLETEDPHASE12012-122014-032014-03
NCT01426971Ibuprofen Versus Ibuprofen Plus Caffeine in the Treatment of Migraine.WITHDRAWNPHASE32012-122013-062013-06
NCT03202875A Study to Compare Pharmacokinetics (PK) and Pharmacodynamics (PD) of SAR341402 to Insulin Aspart in Subjects With Type 1 Diabetes MellitusCOMPLETEDPHASE12012-11-142012-12-282012-12-28
NCT01732627Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and OlderCOMPLETEDPHASE22012-11-122013-01-172013-01-17
NCT01458106Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia ACOMPLETEDPHASE32012-112013-122013-12
NCT01661179Evaluate the Safety and Tolerability of Vandetanib in Japanese Patients With Medullary Thyroid CarcinomaCOMPLETEDPHASE1, PHASE22012-112014-072013-12
NCT01723735Effect of Alirocumab (SAR236553/REGN727) Administered on Top of Ezetimibe or Fenofibrate on Lipid Profiles in Healthy SubjectsCOMPLETEDPHASE12012-112013-072013-07
NCT01795183Effectiveness and Safety of Amisulpride in Chinese Patients With SchizophreniaCOMPLETEDPHASE42012-112013-122013-12
NCT01724788Pharmacokinetic Profile and Pharmacodynamic Characteristics of a Furosemide High Dosage Formulation in Patients With Chronic Renal Failure Undergoing Peritoneal DialysisCOMPLETEDPHASE12012-112013-012013-01
NCT01559363A Safety, Pharmacokinetic & Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney DiseaseCOMPLETEDPHASE1, PHASE22012-10-112019-02-082019-02-08
NCT01663402ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With AlirocumabCOMPLETEDPHASE32012-102018-01-232018-01-23
NCT01709578To Evaluate The Effect Of SAR153191 (REGN88) Added To Other RA Drugs In Patients With RA Who Are Not Responding To Or Intolerant Of Anti-TNF Therapy (SARIL-RA-TARGET)COMPLETEDPHASE32012-102015-032015-03
NCT01632163Assessment of the Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Insufficiently Controlled With Basal Insulin +/- MetforminCOMPLETEDPHASE32012-102015-052015-05
NCT01712984Study of Intradermal Quadrivalent Influenza Vaccine in Adults Aged 18 Through 64 YearsCOMPLETEDPHASE32012-102013-102013-06
NCT01710826A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of Genz-682452 in Healthy VolunteersCOMPLETEDPHASE12012-102013-022013-02
NCT01618708A Study of the Safety and Effectiveness of Synvisc-One® (Hylan G-F 20) in Patients With Primary Osteoarthritis of the HipCOMPLETEDNA2012-092015-062015-06
NCT01657214Phase I, Dose Escalation of SAR125844 in Asian Solid Tumor PatientsCOMPLETEDPHASE12012-092016-012016-01
NCT01683266Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes MellitusCOMPLETEDPHASE32012-092014-032013-09
NCT01689129Comparison of a New Formulation of Insulin Glargine With Lantus® in Japanese Patients With Type 1 Diabetes MellitusCOMPLETEDPHASE32012-092014-042013-10
NCT01689142Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE32012-092014-062013-11
NCT01699932Efficacy and Safety of the Fixed Dose Combination of Glimepiride+Metformin in Type 2 Diabetic Patients Inadequately ControlledCOMPLETEDPHASE32012-092014-042014-04
NCT01691326Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formulation)COMPLETEDPHASE42012-092013-022012-12
NCT01689324Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in AdolescentsCOMPLETEDPHASE1, PHASE22012-092013-052012-11
NCT01691339Study of Fluzone® Influenza Virus Vaccines 2012-2013 Formulation Among Adults.COMPLETEDPHASE42012-092013-022012-11
NCT01676233Repeated Dose Study With a New Insulin Glargine Formulation and Lantus® on 24-hour Glucose Profile in Japanese Patients With Type 1 Diabetes MellitusCOMPLETEDPHASE12012-092013-082013-08
NCT01670734Pharmacokinetic and Tolerability of Alirocumab SAR236553 (REGN727) in Patients With Hepatic Impairment and in Healthy SubjectsCOMPLETEDPHASE12012-092013-052013-05
NCT01670721Colorectal Cancer MetastaticCOMPLETEDPHASE32012-082015-062015-06
NCT01659138Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative ColitisTERMINATEDPHASE22012-082016-042014-06
NCT01644188Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe on Top of Statin in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY COMBO II)COMPLETEDPHASE32012-082015-072014-05
NCT01597596A Noninferiority Study of Alglucosidase Alfa Manufactured at the 160 L and 4000 L Scales in Treatment Naïve Patients With Infantile-Onset Pompe DiseaseTERMINATEDPHASE42012-082014-122014-12
NCT01665391A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS)COMPLETEDPHASE22012-082014-112014-06
NCT01676220Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Non-insulin Antidiabetic TherapyCOMPLETEDPHASE32012-082014-032013-09
NCT01658579Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime InsulinCOMPLETEDPHASE22012-082013-052013-05
NCT01673737A Phase I/Ib Trial for the Evaluation of SAR260301 in Monotherapy or in Combination With Vemurafenib in Patients With Various Advanced CancerCOMPLETEDPHASE12012-082015-022015-02
NCT01674036Safety, Tolerability and Pharmacokinetics of Genz-682452 in Healthy MenCOMPLETEDPHASE12012-082013-012013-01
NCT01576029Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate CancerCOMPLETEDPHASE22012-082013-122013-12
NCT01587040Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination RegimenCOMPLETEDPHASE1, PHASE22012-07-202018-05-232018-05-23
NCT01636479Phase 1 Safety Testing of SAR405838COMPLETEDPHASE12012-07-132018-03-052018-03-05
NCT01661270A Study of Aflibercept Versus Placebo With FOLFIRI in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin ChemotherapyCOMPLETEDPHASE32012-072015-072014-10
NCT01649635Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate CancerCOMPLETEDPHASE42012-072016-062014-01
NCT01623115Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying TherapyCOMPLETEDPHASE32012-072014-122014-04
NCT01659996Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of AgeCOMPLETEDPHASE42012-072015-092014-11
NCT01644474Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Ezetimibe in Patients With HypercholesterolemiaCOMPLETEDPHASE32012-072013-072013-07
NCT01644175Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With High Cardiovascular Risk and Hypercholesterolemia (ODYSSEY COMBO I)COMPLETEDPHASE32012-072014-042014-04
NCT01642589Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South KoreaCOMPLETEDPHASE32012-072013-062013-01
NCT01622062Immunogenicity and Safety of Verorab® in a "One-week" Intradermal Post-exposure Prophylaxis RegimenCOMPLETEDPHASE32012-06-292018-11-142018-11-14
NCT02082028Efficacy of a Chronic Care Model Supported by Self Monitoring of Blood Glucose With BGStar Over Usual Care in Improving Glycemic Control in Patients With Type 2 Diabetes Not Treated With InsulinCOMPLETEDNA2012-06-272015-07-302015-07-30
NCT01496313To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid CancerCOMPLETEDPHASE42012-06-082024-07-112014-04-02
NCT01440946Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia BCOMPLETEDPHASE32012-062014-112014-11
NCT01617655Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia (ODYSSEY HIGH FH)COMPLETEDPHASE32012-062015-012014-05
NCT02073188Comparative Study of a Smartphone-Linked Self-Monitoring System Versus a Traditional One for Improving Metabolic Control and Compliance to Self-Monitoring of Blood GlucoseCOMPLETEDPHASE32012-062014-092014-09
NCT01629589Immunogenicity of Adacel® and BOOSTRIX® Vaccines in AdolescentsCOMPLETEDPHASE42012-062013-062013-03
NCT01596270A Study of the Safety and Pharmacokinetics of SAR245409 Tablets in Patients With Solid Tumors or LymphomaCOMPLETEDPHASE12012-062014-102014-10
NCT01571284Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based RegimenCOMPLETEDPHASE32012-05-302017-01-312017-01-31
NCT01593228Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical TrialCOMPLETEDPHASE32012-052016-092016-09
NCT01596504Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without MetforminCOMPLETEDPHASE22012-052013-072013-07
NCT01574326An Efficacy and Safety Study of Sevelamer Carbonate in Hyperphosphatemic Pediatric Participants With Chronic Kidney DiseaseCOMPLETEDPHASE22012-052015-062015-06
NCT01567904Study of AVE5026 at Weight-adjusted Doses in Children With a Central Venous LineTERMINATEDPHASE22012-052012-072012-07
NCT01659944Study to Evaluate the Effect of Eliglustat on the Pharmacokinetics, Safety and Tolerability of Metoprolol in Healthy AdultsCOMPLETEDPHASE12012-052012-072012-06
NCT01572649Evaluation of the Blood Levels of the Drug (Lixisenatide), the Plasma Glucose Levels and Safety in Paediatric and Adult Patients With Type 2 DiabetesCOMPLETEDPHASE12012-052014-032014-03
NCT01608815Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese SubjectsCOMPLETEDPHASE32012-052012-122012-09
NCT01625494Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine MonotherapyCOMPLETEDPHASE32012-052013-012013-01
NCT01544140Study in Healthy Volunteers to Assess the Pharmacokinetics of Midazolam Administered Alone and in Combination With VandetanibCOMPLETEDPHASE12012-042012-072012-07
NCT01598415Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part IICOMPLETEDPHASE22012-042013-022013-02
NCT01650779A Study Evaluating Glycosphingolipid Clearance in Patients Treated With Agalsidase Alfa Who Switch to Agalsidase BetaCOMPLETEDPHASE42012-042013-032013-03
NCT01527929Pharmacokinetics and Safety Study of Cabazitaxel in Cancer Patients With Renal ImpairmentCOMPLETEDPHASE12012-042013-112013-11
NCT01505062Study of SAR421869 in Participants With Retinitis Pigmentosa Associated With Usher Syndrome Type 1BTERMINATEDPHASE1, PHASE22012-03-262019-08-162019-08-16
NCT01550289Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in IndiaCOMPLETEDPHASE22012-032014-022013-12
NCT01551615A Phase I Study to Assess the Pharmacokinetics of Metformin When Administered Alone and in Combination With VandetanibCOMPLETEDPHASE12012-032012-062012-06
NCT01561781Study in Healthy Volunteers to Assess the Pharmacokinetics (PK) of Digoxin Administered Alone and in Combination With VandetanibCOMPLETEDPHASE12012-032012-072012-07
NCT01511536Cabazitaxel and Abiraterone Acetate in Patients With Metastatic Castrate-Resistant Prostate CancerCOMPLETEDPHASE1, PHASE22012-032014-122014-07
NCT01463397Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic PainCOMPLETEDPHASE22012-032013-052013-05
NCT01586338A Study of the Efficacy and Safety of Synvisc® in Chinese Subjects With Symptomatic Osteoarthritis of the Knee(s)COMPLETEDPHASE42012-032013-092013-09
NCT01526785A Study to Evaluate the Efficacy and Safety of Alglucosidase Alfa Produced at the 4000 L Scale for Pompe DiseaseTERMINATEDPHASE42012-032014-122014-12
NCT01500720Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung CancerCOMPLETEDPHASE22012-032014-042014-04
NCT01551069Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin LesionCOMPLETEDPHASE32012-032014-042013-12
NCT01481454Study of a Quadrivalent Influenza Vaccine Administered Intramuscularly in Children/Adolescents and AdultsCOMPLETEDPHASE32012-032012-122012-10
NCT01537653Safety, Tolerability and Pharmacokinetics of SAR231893 (REGN668) in Healthy Japanese Adult Male SubjectsCOMPLETEDPHASE12012-032012-102012-10
NCT01546909Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRECOMPLETEDPHASE42012-022012-122012-12
NCT01539655Study in Healthy Volunteers to Assess Effect of Omeprazole and Ranitidine on the Pharmacokinetics of VandetanibCOMPLETEDPHASE12012-022012-092012-09
NCT01517412Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on MetforminCOMPLETEDPHASE32012-022013-052013-05
NCT01459809Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes PatientsCOMPLETEDPHASE32012-022014-012014-01
NCT01630369Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 DiabetesCOMPLETEDPHASE42012-022013-052013-05
NCT01537640Comparison of the Pharmacokinetics and Safety of Two SAR231893 (REGN668) Drug Products in Healthy SubjectsCOMPLETEDPHASE12012-022012-072012-07
NCT01472887SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) PatientsCOMPLETEDPHASE22012-012016-092016-09
NCT01529853To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)COMPLETEDPHASE1, PHASE22012-012013-102013-10
NCT01507831Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term)COMPLETEDPHASE32012-012014-112014-11
NCT01485302Single and Repeated Dosing Study to Assess the Safety and the Concentration-time Profile of SAR228810 in Alzheimer's PatientsCOMPLETEDPHASE12012-012015-022015-02
NCT01378286Efficacy and Tolerability of Artesunate Amodiaquine Versus Chloroquine in the Treatment of Uncomplicated Plasmodium Vivax MalariaCOMPLETEDPHASE32012-012013-062013-06
NCT01519713Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese SubjectsCOMPLETEDPHASE32012-012012-122012-09
NCT01439919A Clinical Trial to Assess the Clinical Benefit of SSR411298 as Adjunctive Treatment for Persistent Cancer PainTERMINATEDPHASE22012-012012-022012-02
NCT01511549Safety, Tolerability and Pharmacokinetics of SAR113945 in Japanese Patients With Knee OsteoarthritisCOMPLETEDPHASE12012-012012-092012-09
NCT01515748Docetaxel+Oxaliplatin+S-1 (DOS) Regimen as Neoadjuvant Chemotherapy in Advanced Gastric CancerCOMPLETEDPHASE32011-12-302021-12-132019-01-21
NCT01425723Long-Term Safety and Efficacy of rFIXFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia BCOMPLETEDPHASE32011-12-082017-102017-10
NCT01488890Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever VaccineCOMPLETEDPHASE22011-12-062013-09-272013-09-27
NCT01499095Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic TherapyCOMPLETEDPHASE32011-122013-112013-04
NCT01499082Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime InsulinCOMPLETEDPHASE32011-122013-092013-01
NCT01454739Long-Term Safety and Efficacy of rFVIIIFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia ACOMPLETEDPHASE32011-122017-102017-10
NCT01497964Cabazitaxel in Asian Patients With Advanced Gastric Cancer Who Failed Prior ChemotherapyCOMPLETEDPHASE1, PHASE22011-122013-052013-05
NCT01410513Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic LeukemiaCOMPLETEDPHASE12011-122014-052014-05
NCT01491087Safety of PENTAXIM® Given as a Three-Dose Primary Vaccination at 2, 3, and 4 Months of Age in Infants in ChinaCOMPLETEDPHASE42011-122012-122012-07
NCT01439165Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous DoseCOMPLETEDPHASE42011-112017-022015-12
NCT01483911ALX-0171 Phase I Study, Evaluating Single Ascending Dose and Multiple Dose in Healthy Male VolunteersCOMPLETEDPHASE12011-112012-052012-05
NCT01476475Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic PatientsCOMPLETEDPHASE22011-112012-122012-12
NCT01475539Sequential Inactivated Poliomyelitis Vaccine Followed by Oral Poliomyelitis Vaccine Versus Oral Poliomyelitis VaccineCOMPLETEDPHASE42011-112013-112013-05
NCT01470456Combination of SAR3419 and Rituximab in Relapsed/Refractory Diffuse Large B-Cell LymphomaCOMPLETEDPHASE22011-112014-092013-07
NCT01455532A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid TumorsCOMPLETEDPHASE12011-112014-042013-05
NCT01436565A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor CancersCOMPLETEDPHASE12011-112014-052014-05
NCT01461577Effectiveness and Safety of Treatment of Insulin Glargine in Type 2 Diabetes Mellitus Following Glucagon-like Peptide-1 (GLP-1) FailureCOMPLETEDPHASE42011-112012-122012-12
NCT01463488Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part ICOMPLETEDPHASE12011-112012-082012-08
NCT01485900Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I TreatmentCOMPLETEDPHASE12011-112012-082012-08
NCT01493115Single Dose Study With a New Insulin Glargine Formulation and Lantus® in Japanese Patients With Type 1 Diabetes MellitusCOMPLETEDPHASE12011-112012-042012-04
NCT01440179SAR3419 in Acute Lymphoblastic LeukemiaTERMINATEDPHASE22011-102014-052014-05
NCT01403636A Study of Investigational SAR245409 in Patients With Certain Lymphoma or LeukemiaCOMPLETEDPHASE22011-102014-092014-09
NCT01452542A Phase I Study of the Pharmacokinetic Variability and Relative Bioavailability of the Phase 3 and Common Blend Formulations of Eliglustat in Healthy Adult SubjectsCOMPLETEDPHASE12011-102011-112011-11
NCT01389700Pharmacokinetics, Pharmacodynamics and Safety Evaluation of SAR279356 in Intensive Care Unit Mechanically Ventilated PatientsTERMINATEDPHASE22011-102012-122012-12
NCT01457911Evaluation of Fixed Dose Combination of Glimepiride and Metformin in Chinese Type 2 Diabetes Patients Inadequately Controlled With MetforminCOMPLETEDPHASE32011-102013-022013-02
NCT01445938Anti-parasitic Activity and Safety Assessment of SAR97276A in Children With Uncomplicated MalariaTERMINATEDPHASE22011-102012-012012-01
NCT01436396Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy ToddlersCOMPLETEDPHASE32011-09-072013-09-022013-09
NCT01446926Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and InfantsCOMPLETEDPHASE12011-092013-062013-03
NCT01403376Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on TeriflunomideCOMPLETEDPHASE22011-092012-012012-01
NCT01427309A Study of Fluzone® High-Dose Vaccine Compared With Fluzone® Vaccine In Elderly AdultsCOMPLETEDPHASE42011-092013-112013-05
NCT01579149A Phase I Dose Escalation Study of Plerixafor in Healthy Subjects of Japanese DescentCOMPLETEDPHASE12011-092012-022012-02
NCT01442675Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra VaccineCOMPLETEDPHASE22011-092012-122012-06
NCT01444781Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy InfantsCOMPLETEDPHASE32011-092013-102013-04
NCT01430819Study of Fluzone® Influenza Virus Vaccine 2011-2012 Formulation (Intramuscular Route) Among AdultsCOMPLETEDPHASE42011-092012-022012-02
NCT01357811A Phase 1 Study Evaluating Eliglustat's Effects on Pharmacokinetics, Safety & Tolerability of Digoxin in Healthy AdultsCOMPLETEDPHASE12011-082011-112011-11
NCT01392924Safety and Pharmacokinetics of SAR245408 Daily Oral in Patients With Solid TumorsCOMPLETEDPHASE12011-082014-112012-02
NCT01430611Study of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in ChildrenCOMPLETEDPHASE42011-082012-112012-08
NCT01411241Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy ToddlersCOMPLETEDPHASE32011-07-182014-042014-02-04
NCT01391533Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid TumorsCOMPLETEDPHASE12011-072016-042016-04
NCT01396512Study of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV™) Compared to CD.JEVAX™ in ToddlersCOMPLETEDPHASE32011-072013-062013-03
NCT01389687Study of SP059 Given Subcutaneously as a Three-dose Primary and Booster Vaccination in Infants in JapanCOMPLETEDPHASE32011-072012-012012-01
NCT01443650Injection Site Tolerability, Safety, Pharmacokinetics, Pharmacodynamics in Different Single-Dose Treatments of Alirocumab SAR236553 (REGN727) in Healthy SubjectsCOMPLETEDPHASE12011-072011-112011-11
NCT01245582Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma PatientsWITHDRAWNPHASE32011-072015-082014-02
NCT01374516Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin AmericaCOMPLETEDPHASE32011-06-082018-03-052014-11
NCT01367444Phase I/IIA Study of SAR422459 in Participants With Stargardt's Macular DegenerationTERMINATEDPHASE1, PHASE22011-06-082019-08-162019-08-16
NCT01373281Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in AsiaCOMPLETEDPHASE32011-06-032017-11-212014-08-01
NCT01437423Regulatory Post-Marketing Surveillance Study for TETRAXIM™COMPLETEDPHASE42011-062015-112015-11
NCT01288027Exploratory Muscle Biopsy Assessment Study in Patients With Late-Onset Pompe Disease Treated With Alglucosidase AlfaCOMPLETEDPHASE42011-062013-122013-12
NCT01374503First in Man Study of ALX-0651, a Nanobody Inhibiting CXCR4TERMINATEDPHASE12011-062012-012012-01
NCT01448304Study of the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of Alirocumab SAR236553 (REGN727)COMPLETEDPHASE12011-062011-092011-09
NCT01308567Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate CancerCOMPLETEDPHASE32011-05-052018-052015-09
NCT01448317Ascending Dose Study of the Safety and Tolerability of Alirocumab (SAR236553/REGN727) in Japanese Healthy VolunteersCOMPLETEDPHASE12011-052012-012012-01
NCT01359449Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine ImmunizationsCOMPLETEDPHASE32011-052012-112012-07
NCT01332656Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/PaclitaxelCOMPLETEDPHASE22011-052014-072014-07
NCT01353469Assessment of Efficacy and Safety of Insuman Comb 25 Versus Novolin® 30R Twice Daily Over 24 Weeks in Type 2 Diabetes Patients With Insulin TherapyCOMPLETEDPHASE32011-052012-112012-11
NCT01401764Study Comparing The Tolerability Of Three Excipient Formulations Administered Subcutaneously To Healthy SubjectsCOMPLETEDPHASE12011-052011-062011-06
NCT01202474Apidra Children & Adolescents StudyCOMPLETEDPHASE42011-052012-102012-10
NCT01357330Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid TumorsCOMPLETEDPHASE12011-052012-062012-06
NCT01328522Comparison of the Safety and Pharmacokinetics of Two SAR153191 (REGN88) Drug Products in Rheumatoid Arthritis PatientsCOMPLETEDPHASE12011-052011-092011-09
NCT01308580Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate CancerCOMPLETEDPHASE32011-042015-082015-08
NCT01346293Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of AgeCOMPLETEDPHASE32011-042013-092013-05
NCT01339312Study of the Purified Vero Rabies Vaccine - Serum Free in Comparison With the Reference Purified Vero Rabies VaccineCOMPLETEDPHASE32011-042012-092012-03
NCT01284569Study to Assess Safety and Efficacy of Anti-Interleukin 6-receptor (IL6R) Nanobody in Rheumatoid Arthritis (RA) PatientsCOMPLETEDPHASE1, PHASE22011-032012-092012-09
NCT01312961Efficacy, Safety, and Tolerability of Dupilumab in Patients With Persistent Moderate to Severe Eosinophilic AsthmaCOMPLETEDPHASE22011-032012-102012-10
NCT01311557Study of Adacel® Vaccine Administered to Persons 10 Years of AgeCOMPLETEDPHASE42011-032012-012011-11
NCT01349855Repeated Dosing Study With a New Insulin Glargine Formulation and Lantus® in Patients With Type 1 Diabetes MellitusCOMPLETEDPHASE12011-032011-052011-05
NCT01298323Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib TreatmentCOMPLETEDPHASE32011-02-252025-03-132013-04-26
NCT01266525Effect of Different Doses of SAR110894 on Cognition in Patients With Mild to Moderate Alzheimer's Disease on DonepezilCOMPLETEDPHASE22011-022013-012013-01
NCT01263886Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung CancerCOMPLETEDPHASE22011-022012-102012-03
NCT01223131Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.COMPLETEDPHASE32011-022014-032014-03
NCT01306721Fexofenadine HCL - Pseudoephedrine HCL Combination Versus Allegra in Patients With Seasonal Allergic RhinitisCOMPLETEDPHASE32011-022011-042011-04
NCT01448239Injection Site Tolerability, Safety, Pharmacokinetics and Pharmacodynamics Study After a Single Dose Subcutaneous Treatment of Alirocumab SAR236553 (REGN727)COMPLETEDPHASE12011-022011-052011-05
NCT01151423Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)COMPLETEDPHASE22011-012014-032014-03
NCT01287949Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or OlderCOMPLETEDPHASE32011-012012-052012-05
NCT01293630A Dose-escalation Study of Ombrabulin in Combination With Paclitaxel and Carboplatin in Patients With Advanced Solid TumorsCOMPLETEDPHASE12011-012013-102013-10
NCT01288443Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin TherapyCOMPLETEDPHASE22011-012011-122011-12
NCT01288469Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) When Co-administered With High Dose of Atorvastatin in Patients With Primary HypercholesterolemiaCOMPLETEDPHASE22011-012011-092011-09
NCT01324583Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate CancerCOMPLETEDPHASE12011-012014-112014-11
NCT01266512Concurrent Chemoradiotherapy Using Intensity Modulated Radiotherapy (IMRT) & Docetaxel-cisplatin (or Carboplatin) Followed by Adjuvant Chemotherapy for Inoperable Stage III Non-small-cell Lung CancerCOMPLETEDPHASE22011-012014-032014-03
NCT01252355Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-betaTERMINATEDPHASE32011-012013-042013-04
NCT01240460Exploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical ResectionCOMPLETEDPHASE12011-012012-062012-06
NCT01254422Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in MalaysiaCOMPLETEDPHASE32010-12-022013-012012-09-28
NCT01254279Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing RegimenCOMPLETEDPHASE32010-122014-122014-12
NCT01270503Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the PhilippinesCOMPLETEDPHASE42010-122014-072013-12
NCT01278433A Safety Study of IMOVAX Polio Vaccine in Selected Cities in ChinaCOMPLETEDPHASE42010-122012-062011-12
NCT01203111Intensive Insulin Glulisine Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Basal Insulin and Oral Glucose-lowering DrugsCOMPLETEDPHASE42010-122012-072012-07
NCT01204580ADIponectin and Asymmetric Dimethylarginine (ADMA) Level in Type-2 Diabetes Patients After 12 Weeks of Treatment With GlimepiRide And Metformin Fixed Dose CombinationCOMPLETEDPHASE42010-122012-032012-03
NCT01194882Benefit/Risk Evaluation of Insuman Implantable Versus Insuplant Using Medtronic MiniMed Implantable Pump System in Patients With Type 1 DiabetesCOMPLETEDPHASE32010-11-162018-02-012018-02-01
NCT01217814Effect of SAR153191 (REGN88) With Methotrexate in Patients With Active Rheumatoid Arthritis Who Failed TNF-α BlockersTERMINATEDPHASE22010-112011-092011-09
NCT01181128Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Subjects With Severe Hemophilia ACOMPLETEDPHASE32010-112012-082012-08
NCT01258595A Study of High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of AgeCOMPLETEDPHASE22010-112011-042011-03
NCT01240746Study of Quadrivalent Influenza Vaccine Among ChildrenCOMPLETEDPHASE32010-112012-022011-12
NCT01204593baSal BoluS Therapy in patIenTs With TypE 1 Diabetes MellitusCOMPLETEDPHASE42010-112013-012013-01
NCT01244230Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD)COMPLETEDPHASE2, PHASE32010-112011-082011-07
NCT01244464A Study of the Safety of IMOVAX Polio™ in ChinaCOMPLETEDPHASE42010-112011-122011-06
NCT01239043Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial VaccinationCOMPLETEDPHASE22010-112012-022011-04
NCT01239459Pharmacokinetic and Tolerability Study of 14 mg Single Dose of Teriflunomide in Subjects With Severe Renal ImpairmentCOMPLETEDPHASE12010-112011-032011-02
NCT00418821A Study of the Effect of Aldurazyme® (Laronidase) Treatment on Lactation in Female Patients With Mucopolysaccharidosis I (MPS I) and Their Breastfed InfantsTERMINATEDPHASE42010-10-222022-12-212022-12-21
NCT01134263Study of a Tetravalent Dengue Vaccine in Healthy Adults in AustraliaCOMPLETEDPHASE32010-10-052013-022012-11
NCT01215669Study of Sanofi Pasteur's Intradermal Influenza Vaccine (IDflu™) in Adults and Elderly in KoreaCOMPLETEDPHASE42010-102011-042011-02
NCT01230957Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in AdultsCOMPLETEDPHASE22010-102013-032012-11
NCT01249183Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years OldCOMPLETEDPHASE32010-102011-092011-09
NCT01164475Evaluation of Approved Weight-Based Dose Compared to Fixed Dose of Plerixafor in Patients With Non-Hodgkin's Lymphoma (NHL) Weighing Less Than 70 KilogramsCOMPLETEDPHASE42010-102013-022013-02
NCT01244217Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Perennial Allergic Rhinitis (PAR)COMPLETEDPHASE2, PHASE32010-102011-082011-07
NCT01218646Study of Quadrivalent Influenza Vaccine Among AdultsCOMPLETEDPHASE32010-102011-042011-03
NCT01226043Patient Preference and Satisfaction With Insulin Glargine (Lantus) Solostar Pen vs Conventional Vial-Syringe Method of Lantus Injection Therapy in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE42010-102012-052012-05
NCT01199081Pharmacokinetics and Optimal Timing of Dronedarone Initiation Following Long-term Amiodarone in Patients With Paroxysmal or Persistent Atrial FibrillationCOMPLETEDPHASE42010-102012-042012-04
NCT01284036A Single Dose Study Of The Safety And Investigational Product Level Measurement In Healthy SubjectsCOMPLETEDPHASE12010-102011-112011-11
NCT01156870First in Man Study of SAR566658 Administered in Patients With CA6-Positive and Refractory Solid TumorCOMPLETEDPHASE12010-09-082017-04-072017-04-07
NCT01204125Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer PatientsCOMPLETEDPHASE22010-092017-022012-10
NCT01193595Dose-escalation, Safety, Pharmacokinetics Study of AVE8062 Combined With Bevacizumab in Patients With Advanced Solid TumorsCOMPLETEDPHASE12010-092014-102014-10
NCT01213368Dose Ranging Study of Dronedarone for the Control of Ventricular Rate in Japanese Patients With Permanent Atrial FibrillationCOMPLETEDPHASE22010-092011-042011-04
NCT01213381Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid TumorsCOMPLETEDPHASE12010-092013-022013-02
NCT01198873Effects of Dronedarone on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial EnlargementTERMINATEDPHASE42010-092012-012012-01
NCT00931853Efficacy and Tolerability of Cassia Fistula Plus Senna Alexandrina Miller (Sugar Free) in the Chronic Functional Constipation (CFC).COMPLETEDPHASE32010-092011-122011-12
NCT01214889Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants.COMPLETEDPHASE32010-092011-122011-11
NCT01140581Optimal Timing of Dronedarone Initiation After Conversion in Patients With Persistent Atrial FibrillationCOMPLETEDPHASE42010-092011-122011-12
NCT01190228Study of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With JE-CVCOMPLETEDPHASE32010-08-252015-10-122010-10-29
NCT01187433Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South AmericaCOMPLETEDPHASE22010-082012-122012-10
NCT01175473Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 DiabetesCOMPLETEDPHASE22010-082010-112010-11
NCT01188343Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese ToddlersCOMPLETEDPHASE32010-082012-122012-07
NCT01177722A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American InfantsCOMPLETEDPHASE32010-082011-122011-10
NCT01196013A Study of Clofarabine in Japanese Paediatric Patients With Relapsed or Refractory Acute Lymphoblastic LeukaemiaCOMPLETEDPHASE12010-082011-052011-05
NCT01212913Comparison of Insulin Glargine/Insulin Glulisine Regimen to Insulin Aspart/Insulin Aspart Protamine 30/70 in Type 2 Diabetes Mellitus Patients (T2DM)COMPLETEDPHASE42010-082012-052012-05
NCT01169818Evaluation of the Effectiveness and Safety of Physician Versus Patient-led of Insulin Glargine Initiation and Titration in Type 2 Diabetes MellitusCOMPLETEDPHASE42010-082012-062012-06
NCT01195454Euglycemic Clamp Dose-response Study Comparing a New Insulin Glargine Formulation With Lantus®COMPLETEDPHASE12010-082010-122010-11
NCT01126606Comparative Safety and Efficacy Evaluation Between Dermacyd Silver and Glycerine Vegetal Soap Granado TraditionalCOMPLETEDPHASE32010-082010-112010-11
NCT06159452Study of the Tolerability of Different SAR153191 Drug Products, That Differ With Respect to Manufacturing Processes and Formulation, at Different Concentrations and Doses in Healthy Male SubjectsCOMPLETEDPHASE12010-07-092010-12-212010-12-21
NCT01169779Efficacy and Safety of Lixisenatide in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled by MetforminCOMPLETEDPHASE32010-072011-122011-12
NCT01173497A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain MetastasisCOMPLETEDPHASE22010-072013-072012-10
NCT01121848Randomized Study With Oxaliplatin in 2nd Line Pancreatic CancerCOMPLETEDPHASE32010-072013-102013-10
NCT01117350Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents FailureCOMPLETEDPHASE42010-072013-032012-10
NCT01122979Evaluation of the Safety and Efficacy of Insulin Glargine + Glulisine or Insulin Regular + NPH Insulin (Isophane Insulin) Use in Type 2 Diabetes Mellitus Patients With Moderate Renal Failure.COMPLETEDPHASE42010-072013-102013-10
NCT01161836An Open-label Study Investigating the Disposition and QT/QTc Interval Effects of 400 mg [14C]-Iniparib(3.7 MBq, 100 µCi)COMPLETEDPHASE12010-072011-062011-02
NCT01135017Effects of Dronedarone on Atrial Fibrillation Burden in Subjects With Permanent PacemakersTERMINATEDPHASE42010-072012-022012-02
NCT01151137Permanent Atrial fibriLLAtion Outcome Study Using Dronedarone on Top of Standard TherapyTERMINATEDPHASE32010-072011-092011-09
NCT01148615A Study of Intravenous Aflibercept With Docetaxel in Chinese Patients With Solid TumorsCOMPLETEDPHASE12010-072011-122011-09
NCT01158365Dermacyd in Odor Reducing.COMPLETEDPHASE32010-072010-122010-12
NCT01146652Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND)COMPLETEDPHASE32010-06-212020-12-312020-12-31
NCT01137435Post Marketing Surveillance for ADACEL™ in South KoreaCOMPLETEDPHASE42010-062016-092016-03
NCT01118728Extension Study for Long Term Evaluation of SAR153191 (REGN88) in Patients With Ankylosing SpondylitisTERMINATEDPHASE22010-062011-122011-12
NCT01074944A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease to Evaluate Once Daily Versus Twice Daily Dosing (EDGE)COMPLETEDPHASE32010-062015-102015-10
NCT01147250Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)COMPLETEDPHASE32010-062015-022015-02
NCT01082068Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast CancerCOMPLETEDPHASE1, PHASE22010-062013-042013-04
NCT01138397Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intradermal Route)COMPLETEDPHASE32010-062010-072010-07
NCT01444352Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy AdultsCOMPLETEDPHASE12010-062011-012011-01
NCT01154153Nasacort AQ Hypothalamic-Pituitary-Adrenal (HPA) Axis Study in Children With Allergic RhinitisCOMPLETEDPHASE42010-062010-102010-10
NCT01086969A Study of Meningococcal Vaccine, Menactra® in Healthy Subjects in IndiaCOMPLETEDPHASE32010-062011-062011-02
NCT01146678Relative Bioavailability and Activity of Different Formulations of Insulin Glargine and Lixisenatide in Patients With Diabetes Mellitus Type 1COMPLETEDPHASE12010-062011-012010-09
NCT01084252Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological MalignanciesCOMPLETEDPHASE1, PHASE22010-05-112023-07-132018-12-21
NCT01121822Immunogenicity and Safety of a Vaccine Against Influenza (2010-2011 Northern Hemisphere Season, Intramuscular Route)COMPLETEDPHASE32010-052010-062010-06
NCT01140607Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver ImpairmentCOMPLETEDPHASE12010-052014-072014-07
NCT01127269Safety and Effectiveness Study of Insulin Glargine (LANTUS) Initiation and Titration in Patients With Type 2 DiabetesCOMPLETEDPHASE42010-052013-062013-06
NCT01126086Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild and Moderate Hepatic ImpairmentCOMPLETEDPHASE12010-052011-042011-04
NCT01095302Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid TumorsCOMPLETEDPHASE12010-052011-122011-12
NCT01086254SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung CancerCOMPLETEDPHASE22010-052011-122011-12
NCT01144728Initiation and Titration of AmarylCOMPLETEDPHASE42010-052010-122010-12
NCT01076764Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive StrategyCOMPLETEDPHASE32010-042013-052013-05
NCT01120314Pharmacokinetic, Pharmacodynamic and Tolerability Study of Otamixaban in Patients With Mild, Moderate and Severe Renal ImpairmentCOMPLETEDPHASE12010-042011-072011-07
NCT01047566Effect of Addition of Dronedarone to Standard Rate Control Therapy on Ventricular Rate During Persistent Atrial Fibrillation (AFRODITE)COMPLETEDPHASE42010-042011-092011-09
NCT01113333Safety, Tolerability and Pharmacokinetics of SAR113945 Following Intra-articular Administration in Patients With Knee OsteoarthritisCOMPLETEDPHASE12010-042011-022011-02
NCT01061736Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis PatientsCOMPLETEDPHASE2, PHASE32010-032013-102013-10
NCT01082549Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC)COMPLETEDPHASE32010-032013-042013-04
NCT01736150Dose-Titration Study of Sevelamer Carbonate in Chronic Kidney Disease (CKD) Patients on HemodialysisCOMPLETEDPHASE32010-032010-092010-09
NCT01089660A Study of the Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy AdultsCOMPLETEDPHASE22010-032010-122010-09
NCT01092507A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and ToddlersCOMPLETEDPHASE32010-032011-102011-09
NCT01107756A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based RegimenCOMPLETEDPHASE42010-032012-072012-07
NCT01097382Sleep Satisfaction and Psychomotor Performance of AdultsCOMPLETEDPHASE42010-032011-042011-04
NCT01087021Effect of Cabazitaxel on the QTc Interval in Cancer PatientsCOMPLETEDPHASE12010-032011-112011-04
NCT01021150Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Cisplatin in Patients With Solid TumorsCOMPLETEDPHASE12010-032011-052011-05
NCT02389452Study of Safety and Efficacy of 6 mL Synvisc-One (Hylan G-F 20) in Indian Patients With Symptomatic Osteoarthritis of Knee(s) After Initial and Repeat TreatmentCOMPLETEDPHASE42010-022011-092011-09
NCT01061723Dose Ranging Study to Evaluate the Efficacy and Safety of SAR153191 (REGN88) in Patients With Ankylosing SpondylitisCOMPLETEDPHASE22010-022011-062011-06
NCT01042925Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based RegimenCOMPLETEDPHASE1, PHASE22010-022012-122012-12
NCT00923182A Safety Confirmatory Study of Alemtuzumab in Japanese Patients With Relapsed or Refractory Chronic Lymphocytic LeukemiaCOMPLETEDPHASE12010-022011-082011-08
NCT01090167A Study of Clofarabine in Japanese Patients With Acute Myeloid Leukemia (AML)COMPLETEDPHASE12010-022011-042011-04
NCT01045304Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast CancerCOMPLETEDPHASE22010-022012-112011-03
NCT01087658Oral Glutamine in the Prevention of Oxaliplatin-induced NeurotoxicityCOMPLETEDPHASE32010-022013-032013-03
NCT01121835Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative StudyCOMPLETEDPHASE42010-022012-032012-03
NCT01063803Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid ArthritisCOMPLETEDPHASE22010-022012-022012-02
NCT01081938Insulin Glargine for Diabetes Metabolism(DM)Type II Patients Under Enteral NutritionTERMINATEDPHASE42010-022011-022011-02
NCT01444339Study of Two Investigational Pneumococcal Vaccines in Healthy AdultsCOMPLETEDPHASE12010-022010-092010-09
NCT01053728Study of How Single Rising Doses of SAR161271 Are Absorbed and Act in Patients With Type 1 Diabetes Mellitus (T1DM)COMPLETEDPHASE1, PHASE22010-022010-112010-05
NCT01034995A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive DisorderCOMPLETEDPHASE22010-022011-032011-03
NCT01024998Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)COMPLETEDPHASE12010-01-112018-072014-07
NCT01013324Study of XL147 (SAR245408) in Advanced or Recurrent Endometrial CarcinomaCOMPLETEDPHASE22010-012013-032013-03
NCT01053143Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in IndiaCOMPLETEDPHASE32010-012010-092010-08
NCT01079364Better Acceptance of Single Injection Apidra Added to Once Daily Lantus Versus Twice Daily Premixed Insulin in Real Life Use SettingTERMINATEDPHASE42010-012012-072012-07
NCT01064141A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the PhilippinesCOMPLETEDPHASE22010-012012-112012-09
NCT01063946A Study to Investigate the Disposition of Radio-labeled AVE8062 Compound Administered as a 30-minute IV Infusion to Patients With Advanced Solid TumorCOMPLETEDPHASE12010-012011-092011-03
NCT01062477A Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy InfantsCOMPLETEDPHASE32010-012011-122011-09
NCT01049035A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and ToddlersCOMPLETEDPHASE22009-12-162012-02-132012-02-13
NCT01027364Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia BCOMPLETEDPHASE32009-122012-072012-07
NCT01027377Study of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Subjects With Severe Hemophilia ACOMPLETEDPHASE12009-122011-052010-07
NCT01040052A Study to Assess the Safety of Adacel® VaccineCOMPLETEDPHASE32009-122010-042010-02
NCT01033292A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Resistant Recurrent Ovarian CancerCOMPLETEDPHASE22009-122012-122012-12
NCT01033123A Single-Arm Study Evaluating Carboplatin/Gemcitabine in Combination With BSI-201 in Patients With Platinum-Sensitive Recurrent Ovarian CancerCOMPLETEDPHASE22009-122012-022012-02
NCT00990054Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid LeukemiaCOMPLETEDPHASE12009-122012-032012-03
NCT01031303Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of AgeCOMPLETEDPHASE42009-122011-012010-09
NCT00891202A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)COMPLETEDPHASE32009-112016-012012-07
NCT01023399Artesunate Plus Amodiaquine in Malaria in Cote d'IvoireCOMPLETEDPHASE42009-112013-102013-10
NCT01026090Dronedarone Pattern of Use in Patients Scheduled for Elective Cardioversion (ELECTRA)TERMINATEDPHASE42009-112011-122011-12
NCT01038661Tax First-line Chemotherapy With Different Doses and Then Maintenance TherapyCOMPLETEDPHASE32009-112012-082012-08
NCT01001221Dose-Escalation, Safety, Pharmacokinetics Study of Cabazitaxel With Gemcitabine In Patients With Solid TumorTERMINATEDPHASE1, PHASE22009-112011-102011-10
NCT01007175Study Evaluating Multiple Ascending Doses Of ATN-103 In Japanese Subjects With Rheumatoid ArthritisCOMPLETEDPHASE1, PHASE22009-112010-092010-09
NCT01024192Efficacy and Safety Assessment of ZOlpidem (Stilnox CR) in Patients With Chronic insomNIACOMPLETEDPHASE42009-112010-072010-07
NCT00993447Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin AmericaCOMPLETEDPHASE22009-102012-032011-09
NCT0097528624-week Treatment With Lixisenatide in Type 2 Diabetes Insufficiently Controlled With Metformin and Insulin GlargineCOMPLETEDPHASE32009-102011-082011-08
NCT00991133A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL)COMPLETEDPHASE12009-102011-042011-04
NCT00701129An Exploratory Study of the Safety and Efficacy of Prophylactic Immunomodulatory Treatment in Myozyme-naive Cross-Reacting Immunologic Material (CRIM[-]) Patients With Infantile-Onset Pompe DiseaseCOMPLETEDPHASE42009-102013-032013-03
NCT00988143A Study of Influenza Virus Vaccines in Children and AdultsCOMPLETEDPHASE22009-102010-032009-12
NCT009934736-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 DiabetesCOMPLETEDPHASE32009-102011-032011-03
NCT01013571Self Titration With Apidra to Reach Target Study (START)COMPLETEDPHASE42009-102012-012012-01
NCT00952276A Study of Different Formulations of an Adjuvanted A/H1N1 Pandemic Vaccine in Healthy Adults and the ElderlyCOMPLETEDPHASE22009-102011-032010-12
NCT00988507Dose Ranging Study of Ferroquine With Artesunate in African Adults and Children With Uncomplicated Plasmodium Falciparum MalariaTERMINATEDPHASE22009-102010-112010-11
NCT00988897Colorectal Cancer RECHALLENGEWITHDRAWNPHASE22009-102012-052012-05
NCT05918627A Study to Determine the Effect of Multiple Oral Doses of SLx-2119 in Healthy Male SubjectsCOMPLETEDPHASE12009-09-212009-12-092009-12-09
NCT01020383Comparative Study of ALX-0081 Versus GPIIb/IIIa Inhibitor in High Risk Percutaneous Coronary Intervention (PCI) PatientsCOMPLETEDPHASE22009-092012-032011-04
NCT00943111A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ENCORE)COMPLETEDPHASE32009-092015-062012-11
NCT00993382Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or DeathCOMPLETEDPHASE22009-092011-052011-05
NCT01011049Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IMCOMPLETEDPHASE22009-092010-102010-05
NCT00968916Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 in Patients With Solid TumorsCOMPLETEDPHASE12009-092011-082011-08
NCT00956046A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 MonthsCOMPLETEDPHASE22009-092011-062011-01
NCT00994851Evaluation of Cassia Fistula + Senna Alexandrina Miller in the Chronic Functional Constipation Treatment.COMPLETEDPHASE32009-092012-082012-08
NCT00959036Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid ArthritisCOMPLETEDPHASE1, PHASE22009-092011-012011-01
NCT00976027Multi-Year Study of Fluzone High-Dose Influenza Vaccine Compared With Fluzone® Vaccine in Adults Aged 65 Years and OlderTERMINATEDPHASE32009-092012-042011-05
NCT00981240Dose Escalation, Safety and Pharmacokinetic Study of SAR103168 in Patients Refractory/ Relapsed Acute Leukemias or High-risk Myelodysplastic SyndromesCOMPLETEDPHASE12009-092012-022012-01
NCT00995293Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration TrialCOMPLETEDPHASE32009-08-272018-01-262018-01-26
NCT01001988Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in ToddlersCOMPLETEDPHASE32009-08-072013-10-162013-10-16
NCT00930553An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of AlemtuzumabCOMPLETEDPHASE32009-082016-022016-02
NCT0097693724-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 YearsCOMPLETEDPHASE32009-082011-032011-03
NCT00952419A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Children Aged 6 Months to 9 YearsCOMPLETEDPHASE22009-082010-062010-03
NCT00953524A Study of Different Formulations of an A/H1N1 Pandemic Vaccine in Healthy Adults and the ElderlyCOMPLETEDPHASE22009-082010-122010-03
NCT00954798A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the ElderlyCOMPLETEDPHASE22009-082011-032010-12
NCT00956202A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 YearsCOMPLETEDPHASE22009-082010-112010-09
NCT01129427Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Pantoprazole 80 mg in Healthy SubjectsCOMPLETEDPHASE12009-082009-112009-11
NCT00971581Safety, Tolerability and Efficacy Study With a Fixed-Dose Combination (FDC) Ketoprofen Plus OmeprazoleCOMPLETEDPHASE32009-082010-052010-05
NCT00928785Study Comparing a Tdap-IPV Combined Vaccine With a Tetanus Monovalent Vaccine in Healthy AdultsCOMPLETEDPHASE32009-072009-122009-12
NCT00948272Study of Purified Vero Rabies Vaccine Serum Free Compared With Reference Purified Vero Rabies Vaccine in Healthy AdultsCOMPLETEDPHASE22009-072011-082011-02
NCT00942799Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid TumorsCOMPLETEDPHASE12009-072013-012013-01
NCT00938652A Phase 3, Multi-Center Study of Gemcitabine/Carboplatin, With or Without BSI-201, in Patients With ER-, PR-, and Her2-Negative Metastatic Breast CancerCOMPLETEDPHASE32009-072012-022011-01
NCT00965549Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes PatientsCOMPLETEDPHASE42009-072012-122012-12
NCT00949442Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) TreatmentCOMPLETEDPHASE42009-072012-072012-07
NCT00964574Test of the Efficacy and Safety of Insulin Glulisine Injected Subcutaneously in Patients With Type 1 Diabetes MellitusCOMPLETEDPHASE42009-072010-072010-07
NCT01008774START: Swiss Taxotere Alopecia Prevention TrialCOMPLETEDNA2009-072011-102011-10
NCT00950534Effectiveness and Safety of Two Approaches to the Management of Type 2 Diabetes Mellitus in Australian Primary CareTERMINATEDPHASE42009-072010-082010-08
NCT00950066Irbesartan and Amlodipine Combination in Controlling Blood PressureCOMPLETEDPHASE22009-072010-012010-01
NCT00957060Superiority of Glimepiride Over Sitagliptin in Naive Type 2 Diabetes PatientsCOMPLETEDPHASE42009-072010-102010-10
NCT00956644Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg MonotherapyCOMPLETEDPHASE32009-072010-082010-08
NCT00957554Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Irbesartan 150 mg MonotherapyCOMPLETEDPHASE32009-072010-092010-09
NCT06143904A Study to Evaluate Absolute Bioavailability, Absorption, Metabolism, and Excretion of Genz-112638 in Healthy Male ParticipantsCOMPLETEDPHASE12009-06-032009-07-052009-07-05
NCT00925743A Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid CancerCOMPLETEDPHASE12009-062013-032013-03
NCT00921661Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal CancerCOMPLETEDPHASE12009-062012-062012-06
NCT00941369Health Assessment, Patient Treatment Satisfaction and Quality-of-Life in Insulin-Naive Type 2 Diabetes PatientsCOMPLETEDPHASE42009-062012-102012-10
NCT00917748Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF)COMPLETEDPHASE32009-062011-032011-03
NCT00851903Evaluation of Insulin Glargine in Combination With Sitagliptin in Type 2 Diabetes Patients: EASIE Extension TrialCOMPLETEDPHASE32009-062011-092011-09
NCT00931372Lixisenatide for Restoration of Insulin Release in Subjects With Diabetes Mellitus Type 2COMPLETEDPHASE12009-062009-082009-08
NCT01129414Interaction Study of Clopidogrel 600/150 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy SubjectsCOMPLETEDPHASE12009-062009-082009-08
NCT00913614Single Dose Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluation of Eplivanserin in Children With InsomniaCOMPLETEDPHASE12009-062009-122009-12
NCT00932984Dermacyd Silver Floral (Lactic Acid) - Photo EvaluationCOMPLETEDPHASE32009-062009-072009-07
NCT00933712Dermacyd Silver Floral (Lactic Acid) - Compatibility.COMPLETEDPHASE32009-062009-072009-07
NCT00933946Dermacyd Silver Frutal (Lactic Acid) - Compatibility.COMPLETEDPHASE32009-062009-072009-07
NCT00933075Dermacyd Silver Frutal (Lactic Acid) - Photo Evaluation.COMPLETEDPHASE32009-062009-072009-07
NCT00933257Dermacyd PH_DESILSTY_FR (Lactic Acid) - Photo Evaluation - Stay on FrutalCOMPLETEDPHASE32009-062009-072009-07
NCT00933413Dermacyd Silver Frutal (Lactic Acid) - Acceptability.COMPLETEDPHASE32009-062009-072009-07
NCT00933907Dermacyd PH_DESILSTY_FR (Lactic Acid) - Compatibility - Stay on FrutalCOMPLETEDPHASE32009-062009-072009-07
NCT00933504Dermacyd Silver Floral (Lactic Acid) - Compatibility - Stay on FloralCOMPLETEDPHASE32009-062009-072009-07
NCT00933699Dermacyd PH_DESILSTY_FL (Lactic Acid) - Acceptability - Stay on Floral.COMPLETEDPHASE32009-062009-072009-07
NCT00932945Dermacyd PH_DESILSTY_FR (Lactic Acid) - Acceptability - Stay on FrutalCOMPLETEDPHASE32009-062009-072009-07
NCT00933842Dermacyd PH_DESILSTY_FL (Lactic Acid) - Photo Evaluation - Stay on FloralCOMPLETEDPHASE32009-062009-072009-07
NCT00933569Dermacyd Silver Floral (Lactic Acid) - Acceptability.COMPLETEDPHASE32009-062009-072009-07
NCT00929877KRYSTAL- KetopRofen lYsinate Sore ThroAt LozengesCOMPLETEDPHASE32009-062010-042010-04
NCT00905255GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy (GETGOAL-MONO Japan LTS)COMPLETEDPHASE32009-052011-012011-01
NCT00807170Investigate the Maximum Tolerated Dose of Vandetanib and Concurrent Whole Brain Radiotherapy (WBRT) in Patients With Non-small Cell Lung Cancer (NSCLC) and Brain MetastasesTERMINATEDPHASE12009-052010-082010-08
NCT00946179Study of Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 FormulationCOMPLETEDPHASE22009-052009-072009-06
NCT00945438Study of the Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation (Intradermal Route)COMPLETEDPHASE22009-052009-072009-06
NCT00924573Comparative Study of HOE490 O (Glimepiride and Metformin) Compared With Placebo on Top of GlimepirideCOMPLETEDPHASE32009-052010-032010-03
NCT00914277SAR407899 Single-dose in Treatment of Mild to Moderate Erectile DysfunctionCOMPLETEDPHASE22009-052009-102009-09
NCT00880893Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in SingaporeCOMPLETEDPHASE22009-04-072014-10-142014-10
NCT00862836Addition of Vandetanib to Standard Therapy Pegliposomal Doxorubicin (PLD)TERMINATEDPHASE1, PHASE22009-042010-092010-09
NCT00876044A Study to Evaluate the Effects of Aflibercept on QTc Interval in Cancer PatientsCOMPLETEDPHASE12009-042010-112010-02
NCT00883337A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple SclerosisCOMPLETEDPHASE32009-042015-052011-09
NCT00884182Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in ChildrenCOMPLETEDPHASE22009-042010-062010-03
NCT00885157Immunogenicity and Safety of a Fractional Booster Dose of IPV Intradermally Versus Full Dose IntramuscularlyCOMPLETEDPHASE22009-042009-122009-10
NCT00908921Efficacy and Safety of Glimepiride as Oral Anti-Diabetic (OAD) Initiation Mono-therapy in Chinese Type 2 Diabetes Mellitus (T2DM)COMPLETEDPHASE42009-042010-092010-09
NCT01129271Food Effect Study on Pharmacodynamic and Bioavailability of Clopidogrel 300/75 mg in Healthy SubjectsCOMPLETEDPHASE12009-042009-062009-06
NCT01123824Pharmacodynamic and Pharmacokinetic Study of 2 Different Dose Regimen of Clopidogrel in CYP2C19 Genotyped Healthy SubjectsCOMPLETEDPHASE12009-042009-082009-08
NCT00906048LEVOS - Levofloxacin and Rifampicin Therapy in the Treatment of OsteoArticular Prothethic InfectionTERMINATEDPHASE32009-042010-042010-04
NCT00875524Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy SubjectsCOMPLETEDPHASE22009-032014-122014-08
NCT00866658GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA)COMPLETEDPHASE32009-032010-062010-06
NCT01129388Interaction Study of Clopidogrel 300/75 mg Given Alone or With Omeprazole 80 mg 12 Hours Apart in Healthy SubjectsCOMPLETEDPHASE12009-032009-052009-05
NCT01129063Pharmacokinetic Study of Single Doses of Clopidogrel, 75 mg and 300 mg, in Healthy SubjectsCOMPLETEDPHASE12009-032009-052009-05
NCT00881270Dermacyd Infantile - Acceptability.COMPLETEDPHASE42009-032009-032009-03
NCT00842530Efficacy and Safety of Dengue Vaccine in Healthy ChildrenCOMPLETEDPHASE22009-022014-022013-09
NCT00851084Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal CancerCOMPLETEDPHASE22009-022012-012011-04
NCT00853242Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on HemodialysisCOMPLETEDPHASE22009-022009-082009-08
NCT00772343Study of a Clostridium Difficile Toxoid Vaccine (ACAM-CDIFF™) in Subjects With Clostridium Difficile InfectionCOMPLETEDPHASE22009-022012-062011-07
NCT00862420Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial DiseaseCOMPLETEDPHASE32009-022011-052011-05
NCT01129375Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy SubjectsCOMPLETEDPHASE12009-022009-052009-05
NCT00881348Dermacyd Infantile (Lactic Acid) - Photo Evaluation.COMPLETEDPHASE42009-022009-032009-03
NCT00881374Dermacyd Infantile (Lactic Acid)- Compatibility.COMPLETEDPHASE42009-022009-032009-03
NCT00833768A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on DialysisTERMINATEDPHASE32009-012009-092009-09
NCT00830648Safety of a Second Dose of Biken's Varicella VaccineCOMPLETEDPHASE42009-012009-122009-10
NCT00833703Long Term Safety of Clopidogrel in Neonates/Infants With Systemic to Pulmonary Artery Shunt PalliationCOMPLETEDPHASE32009-012010-072010-07
NCT00841880China Medical University Hospital (CMUH) Triapin ListingCOMPLETEDPHASE42009-012009-092009-09
NCT00701701Immune Tolerance Induction StudyTERMINATEDPHASE42008-12-142020-02-182020-02-18
NCT00752986ZACtima FASlodex Trial in Postmenopausal Advance Breast Cancer Patients Instead of ZACtima FASlodex TrialTERMINATEDPHASE22008-122013-092013-09
NCT00813956A Phase 2 Study of Standard Chemotherapy Plus BSI-201 (a PARP Inhibitor) in the Neoadjuvant Treatment of Triple Negative Breast CancerCOMPLETEDPHASE22008-122012-102012-10
NCT00805350Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance DifficultiesCOMPLETEDPHASE32008-122009-062009-06
NCT00811902Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple SclerosisCOMPLETEDPHASE22008-122010-032010-03
NCT00814268COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic StrokeCOMPLETEDPHASE42008-122012-052012-05
NCT00822744An Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly PatientsCOMPLETEDPHASE22008-122010-022010-02
NCT00816543Docetaxel + Oxaliplatin + S-1 in Potentially Operable Gastric or Gastroesophageal AdenocarcinomaCOMPLETEDPHASE22008-122012-052012-05
NCT00821834Safety Evaluation of Clopidogrel Sulfate in Patients With Stable Angina/Old Myocardial Infarction to Whom Percutaneous Coronary Intervention is Being PlannedCOMPLETEDPHASE32008-122010-082010-08
NCT03099213An Open-label, Non-comparative Study to Document the Tolerability to Ramipril in Patients With at Least One High Risk for Developing a Major Cardiovascular EventCOMPLETEDPHASE42008-11-012010-04-232010-04-23
NCT00799838Evaluation of Inflammatory Symptoms Reduction With Amoxicillin + Ketoprofen in Acute Pharyngeal Tonsillitis in Pediatric PatientsTERMINATEDPHASE42008-112013-062013-06
NCT00916110Study Of Single Dose Of ATN-103 Administered To Healthy Japanese Male SubjectsCOMPLETEDPHASE12008-112009-112009-11
NCT00797511Immunogenicity and Safety of Adacel Polio VaccineCOMPLETEDPHASE32008-112009-072009-04
NCT00751114Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-naive PatientsCOMPLETEDPHASE42008-112011-072011-07
NCT00811447Taxotere New Indication - Gastric Cancer Treatment Registration TrialCOMPLETEDPHASE32008-112012-062012-06
NCT00799656Efficacy and Safety Study of Ataciguat Versus Placebo in Patients With Neuropathic PainCOMPLETEDPHASE22008-112009-092009-06
NCT00791544Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver CarcinomaTERMINATEDPHASE1, PHASE22008-112009-112009-11
NCT00810121Study of Non Inferiority Bi-Profenid® 200mg Versus Bi-Profenid® 300mg Among Patients Presenting of the Post-traumatic or Rheumatologic Acute Affections of the Locomotor Apparatus (BIPROPAIN)COMPLETEDPHASE32008-112009-062009-06
NCT00788515Comparison of Volinanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance DifficultiesTERMINATEDPHASE32008-112009-012009-01
NCT00793026Dermacyd Breeze Pocket BR (Lactic Acid) - AcceptabilityCOMPLETEDPHASE32008-112008-11
NCT00794612Dermacyd Femina Pocket BR (Lactic Acid)- Acceptability.COMPLETEDPHASE32008-112008-11
NCT00693186A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXACOMPLETEDPHASE32008-102010-032009-12
NCT00753675Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract CancerCOMPLETEDPHASE22008-102012-092012-09
NCT00777179Phase II of Zactima Maintenance for Locally Advanced or Metastatic Non-small-cell Lung Carcinoma (NSCLC) Following Platinum-doublet ChemotherapyCOMPLETEDPHASE22008-102011-122010-01
NCT00753714Zactima in Non Small Cell Lung Cancer (NSCLC) ELderly Patients In Combination With or Versus GemcitabineCOMPLETEDPHASE22008-102011-122011-04
NCT00772109Study of Fluzone Vaccine Administered by Intradermal Route in Comparison With Standard Fluzone® in AdultsCOMPLETEDPHASE32008-102009-072009-05
NCT00766688Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing High Doses of Statins in Patients With Primary Severe HypercholesterolemiaTERMINATEDPHASE32008-102009-062009-04
NCT00778479Evaluation of the Safety of Sepraspray in Open Abdominal SurgeryTERMINATEDNA2008-102009-052009-05
NCT00746798Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy AdultsCOMPLETEDPHASE22008-102009-122009-06
NCT00775450Influenza Vaccine Revaccination in Ambulatory Elderly SubjectsCOMPLETEDPHASE22008-102009-072009-06
NCT00796731SAR3419 Administered Weekly in Patients With Relapsed/Refractory CD19-positive B-cell Non-Hodgkin's LymphomaCOMPLETEDPHASE12008-102012-062012-06
NCT00785811Effect of Chronic Supplementation of L-arginine in the Muscular PerformanceTERMINATEDPHASE42008-102008-122008-12
NCT00774878Study of AVE1642 (IGF-1R/CD221) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Patients With Advanced Hormono-dependent Breast CancerTERMINATEDPHASE22008-102010-112010-11
NCT00784121Dermacyd Breeze (Lactic Acid) Pocket BR - CompatibilityCOMPLETEDPHASE32008-102008-11
NCT00783861Dermacyd Femina (Lactic Acid) Pocket BR - CompatibilityCOMPLETEDPHASE32008-102008-11
NCT00783640Dermacyd Femina (Lactic Acid) Pocket BR - Photo EvaluationCOMPLETEDPHASE32008-102008-11
NCT00784069Dermacyd Breeze (Lactic Acid) Pocket BR - Photo EvaluationCOMPLETEDPHASE32008-102008-11
NCT00788151Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 YearsCOMPLETEDPHASE22008-09-262010-08-162010-02-16
NCT00763451GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of MetforminCOMPLETEDPHASE32008-092011-012011-01
NCT00763815GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of PioglitazoneCOMPLETEDPHASE32008-092011-062011-06
NCT00701415A Study of Two Fabrazyme (Agalsidase Beta) Dosing Regimens in Treatment-naïve, Male Pediatric Patients Without Severe SymptomsCOMPLETEDPHASE32008-092015-062015-06
NCT00754689Study of Rimonabant/Metformin Combinations to Investigate Diabetes (Blood Sugar) Control in Patients With Type 2 DiabetesWITHDRAWNPHASE32008-092008-112008-11
NCT00755274Annual Study for Serum Collection for Immunogenicity and Safety Evaluation in Healthy Children Receiving Fluzone®COMPLETEDPHASE42008-092009-012009-01
NCT00772525Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple SclerosisCOMPLETEDPHASE22008-092009-062009-06
NCT00813397Manageability and Safety Assessment of Sepraspray in Abdominal Surgery.COMPLETEDNA2008-092009-072009-07
NCT00750334A Study of Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS)TERMINATEDPHASE12008-092008-102008-10
NCT00838357A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma).COMPLETEDPHASE32008-092010-112010-11
NCT00741338Immune Tolerance Study With Aldurazyme® (Laronidase)COMPLETEDPHASE1, PHASE22008-092012-092012-09
NCT00756847Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid TumorsCOMPLETEDPHASE12008-092012-102012-05
NCT00761670Efficacy Study on Cognitive Functions in Schizophrenic PatientsCOMPLETEDPHASE42008-092010-012010-01
NCT00783939Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid) - Safety.COMPLETEDPHASE32008-092008-09
NCT00486889Growth and Development Study of Alglucosidase AlfaCOMPLETEDPHASE42008-08-262021-11-232021-11-23
NCT00751881An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple SclerosisCOMPLETEDPHASE32008-082015-082012-04
NCT00741715Evaluation of Efficacy and Safety of AVE5530 Co-administered With Atorvastatin in Primary HypercholesterolemiaTERMINATEDPHASE32008-082009-062009-05
NCT00743275A Study to Evaluate the Safety and Immune Responses to Fluzone® VaccinationCOMPLETEDPHASE42008-082008-112008-11
NCT00735644Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the PhilippinesCOMPLETEDPHASE32008-082009-082009-05
NCT00740155Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve AdultsCOMPLETEDPHASE22008-082010-012009-10
NCT00704080A Study of XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant GliomasCOMPLETEDPHASE12008-082013-022012-02
NCT00777699Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid TumorsCOMPLETEDPHASE12008-082011-022011-02
NCT00739206Study of SAR97276A in the Treatment of Uncomplicated and Severe Malaria in Adults and Children.TERMINATEDPHASE22008-082009-062009-06
NCT00785720Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Photo AvaluationCOMPLETEDPHASE32008-082008-092008-09
NCT00783666Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid) - Photo EvaluationCOMPLETEDPHASE32008-082008-092008-09
NCT00784056Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid) - Photo EvaluationCOMPLETEDPHASE32008-082008-092008-09
NCT00785590Dermacyd PH_DETINLYN (Lactic Acid) Sweet Flower - Photo Evaluation.COMPLETEDPHASE32008-082008-092008-09
NCT00785850Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Safety.COMPLETEDPHASE32008-082008-09
NCT00785642Dermacyd PH_DETINLYN Tangerine Mix (Lactic Acid) - Safety.COMPLETEDPHASE32008-082008-09
NCT00785148Dermacyd PH_DETINLYN Sweet Flower (Lactic Acid) - SafetyCOMPLETEDPHASE32008-082008-09
NCT00713830GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of SulfonylureaCOMPLETEDPHASE32008-072011-012011-01
NCT00715624GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal InsulinCOMPLETEDPHASE32008-072011-022011-02
NCT00729027Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing Statins in Patients With Primary HypercholesterolemiaTERMINATEDPHASE32008-072009-062009-06
NCT00718965Evaluation of Efficacy and Safety of AVE5530 in Patients With Primary HypercholesterolemiaTERMINATEDPHASE32008-072009-062008-11
NCT00728091A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional HyponatremiaTERMINATEDPHASE32008-072008-122008-12
NCT00687765Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant GliomaCOMPLETEDPHASE1, PHASE22008-072015-062015-06
NCT00719524AVE8062 in Combination With Platinum-taxane Doublet in Advanced Solid TumorCOMPLETEDPHASE12008-072013-022013-02
NCT00714597Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted MobilityTERMINATEDPHASE32008-072009-032009-03
NCT00721760Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture SurgeryCOMPLETEDPHASE32008-072009-102009-10
NCT00718224Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement SurgeryCOMPLETEDPHASE32008-072009-052009-05
NCT00785655Dermacyd PH_DETINLYN (Lactic Acid) Sweet Flower - CompatibilityCOMPLETEDPHASE32008-072008-092008-09
NCT00785681Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - CompatibilityCOMPLETEDPHASE32008-072008-092008-09
NCT00784160Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid)- CompatibilityCOMPLETEDPHASE32008-072008-092008-09
NCT00786097Dermacyd PH_DETINLYN (Lactic Acid) Tangerine Mix - CompatibilityCOMPLETEDPHASE32008-072008-092008-09
NCT00729599Safety Dermatological Evaluation: Acceptability With Odontological Follow up - Cepacol Teen.COMPLETEDPHASE32008-072008-08
NCT00712673GLP-1 Receptor Agonist Lixisenatide (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of MetforminCOMPLETEDPHASE32008-062011-032011-03
NCT00707031GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of MetforminCOMPLETEDPHASE32008-062010-112010-11
NCT00613509Study of a Multi-Antigen Therapeutic Vaccine in Patients With Metastatic MelanomaTERMINATEDPHASE22008-062010-062010-04
NCT00700635Dose Comparison Study of Menactra® in US ChildrenCOMPLETEDPHASE22008-062009-102009-05
NCT00700713Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26COMPLETEDPHASE22008-062009-032009-02
NCT00699517A Study of AVE8062 in Advanced-stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide ChemotherapiesCOMPLETEDPHASE32008-062013-042013-04
NCT00694590Study of AMD3100 (Plerixafor) and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaCOMPLETEDPHASE12008-062011-092010-11
NCT00712959Immune Responses in Adults to Revaccination With ADACEL® 10 Years After a Previous DoseCOMPLETEDPHASE42008-062009-122009-09
NCT00718146Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 FormulationCOMPLETEDPHASE22008-062008-092008-08
NCT00677079Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerCOMPLETEDPHASE22008-062008-122008-12
NCT00709904Evaluation of AVE5026 as Compared to Placebo for the Extended Prophylaxis of Venous Thromboembolism in Patients Having Undergone Hip Fracture SurgeryCOMPLETEDPHASE32008-062010-012010-01
NCT00694382Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Cancer Patients Undergoing ChemotherapyCOMPLETEDPHASE32008-062010-112010-11
NCT00697099Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement SurgeryCOMPLETEDPHASE32008-062009-062009-06
NCT00708344ACTUAL: Efficacy and Safety of Irbesartan/Hydrochlorothiazide CombinationCOMPLETEDPHASE42008-062009-072009-07
NCT00699920Cohort Study in Uganda Comparing Artesunate + Amiodaquine (Coarsucam) Versus Artemether + Lumenfantrine (Coartem) in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria AttacksCOMPLETEDPHASE42008-062010-062010-06
NCT00712868Acceptability of Lactacyd FeminaCOMPLETEDPHASE42008-062008-082008-08
NCT00694720Evaluation of the Effect of AVE0657 in Cheynes-Stokes Breathing Syndrome PatientsTERMINATEDPHASE22008-062009-032009-03
NCT00688701GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in MonotherapyCOMPLETEDPHASE32008-052009-122009-12
NCT00686036Trial Assessing Zactima Against Placebo in Prostate Cancer Subjects Undergoing Intermittent Androgen Deprivation Hormonal TherapyTERMINATEDPHASE22008-052010-102010-04
NCT00690456Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 DiabetesTERMINATEDPHASE32008-052009-022009-02
NCT00831753Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian InfantsCOMPLETEDPHASE32008-052009-112009-05
NCT00687687Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine CarcinosarcomaCOMPLETEDPHASE22008-052011-122010-03
NCT00692640Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid TumorsCOMPLETEDPHASE12008-052011-112011-11
NCT00708578Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin)COMPLETEDPHASE42008-052009-122009-12
NCT00701831Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic ControlCOMPLETEDPHASE42008-052010-102010-10
NCT00761800Dermacyd Teen Care Tangerina Mix - CompatibilityCOMPLETEDPHASE32008-052008-052008-05
NCT00617344Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the USCOMPLETEDPHASE22008-04-172010-022009-12
NCT00716716Phase I/IIa Study of FIXFc in Hemophilia B PatientsCOMPLETEDPHASE12008-042009-102009-10
NCT00631995Safety and Immunogenicity of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in ToddlersCOMPLETEDPHASE12008-042009-042009-02
NCT00601107A Study to Evaluate the Safety and Effectiveness of Doxercalciferol Capsules in Participants With Moderate to Severe PsoriasisCOMPLETEDPHASE22008-042009-062009-02
NCT00679588Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal SurgeryCOMPLETEDPHASE32008-042010-082010-08
NCT00664417Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted VaccineCOMPLETEDPHASE12008-042010-082009-09
NCT00693771Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed InsulinCOMPLETEDPHASE42008-042009-072009-07
NCT00670228Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial InfarctionTERMINATEDPHASE32008-042009-112009-11
NCT00679900Comparison of Eplivanserin and Lormetazepam in the Treatment of Insomnia Characterized by Sleep Maintenance DifficultiesCOMPLETEDPHASE32008-042009-032009-03
NCT00679146Efficacy Safety of a Combination Thiocolchicoside+Ketoprofen Compared to Thiocolchicoside Twice a Day for 7 Days in Patients Suffering From Acute Non Specific Low Back PainCOMPLETEDPHASE32008-042009-062009-06
NCT00670566Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive PatientsCOMPLETEDPHASE42008-042009-03
NCT00678483Long-Term Effect of 10 mg Versus 20 mg Rimonabant in Overweight or Obese PatientsTERMINATEDPHASE32008-042009-022008-11
NCT00705276Dermacyd Femina Delicata (Lactic Acid)- Photo Dermatological Evaluation of the Irritation and Sensitivity PotentialCOMPLETEDPHASE32008-042008-05
NCT00705744Dermacyd Femina (Lactic Acid) - Photo Dermatological Evaluation of the Irritation and Sensitivity Potential.COMPLETEDPHASE32008-042008-05
NCT00644124Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell LymphomaCOMPLETEDPHASE12008-032011-102011-10
NCT00654901Study of the DTaP-IPV-Hep B-PRP~T Combined Vaccine Following a Primary Series of DTacP IPV-HepB-PRP-T or Infanrix Hexa™COMPLETEDPHASE32008-032009-072009-05
NCT00621764Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and ChildrenCOMPLETEDPHASE22008-032013-052009-12
NCT00659477Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With Oral Antidiabetic Drugs (OADs) in Patients With Diabetes Mellitus, Type 2 (DMT2)COMPLETEDPHASE42008-032009-062009-06
NCT00679562Lactacyd Radiance (Lactic Acid) Prophetic Patch TestCOMPLETEDPHASE22008-032008-04
NCT00622700Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple SclerosisCOMPLETEDPHASE32008-022016-022012-12
NCT00659438Efficacy and Safety of Zactima™ in Patients With Castration-refractory Metastatic Prostate CancerCOMPLETEDPHASE22008-022011-072010-11
NCT00629551An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive DisorderCOMPLETEDPHASE32008-022009-022009-02
NCT00625664Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder CancerCOMPLETEDPHASE32008-022011-022011-02
NCT00602745S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based RegimenTERMINATEDPHASE32008-022010-032010-03
NCT00577148An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients With Type 2 DiabetesTERMINATEDPHASE32008-022009-022009-02
NCT00690937A Multicenter, Active and Placebo-controlled Study of Enteric Coated Sevelamer in Patients With Mild to Moderate HypercholesteremiaCOMPLETEDPHASE22008-022008-122008-12
NCT00623181Study to Determine a Preference for Fluzone Vaccine Given Intradermally (ID) and Intramuscularly (IM) in Healthy AdultsCOMPLETEDPHASE22008-012008-062008-05
NCT00576667An Efficacy and Safety Study of Rimonabant for Treatment of Nonalcoholic Steatohepatitis (NASH) in Patients Without DiabetesTERMINATEDPHASE32008-012009-022009-02
NCT00603577Role of Xaliproden on Recovery Rate From Severe Neuropathy in Patients Who Have Completed Adjuvant Chemotherapy With Oxaliplatin Based RegimensTERMINATEDPHASE32008-012009-112009-11
NCT00604058Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses IntramuscularlyCOMPLETEDPHASE22008-012008-122008-09
NCT00622648Study to Evaluate the Mortality Reduction of Enoxaparin in Hospitalized Acutely Ill Medical Receiving EnoxaparinCOMPLETEDPHASE42008-012010-122010-12
NCT00607087Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes MellitusCOMPLETEDPHASE42008-012009-062009-06
NCT00627471Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2)TERMINATEDPHASE42008-012009-03
NCT00614250Evaluation of the Effect of AVE0657 on Obstructive Sleep ApneaCOMPLETEDPHASE22008-012009-012009-01
NCT00602680Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's DiseaseTERMINATEDPHASE22008-012008-072008-07
NCT00668486Dermacyd Delicata Breeze - Photo EvaluationCOMPLETEDPHASE32008-012008-02
NCT00664391Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd BreezeCOMPLETEDPHASE32008-012008-02
NCT00687037Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela PowerCOMPLETEDPHASE32008-012008-02
NCT00597116An Efficacy and Safety Study With Vandetanib to Treat Inoperable or Relapsed Malignant MesotheliomaTERMINATEDPHASE22007-122010-012010-01
NCT00574275Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic CancerTERMINATEDPHASE32007-122010-112009-10
NCT00619502Study of Immunogenicity and Safety of a Booster Dose of DTaP-IPV-HB-PRP~T Combined Vaccine in Healthy Turkish InfantsCOMPLETEDPHASE32007-122008-072008-07
NCT00580216Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial FibrillationTERMINATEDPHASE32007-122010-102010-10
NCT00576823Alfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic EtiologyCOMPLETEDPHASE32007-122009-102009-01
NCT00596206Leflunomide EfficAcy Response Related to Dosing Regimen in Early Rheumatoid ArthritisCOMPLETEDPHASE32007-122009-102009-10
NCT00599417PulmonarOM (Bacterial Lysates) in Respiratory Tract InfectionsCOMPLETEDPHASE42007-122008-092008-09
NCT00668577Dermatological Evaluation of Topic Compatibility - Dermacyd BreezeCOMPLETEDPHASE32007-122008-02
NCT00669058Dermatological Evaluation of Topic Compatibility-Dermacyd Tina Gel Tangerina MixCOMPLETEDPHASE32007-122008-01
NCT00668668Dermatological Evaluation of Topic Compatibility-Dermacyd Tina Gel Sweet FlowerCOMPLETEDPHASE32007-122008-01
NCT00663325Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet FlowerCOMPLETEDPHASE32007-122008-01
NCT00663390Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Delicata Pocket BRCOMPLETEDPHASE32007-122008-01
NCT00663273Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet FlowerCOMPLETEDPHASE32007-122008-01
NCT00668226Dermacyd Delicata Pocket BR - Photo EvaluationCOMPLETEDPHASE32007-122008-01
NCT00624390Sepraspray™ Laparoscopic Myomectomy StudyCOMPLETEDNA2007-112008-122008-12
NCT00564226SSR240600C Treatment in Women With Overactive BladderCOMPLETEDPHASE22007-112009-022009-02
NCT00566657Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin LesionsCOMPLETEDPHASE32007-112012-082010-08
NCT00565448Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and AdolescentsCOMPLETEDPHASE22007-112012-012009-03
NCT00594347Immunogenicity and Safety of a Booster Dose of Pneumo 23® in 12 to 18 Months-Old Children Primed With PrevnarCOMPLETEDPHASE32007-112009-042008-03
NCT00665314Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM).COMPLETEDPHASE22007-112009-062008-04
NCT00606359Immunogenicity of the Inactivated Split-Virion Influenza Vaccine in Renal Transplant SubjectsCOMPLETEDPHASE22007-112008-062008-02
NCT00561470Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based RegimenCOMPLETEDPHASE32007-112012-062011-02
NCT00668889Dermacyd Tina Gel Tangerina Mix - Photo EvaluationCOMPLETEDPHASE32007-112008-01
NCT00668629Dermacyd Tina Gel Sweet Flower - Photo EvaluationCOMPLETEDPHASE32007-112008-01
NCT00668460Dermatological Evaluation of Topic Compatibility-Dermacyd Delicata Pocket BRCOMPLETEDPHASE32007-112008-01
NCT00554333Comparative Study of Immunogenicity and Safety of Flu-ID Vaccine Versus Flu-IM VaccineCOMPLETEDPHASE32007-102007-122007-12
NCT00545454Activity and Safety of Oral Administration of SSR150106XB for the Reduction of Inflammation in Patients With Active Rheumatoid ArthritisCOMPLETEDPHASE22007-102008-062008-06
NCT00548405Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study TwoCOMPLETEDPHASE32007-102011-092011-09
NCT00561002Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® VaccineCOMPLETEDPHASE42007-102008-062008-05
NCT00551031Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly SubjectsCOMPLETEDPHASE22007-102008-112008-06
NCT00542828Rabbit Anti-thymocyte Globulin in the Treatment of Patients With Low to Intermediate-1 Risk Myelodysplastic SyndromeTERMINATEDPHASE22007-102009-072009-05
NCT00549939Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder DysfunctionCOMPLETEDPHASE32007-102009-122009-03
NCT00607152Rasburicase (Fasturtec) Registration TrialTERMINATEDPHASE32007-102009-012009-01
NCT00545701Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in AdultsCOMPLETEDPHASE22007-102008-092008-06
NCT00545246A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer PatientsCOMPLETEDPHASE12007-102012-072012-07
NCT00874549Exploratory Trial to Evaluate the Safety and Immunogenicity of Menactra® and Menomune® Vaccines in Subjects ≥ 56 YearsCOMPLETEDPHASE1, PHASE22007-102008-102008-01
NCT00811395Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple SclerosisCOMPLETEDPHASE22007-102010-042010-04
NCT00540358A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast CancerCOMPLETEDPHASE22007-102010-062009-11
NCT00845429Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult SubjectsCOMPLETEDPHASE22007-102008-112008-08
NCT00549185Multi-dose-escalation Safety and Pharmacokinetic Study of SAR3419 as Single Agent in Relapsed/Refractory B-cell Non Hodgkin's LymphomaCOMPLETEDPHASE12007-102012-012012-01
NCT00546325REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic AgentsCOMPLETEDPHASE32007-102009-022009-02
NCT00563914A Comparative Safety and Activity Study With Ferroquine Associated With Artesunate Versus Amodiaquine Associated With Artesunate in African Adult Patients With Uncomplicated MalariaCOMPLETEDPHASE1, PHASE22007-102008-112008-11
NCT00547261Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory CancerTERMINATEDPHASE12007-102008-082008-08
NCT00537095Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid CancerCOMPLETEDPHASE22007-09-282021-11-242009-12-02
NCT00539981Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlokCOMPLETEDPHASE32007-09-152008-05-282008-05-28
NCT00532155A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung CancerCOMPLETEDPHASE32007-092011-102011-01
NCT00514709Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino InfantsCOMPLETEDPHASE32007-092009-042008-12
NCT00539032Immunology and Safety of Menactra® in Children in Saudi ArabiaCOMPLETEDPHASE32007-092009-022008-08
NCT00531622An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive DisorderCOMPLETEDPHASE32007-092009-012009-01
NCT00776438Study of Immune Response in Adults and Elderly Subjects Vaccinated With Inactivated Influenza VaccinesCOMPLETEDPHASE22007-092009-042009-02
NCT00692250A Study to Assess Any Potential Interaction Between Colesevelam and Ciclosporin in Healthy VolunteersCOMPLETEDPHASE12007-092007-12
NCT00534833Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™COMPLETEDPHASE32007-092009-032008-09
NCT00562172Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study)COMPLETEDPHASE42007-092010-102010-10
NCT00559455Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular CarcinomaCOMPLETEDPHASE22007-092010-012010-01
NCT01159353Pharmacodynamic and Pharmacokinetic Effects of Insulin Glulisine in Obese Subjects With Type 2 Diabetes After a Standard Meal in Comparison to Insulin AspartCOMPLETEDPHASE12007-092008-042008-04
NCT00540410Cohort Study in Senegal Comparing Artesunate + Amiodaquine in the Treatment of Repeated Uncomplicated Plasmodium Falciparum Malaria AttacksCOMPLETEDPHASE42007-092009-022009-02
NCT00543972Dose Escalation Safety and Pharmacokinetic Study of AVE9633 as Single Agent in Relapsed/Refractory CD33-Positive Acute Myeloid LeukemiaTERMINATEDPHASE12007-092008-082008-08
NCT00556179Lactoserum (Dermacyd Femina®) and Prevention of Recurrence of Bacterial VaginosisCOMPLETEDPHASE42007-092008-12
NCT00519285Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate CancerCOMPLETEDPHASE32007-082012-042012-04
NCT00524940Trial to Describe the Safety and Immunogenicity of Fluzone®COMPLETEDPHASE22007-082007-122007-09
NCT00530348Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study OneCOMPLETEDPHASE32007-082011-042011-04
NCT00655265A Study of the Safety and Efficacy of Patients With Familial Hypercholesterolaemia Taking Colesevelam as add-on Therapy to Their Existing MedicationCOMPLETEDPHASE42007-082009-102008-12
NCT00454220Study to Determine the Dose, the Safety and Effectiveness of a New Drug, Modified Release rhTSH, in Patients With Multinodular GoiterCOMPLETEDPHASE22007-072011-072011-07
NCT00502515Dose-effect of SSR180575 in Diabetic NeuropathyCOMPLETEDPHASE22007-072009-022009-02
NCT00508001Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)COMPLETEDPHASE22007-072009-062008-11
NCT00665730Evaluation of the Safety and Effectiveness of Sepraspray™ in Reducing Post-surgical AdhesionsTERMINATEDNA2007-072008-062008-06
NCT00514917A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)TERMINATEDPHASE32007-072012-092012-09
NCT00819013Safety Study of Recombinant M2e Influenza-A Vaccine in Healthy AdultsCOMPLETEDPHASE12007-072009-022009-01
NCT00622115Etude (Study) Phase I Enox - UnFractionated Heparin (UFH)COMPLETEDPHASE12007-072007-112007-11
NCT00526513Study of Safety and Effectiveness of Apidra® in Combination With Basal Insulin in Patients With Type 1 & 2 Diabetes MellitusCOMPLETEDPHASE42007-072008-052008-05
NCT00500604Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate HypertensionCOMPLETEDPHASE42007-072010-012010-01
NCT00495885Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes MellitusCOMPLETEDPHASE32007-062008-102008-10
NCT00483470Immunogenicity and Safety of Sanofi Pasteur's AVAXIM 80U Pediatric Vaccine Followed by Booster DoseCOMPLETEDPHASE32007-062008-082008-05
NCT00491257A Study of the Immunogenicity and Safety of the 2007-2008 Influenza VaccineCOMPLETEDPHASE22007-062007-072007-07
NCT00491985Safety and Immunogenicity of 2 Formulations of an Intramuscular A/H5N1 Pandemic Influenza Vaccine in ChildrenCOMPLETEDPHASE22007-062010-062009-12
NCT00485719Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid TumorsCOMPLETEDPHASE12007-062012-092012-09
NCT00486135Study of the Safety and Pharmacokinetics of XL147 (SAR245408) in Adults With Solid Tumors or LymphomaCOMPLETEDPHASE12007-062012-102012-10
NCT00485979Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer PatientsCOMPLETEDPHASE22007-062010-082010-08
NCT00489736Efficacy & Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial FibrillationCOMPLETEDPHASE32007-062008-102008-10
NCT00507845Use of Ramipril and Felodipine Combination Therapy in Hypertension: An Effectiveness Study With Local Patients in ArgentinaCOMPLETEDPHASE42007-062008-04
NCT00495339MDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary TuberculosisCOMPLETEDPHASE42007-062008-04
NCT00531232A Dose Confirmation Study of Oral Clofarabine for Adult Patients Previously Treated for Myelodysplastic Syndromes (MDS)COMPLETEDPHASE22007-05-072011-05-122011-05-12
NCT00483574Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy ToddlersCOMPLETEDPHASE32007-052009-042009-01
NCT00444626A Study to Compare the Safety and Effectiveness of a Non-FDA Approved Device Dermal Gel Extra (DGE) and an FDA Approved Device for the Correction of Nasolabial Folds (NLFs)COMPLETEDPHASE32007-052008-072008-02
NCT00464321Safety Study of GC1008 in Patients With Focal Segmental Glomerulosclerosis (FSGS) of Single Doses of GC1008 in Patients With Treatment Resistant Idiopathic FSGSCOMPLETEDPHASE12007-052010-022010-01
NCT00483379High Dose or High Dose Frequency Study of Alglucosidase AlfaCOMPLETEDPHASE42007-052010-072009-12
NCT00489489Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple SclerosisCOMPLETEDPHASE22007-052009-062009-06
NCT00497783Acceptability Lactoserum (Dermacyd Delicata - New Fragrance)COMPLETEDPHASE42007-05
NCT00497692Topic Compatibility Lactoserum (Dermacyd Delicata - New Fragrance)COMPLETEDPHASE42007-05
NCT00464243Efficacy and Safety of Volinanserin on Sleep Maintenance Insomnia - Polysomnographic StudyCOMPLETEDPHASE32007-042008-012008-01
NCT00478595Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients With Oral Anti-diabetic DrugTERMINATEDPHASE32007-042009-022009-02
NCT00478972Japanese Study With Rimonabant in Obese Type 2 Diabetic Patients on Diet and ExerciseTERMINATEDPHASE32007-042009-012009-01
NCT00464061Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes MellitusTERMINATEDPHASE32007-042009-032009-03
NCT00463021A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® InjectionCOMPLETEDPHASE42007-042007-12
NCT00466635A Study to Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated DiarrheaTERMINATEDPHASE32007-042007-08
NCT00467519Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of AgeCOMPLETEDPHASE32007-042009-122009-11
NCT00475865Phase II Study of Teriflunomide as Adjunctive Therapy to Glatiramer Acetate in Subjects With Multiple SclerosisCOMPLETEDPHASE22007-042009-102009-10
NCT00488527DOMME Dose Optimization Multicentric Mexican EvaluationCOMPLETEDPHASE42007-042008-122008-12
NCT00539448Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics StudyCOMPLETEDPHASE42007-042008-122008-12
NCT00500292A Phase II Study of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal CancerCOMPLETEDPHASE22007-032016-112008-03
NCT00454116A Phase II, Double Blind Study of 2 Doses of ZACTIMA™(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in PatientsCOMPLETEDPHASE22007-032009-112008-03
NCT00449605A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 DiabetesTERMINATEDPHASE32007-032009-032008-11
NCT00455195Late-Onset Treatment Study Extension ProtocolCOMPLETEDPHASE42007-032008-112008-10
NCT00464633Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)COMPLETEDPHASE22007-032011-122011-12
NCT00457249A Trial to Evaluate the Safety and Immunogenicity of ADACEL® Vaccine in Persons 65 Years of Age and OlderCOMPLETEDPHASE42007-032008-112008-09
NCT00446030Pilot Study of the Safety & Efficacy of Two Docetaxel-Based Regimens Plus Bevacizumab for the Adjuvant Treatment of Subjects With Node Positive or High Risk Node Negative Breast CancerCOMPLETEDPHASE22007-032010-082010-08
NCT00453570Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 MonthsCOMPLETEDPHASE32007-032009-012008-12
NCT00460733SOLID-Effect of Risedronate Sodium at Distal Radius in Colle's Fracture.COMPLETEDPHASE42007-032011-092011-09
NCT00449072Study of Triamcinolone Acetonide on the Growth Velocity of Children, Ages 3 to 9, With Perennial Allergic Rhinitis (PAR)COMPLETEDPHASE42007-032011-102011-10
NCT00479076A Phase I Study of Intravenous Aflibercept in Combination With S-1 in Japanese Cancer PatientsCOMPLETEDPHASE12007-032011-012011-01
NCT00458081Evaluation of the Rimonabant Impact on the Regression of Asymptomatic Damage Caused by Cardiovascular Risk FactorsTERMINATEDPHASE32007-032009-012009-01
NCT00471965Oxaliplatin + 5-FluoroUracil/LeucoVorin (5-FU/LV) (FOLFOX4) Versus Doxorubicin as Palliative Chemotherapy in Advanced Hepatocellular Carcinoma PatientsCOMPLETEDPHASE32007-032010-032010-03
NCT00723216Japanese Efficacy and Safety Study of Enoxaparin in Patients With Curative Abdominal Cancer SurgeryCOMPLETEDPHASE32007-032007-122007-12
NCT00535340An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Generalized Anxiety DisorderTERMINATEDPHASE32007-032007-082007-08
NCT00457353ENterogermina® (Bacillus Clausii) In the manaGeMent of diarrheA in ChildrenCOMPLETEDPHASE32007-032007-12
NCT00443287Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial DiseaseCOMPLETEDPHASE22007-022008-102008-10
NCT00447525REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old ChildrenCOMPLETEDPHASE32007-022008-012008-01
NCT00439634Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in SchizophreniaTERMINATEDPHASE22007-022009-092009-09
NCT00444951Immunogenicity and Safety of Menactra® Vaccine in Adolescents in Saudi ArabiaCOMPLETEDPHASE32007-022009-022008-02
NCT00454350A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on HemodialysisCOMPLETEDPHASE42007-022007-07
NCT01444001Study of an Investigational Pneumococcal Vaccine in Healthy Adult VolunteersCOMPLETEDPHASE12007-022007-082007-08
NCT00434096Japanese Study of Rimonabant in Obese Patients With Dyslipidemia (VENUS)TERMINATEDPHASE32007-022009-022008-11
NCT00440154A Study Evaluating the Safety and Efficacy of AVE5530 (4 Weeks) in Patients With Mild to Moderate HypercholesterolemiaCOMPLETEDPHASE22007-022007-102007-10
NCT00418886Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC PatientsCOMPLETEDPHASE32007-012023-02-142008-09
NCT00422682A Study Evaluating BSI-201 in Combination With Chemotherapeutic Regimens in Subjects With Advanced Solid TumorsCOMPLETEDPHASE12007-012012-102009-01
NCT00417469A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)COMPLETEDPHASE32007-012007-02
NCT00457509Safety and Immunogenicity of H5N1 Adjuvanted, Inactivated, Split-Virion Pandemic Influenza Vaccine in Healthy AdultsCOMPLETEDPHASE12007-012010-092009-11
NCT00436839Taxotere Prostate Cancer New Indication Registration Trial in ChinaCOMPLETEDPHASE32007-012012-062012-06
NCT00441259Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending AgeCOMPLETEDPHASE22007-012011-122011-02
NCT00429260A Study Evaluating the Safety and Tolerability of Abrupt Discontinuation of Saredutant in Patients With DepressionCOMPLETEDPHASE32007-012007-062007-06
NCT00417079XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate CancerCOMPLETEDPHASE32007-012009-092009-09
NCT00378573Multicenter Evaluation of Docetaxel, Gemcitabine, and Bevacizumab Combination Followed by Bevacizumab Alone in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung CancerTERMINATEDPHASE22007-012008-092008-09
NCT00467376Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes MellitusCOMPLETEDPHASE32007-012008-06
NCT00432575Efficacy and Safety of Surinabant Treatment as an Aid to Smoking Cessation (SURSMOKE)COMPLETEDPHASE22007-012008-042008-04
NCT00432614Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive DisorderCOMPLETEDPHASE32007-012008-022008-02
NCT00450138Open Label, Phase I ZD6474 Head and Neck Cancer StudyCOMPLETEDPHASE12006-122011-112009-11
NCT00417209Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing RegimenCOMPLETEDPHASE32006-122009-112009-07
NCT00417118An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety DisorderCOMPLETEDPHASE32006-122008-042008-04
NCT00415142An Eight-week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive DisorderCOMPLETEDPHASE32006-122008-022008-02
NCT00422292Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy ToddlersCOMPLETEDPHASE32006-122009-042009-01
NCT00410566Safety Study of rhASM Enzyme Replacement Therapy in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease)TERMINATEDPHASE12006-122009-042009-03
NCT01606384Evaluation of the Potential Effects of SSR149415 on the Hypothalamic-pituitary-adrenal Axis in Outpatients With Major Depressive DisorderCOMPLETEDPHASE22006-122007-082007-08
NCT00405808Rimonabant in Abdominally Obese Patients With Impaired Fasting Blood GlucoseTERMINATEDPHASE32006-122009-022009-02
NCT00412698European Trial About Effect of RimoNabant on Abdominal Obese Patients With dysLipidemiaTERMINATEDPHASE32006-122009-012009-01
NCT00477373Gulf Evaluation of VAlproate (Depakine Chrono) in maNia StudyCOMPLETEDPHASE42006-122007-12
NCT00424905DIAMANTE - Diseases Infectious Analysis Microflora Antibiotic EffectCOMPLETEDPHASE42006-122007-12
NCT00410761An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid CancerCOMPLETEDPHASE32006-11-232024-07-262009-07-31
NCT00404924ZD6474 (ZACTIMA™) Phase III Study in EGFR FailuresCOMPLETEDPHASE32006-112014-112009-10
NCT00418600A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on DialysisCOMPLETEDPHASE42006-112007-082007-06
NCT00396877Efficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To Pulmonary Artery Shunt PalliationCOMPLETEDPHASE32006-112010-022010-02
NCT00404651Lot Consistency Study of DTaP-IPV-HB-PRP~T Vaccine Administered at 2-4-6 Months of Age in Healthy InfantsCOMPLETEDPHASE32006-112008-072008-04
NCT00399464Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic HyperplasiaCOMPLETEDPHASE32006-112007-102007-10
NCT00405418Lantus Versus Levemir Treat-To-TargetCOMPLETEDPHASE42006-112008-06
NCT00397098Prevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety DisorderTERMINATEDPHASE32006-112007-092007-09
NCT00803049Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple SclerosisCOMPLETEDPHASE32006-102015-122015-12
NCT00387907Study of Larotaxel in Combination With Weekly Herceptin® in Patients With HER2 Positive Metastatic Breast CancerCOMPLETEDPHASE22006-102008-032008-03
NCT00389532Phase IV Trial to Determine the Safety and Immunogenicity of the WHO Formulation of the 2006-2007 Fluzone® VaccineCOMPLETEDPHASE42006-102008-092008-04
NCT00390884Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation.COMPLETEDPHASE42006-102008-092007-06
NCT00391053Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the ElderlyCOMPLETEDPHASE32006-102008-022007-07
NCT00389857Trial to Collect Safety Data and Sera for Immunogenicity TestingCOMPLETEDPHASE42006-102008-072007-09
NCT00373529A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)COMPLETEDPHASE22006-102010-052008-05
NCT00401531Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai InfantsCOMPLETEDPHASE32006-102008-082007-11
NCT00282581Safety Study of MVA Smallpox Vaccine in HIV-positive Subjects Who Are Vaccinia NaiveTERMINATEDPHASE12006-102007-072007-07
NCT00389103Safety Study of MVA Smallpox Vaccine in Subjects With a History of Atopic Dermatitis (AD)WITHDRAWNPHASE12006-102007-012007-01
NCT00391391Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and ChildrenCOMPLETEDPHASE22006-102007-102007-03
NCT00355121Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®COMPLETEDPHASE22006-102009-072009-06
NCT00396591AVE0005 (VEGF Trap) in Patients With Recurrent Symptomatic Malignant AscitesCOMPLETEDPHASE22006-102008-112008-11
NCT00390650A North-American Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety DisorderCOMPLETEDPHASE32006-102007-112007-11
NCT00408148High Density Lipoprotein TurnoverTERMINATEDPHASE32006-102008-122008-12
NCT00393744Efficacy Study of Pristinamycin Versus Amoxicillin to Treat Tonsillitis Induced by Streptococcus in ChildrenCOMPLETEDPHASE32006-102008-03
NCT00434681Paracetamol Oral Paediatric Suspension at 4.8% : Study of Acceptability and Safety.COMPLETEDPHASE32006-102007-04
NCT00503711Phase I Chinese PKCOMPLETEDPHASE12006-092007-112007-11
NCT00384397A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy ToddlersCOMPLETEDPHASE32006-092009-022008-08
NCT00390533An Eight-week Study to Evaluate the Efficacy and Safety of 2 Doses of Saredutant in Patients With Generalized Anxiety DisorderCOMPLETEDPHASE32006-092008-022008-02
NCT00382304A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated DiarrheaCOMPLETEDPHASE22006-092007-09
NCT00355654Study to Compare Booster Vaccination With Pediacel® to Infanrix® Hexa When Both Are Co-Administered With Prevenar®COMPLETEDPHASE32006-092008-072007-09
NCT00356460Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant MelanomaCOMPLETEDPHASE12006-092009-052009-05
NCT00313950Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined VaccineCOMPLETEDPHASE42006-092010-042009-12
NCT00383526Study of Inactivated, Split-Virion Influenza Vaccine Compared With the Reference Vaccine Vaxigrip® in the ElderlyCOMPLETEDPHASE32006-092009-092009-06
NCT00383539Lot-to-Lot Consistency Study of the Investigational, Inactivated, Split-Virion Influenza Vaccine in AdultsCOMPLETEDPHASE32006-092007-122007-07
NCT00382720Docetaxel and Oxaliplatin in Gastric CancerCOMPLETEDPHASE22006-092010-042010-04
NCT00388583Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly SubjectsCOMPLETEDPHASE22006-092008-092007-06
NCT00387946Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN)COMPLETEDPHASE32006-092007-092007-09
NCT01233895Study of AVE1642 Anti-IGF1R Monoclonal Antibody in Patients With Advanced Multiple MyelomaCOMPLETEDPHASE12006-092008-092008-09
NCT00941343Benign Prostatic Hyperplasia in TaiwanCOMPLETEDNA2006-092008-092008-09
NCT00386191Safety and Efficacy of Clopidogrel for Cerebral Infarction TreatmentCOMPLETEDPHASE42006-092008-122008-12
NCT00349986LANTUSTITR: Insulin Glargine in Type 2 Diabetes MellitusTERMINATEDPHASE42006-092007-06
NCT00443612Irbesartan/Hydrochlorothiazide National Taiwan University Hospital ListingCOMPLETEDPHASE42006-092008-10
NCT00385307Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS)COMPLETEDPHASE32006-092007-112007-11
NCT00380302Activity of AVE1625 in Mild to Moderate Alzheimer's Patients.COMPLETEDPHASE1, PHASE22006-092007-072007-07
NCT00730288Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult SubjectsCOMPLETEDPHASE22006-082008-012007-08
NCT00364351Efficacy Trial Comparing ZD6474 With Erlotinib in NSCLC After Failure of at Least One Prior ChemotherapyCOMPLETEDPHASE32006-082016-112008-09
NCT00358956A Study To Assess ZD6474 (ZACTIMA™) Monotherapy In Locally Advanced or Metastatic Hereditary Medullary Thyroid CancerCOMPLETEDPHASE22006-082014-052008-01
NCT00496509Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal CancerCOMPLETEDPHASE12006-082007-102007-10
NCT00496275Phase I Combination With Vinorelbine or Gemcitabine Plus Cisplatin in Locally Advanced or Metastatic NSCLCCOMPLETEDPHASE12006-082007-05
NCT00374166An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety DisorderCOMPLETEDPHASE22006-082008-022008-02
NCT00366795Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the LiverTERMINATEDPHASE32006-082008-122008-12
NCT00327743Combination Study of a New Taxane and Capecitabine in Patients With Metastatic Breast CancerCOMPLETEDPHASE1, PHASE22006-082009-032009-03
NCT00362336Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPVCOMPLETEDPHASE32006-082009-082008-05
NCT00317642A Study of Clofarabine and Cytarabine for Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia (AML)(CLASSIC I)COMPLETEDPHASE32006-082012-012012-01
NCT00362427Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®COMPLETEDPHASE22006-082009-032009-02
NCT00347958Descriptive, Open-label, Multicenter Study of the Safety of Redosing With ADACEL® VaccineCOMPLETEDPHASE42006-082008-102008-02
NCT00343889Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio VaccineCOMPLETEDPHASE32006-082008-042007-11
NCT00364611Pilot Study of Docetaxel & Bevacizumab +/- Trastuzumab in First-Line Treatment of Patients With Metastatic Breast CancerCOMPLETEDPHASE22006-082012-042011-06
NCT00365365Safety & Efficacy of Three Docetaxel-Based Chemotherapy Regimens Plus Bevacizumab With or Without Trastuzumab for Adjuvant Treatment of Patients With Breast CancerCOMPLETEDPHASE22006-082011-102011-10
NCT00705822Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate CancerTERMINATEDPHASE32006-082009-072009-07
NCT00361491An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive DisorderCOMPLETEDPHASE22006-082007-092007-09
NCT00454402ALF-STONE: Alfuzosin in Uretheric StonesTERMINATEDPHASE32006-082007-07
NCT06165276A Phase I, Randomized, Modified Single-blind, Active-controlled (Infants Only), Four-stage, Step-down, Comparative, Multi-center StudyCOMPLETEDPHASE12006-07-252008-08-272008-08-27
NCT00681798Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas CarcinomaCOMPLETEDPHASE12006-072009-062009-06
NCT00343421Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and ToddlersCOMPLETEDPHASE32006-072009-062008-06
NCT00358878Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)COMPLETEDPHASE32006-072008-122008-12
NCT00359437Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the LiverTERMINATEDPHASE32006-072008-102008-10
NCT00315055Immunogenicity of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® at 2-3-4 Months ScheduleCOMPLETEDPHASE32006-072008-022007-07
NCT00313911Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.COMPLETEDPHASE32006-072008-022008-01
NCT00343681A Study of the Immunogenicity and Safety of the 2006-2007 Influenza VaccineCOMPLETEDPHASE22006-072007-082007-08
NCT00360698Insulin Glulisine in Type 2 Diabetic PatientsCOMPLETEDPHASE42006-072008-082008-08
NCT00356122Docetaxel & Oxaliplatin in Combination With Bevacizumab as First-Line Treatment in Subjects With Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22006-072010-082010-08
NCT00327444Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant AscitesCOMPLETEDPHASE2, PHASE32006-072009-102009-10
NCT00386685XRP9881 in Combination With Trastuzumab in Metastatic Breast CancerCOMPLETEDPHASE22006-072011-012008-10
NCT00629720Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic EtiologyCOMPLETEDPHASE32006-072007-022007-02
NCT00685958Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture SurgeryCOMPLETEDPHASE32006-072007-032007-03
NCT00359229Stilnox Treatment in Elderly Patients With InsomniaCOMPLETEDPHASE42006-072007-09
NCT00358631An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive DisorderCOMPLETEDPHASE22006-072007-122007-12
NCT00361738Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin TreatmentCOMPLETEDPHASE22006-072008-012008-01
NCT00447161Preventing Antibiotic-Associated DiarRhea Using ErcefloraCOMPLETEDPHASE42006-072007-10
NCT00397527Acceptability Dermacyd Wipes - Lactoserum - HygieneCOMPLETEDPHASE32006-07
NCT00400309Safety of REPEVAX® Given One Month After REVAXIS®COMPLETEDPHASE32006-062007-022007-02
NCT00358150A Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher PatientsCOMPLETEDPHASE22006-062015-122009-08
NCT00345618Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic ApproachCOMPLETEDPHASE32006-062010-102010-10
NCT00317395Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary SyndromeCOMPLETEDPHASE22006-062009-032008-10
NCT00343239Docetaxel in Locally Advanced Gastric AdenocarcinomaCOMPLETEDPHASE22006-062012-032012-03
NCT00415129Safety and Immunogenicity of an Intramuscular Pandemic Influenza Vaccine in Adults and the ElderlyCOMPLETEDPHASE22006-062009-032008-12
NCT00348387Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPVCOMPLETEDPHASE32006-062008-122008-09
NCT00329537Study of Sargramostim in Moderately to Severely Active Crohn's DiseaseTERMINATEDPHASE22006-062007-052007-05
NCT00348881Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy InfantsCOMPLETEDPHASE32006-062008-062007-10
NCT01907685Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel in Patients With Advanced Solid TumorsCOMPLETEDPHASE12006-062011-022011-02
NCT00411229Capecitabine and Oxaliplatin Adjuvant Study in Stomach CancerCOMPLETEDPHASE32006-062012-112012-11
NCT00335452Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionSCOMPLETEDPHASE32006-062009-092009-09
NCT00401661Sexuality And Management of Benign Prostatic Hyperplasia With AlfuzosinCOMPLETEDPHASE42006-062007-12
NCT00347100Insulin Glargine in Type 2 Diabetic PatientsCOMPLETEDPHASE42006-062008-05
NCT00349180Total Hip Replacement Study With XRP4563 (Enoxaparin Sodium)COMPLETEDPHASE32006-06
NCT00386503Bioavailability of the Fixed Combination of Amodiaquine and Artesunate Under Fed & Fasted ConditionsCOMPLETEDPHASE12006-062006-12
NCT00345410Dose-Ranging Study Evaluating AVE1625 in Abdominally Obese Patients With Atherogenic DyslipidemiaCOMPLETEDPHASE22006-062007-062007-06
NCT00356967Efficacy and Safety of Dianicline Versus Placebo as an Aid to Smoking CessationCOMPLETEDPHASE32006-062007-062007-06
NCT00370162Acceptability Dermacyd Delicata - New Fragrance - Lactoserum - HygieneCOMPLETEDPHASE32006-06
NCT00230607Study of the Effects of Fabrazyme Treatment on Lactation and InfantsTERMINATEDPHASE42006-05-282024-02-092024-02-09
NCT00312377ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung CancerCOMPLETEDPHASE32006-052014-032008-08
NCT00327171Study of AVE0005 (VEGF Trap) in Patients With Chemoresistant Advanced Ovarian CancerCOMPLETEDPHASE22006-052010-032008-04
NCT00336713A 24-52-week Study to Evaluate the Long-term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA)COMPLETEDPHASE32006-052008-042008-04
NCT00325650Rimonabant In Prediabetic Subjects To Delay Onset Of Type 2 DiabetesTERMINATEDPHASE32006-052009-032009-03
NCT00295763A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.COMPLETEDPHASE32006-052006-092006-07
NCT00328198Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic LeukemiaCOMPLETEDPHASE22006-052011-082011-08
NCT00308087Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-cell Lymphoma, a Form of Non-Hodgkin's LymphomaTERMINATEDPHASE22006-052009-062009-06
NCT00331838Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement SurgeryCOMPLETEDPHASE22006-052007-062007-06
NCT00319553Post-licensure, Modified Double-blind, Multi-center Study Evaluating Safety and Immunogenicity of ADACEL® and BOOSTRIX®COMPLETEDPHASE42006-052008-122008-10
NCT00384085Insulin Glargine "All to Target" TrialCOMPLETEDPHASE42006-052010-032010-03
NCT00421824Study of Neoadjuvant Chemotherapeutic Treatment (XELOX) Followed by Chemoradiotherapy (XELOX/RT) and Surgery Versus Chemoradiotherapy Followed by Surgery and Chemotherapy in Patients With High Risk Rectal CancerCOMPLETEDPHASE22006-052010-112010-11
NCT00347061Long Term Safety of SL77.0499-10 (Alfuzosin) in Patients With BPHCOMPLETEDPHASE32006-052007-102007-10
NCT00334581Irbesartan in Chinese Hypertensive Diabetics With MicroalbuminuriaCOMPLETEDPHASE42006-052008-062008-06
NCT00345098A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive DisorderCOMPLETEDPHASE32006-052008-022008-02
NCT00338897Dose Ranging Study in Elective Total Hip Replacement SurgeryCOMPLETEDPHASE2, PHASE32006-052007-052007-05
NCT00380991Topic Compatibility Dermacyd Delicata - New Fragrance - Lactoserum - HygieneCOMPLETEDPHASE32006-05
NCT00371852Topic Compatibility Dermacyd Wipes - Lactoserum - HygieneCOMPLETEDPHASE32006-05
NCT00347490HENOX: Enoxaparine in HemodialysisCOMPLETEDPHASE42006-052007-062007-04
NCT00311090Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower LimbsCOMPLETEDPHASE32006-042008-012008-01
NCT00312767A Study in Patients With Fabry Disease Who Are on Chronic Hemodialysis Therapy for Treatment of End-stage Renal Insufficiency.WITHDRAWNPHASE42006-04
NCT00319852Immunogenicity and Safety of Tetraxim Versus Local DTP + IPVCOMPLETEDPHASE32006-042008-072008-04
NCT00344942Efficacy and Safety Study of Nasacort in Chronic Non Allergic and Non Infectious Rhinitis in AdultsTERMINATEDPHASE32006-042007-04
NCT00486785SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With AlfuzosinCOMPLETEDPHASE42006-042008-032007-10
NCT00331994EFESO - EFficacy Enterogermina Small Intestinal Bacterial OvergrowthCOMPLETEDPHASE42006-042008-072008-07
NCT00325546Study of Weight-Reducing Effect and Safety of Rimonabant In Obesity in ASIA (RIO-ASIA)COMPLETEDPHASE32006-042007-042007-04
NCT00318448Efficacy, Safety, and Tolerability of Ambien (Zolpidem) in the Treatment of Children Ages 6 to 17 With Attention Deficit Hyperactivity Disorder (ADHD)-Associated InsomniaCOMPLETEDPHASE32006-042006-082006-08
NCT00319709An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With DepressionCOMPLETEDPHASE32006-042007-082007-04
NCT00322075LANCGMS - Lantus Continuous Glucose Monitoring SubcutaneousCOMPLETEDPHASE42006-042006-11
NCT00304265Post-marketing Evaluation of Reactions Following Receipt of Recommended Adolescent Pertussis VaccineCOMPLETEDPHASE42006-032007-102006-10
NCT00315705A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias.COMPLETEDPHASE1, PHASE22006-032010-052010-05
NCT00298675Phase 1/1b Dose Escalation Study Evaluating BSI-201 as a Single Agent and in Combination With Irinotecan in Subjects With Advanced Solid TumorsCOMPLETEDPHASE12006-032011-052010-07
NCT00772954Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study, Safety, Tolerability and ImmunogenicityTERMINATEDPHASE12006-032006-062006-06
NCT00296816TEACO: Taxotere, Eloxatin, Avastin in Cancer of the OvaryCOMPLETEDPHASE22006-032011-082011-08
NCT00362037I SELECT - Irbesartan In Hypertensive Patients With Left Ventricular HypertrophyCOMPLETEDPHASE42006-032008-062008-06
NCT00345644Risedronate in Osteopenic Postmenopausal WomenCOMPLETEDPHASE32006-032009-062009-06
NCT00385411Study of Valproate in Young Patients Suffering From EpilepsyCOMPLETEDPHASE42006-032008-102008-10
NCT00315042TELI TON - Telithromycin in TonsillitisTERMINATEDPHASE32006-032006-082006-08
NCT00332891An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety DisorderCOMPLETEDPHASE32006-032007-042007-04
NCT00316329ATAQ EASY: Artesunate + Amodiaquine Fixed Dose Combination in the Treatment of Uncomplicated Plasmodium Falciparum MalariaCOMPLETEDPHASE32006-03
NCT00299325VIsceral Fat Reduction Assessed by CT-scan On RImonabAntCOMPLETEDPHASE32006-022008-072008-07
NCT00293163A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique.COMPLETEDPHASE42006-022006-10
NCT00287092Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in InfantsCOMPLETEDPHASE32006-022008-092007-05
NCT00444912The Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD)COMPLETEDPHASE22006-022009-062009-06
NCT00299871Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE22006-022007-082007-08
NCT00303316Immunogenicity Study of Antibody Persistence and Booster Effect of PENTAXIM™ at 18 Months in Healthy Argentinean InfantsCOMPLETEDPHASE32006-022007-092007-04
NCT00259337Immunogenicity and Safety of Pentaxim™ in an Indian PopulationCOMPLETEDPHASE32006-022008-122008-04
NCT00303056Efficacy and Safety Study of Intra-articular Multiple Doses of Icatibant in Patients With Painful Knee OsteoarthritisCOMPLETEDPHASE22006-022007-072007-07
NCT00362258I PREVENT - Irbesartan In Hypertensive Diabetic PatientsCOMPLETEDPHASE42006-022008-092008-09
NCT00335673I SAVE - Irbesartan in Mild to Moderate Hypertensive PatientsCOMPLETEDPHASE42006-022006-112006-11
NCT00283049Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory ControlTERMINATEDPHASE42006-022008-112008-11
NCT00308503Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance InsomniaCOMPLETEDPHASE32006-022007-082007-08
NCT00296218ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment ElevationCOMPLETEDPHASE32006-022007-03
NCT00302653Rasburicase in Tumor Lysis SyndromeCOMPLETEDPHASE42006-022006-11
NCT00336921Alfuzosin for Treating Acute Urinary RetentionCOMPLETEDPHASE22006-022007-04
NCT00315549TELI TAD - Telithromycin in Tonsillitis in Adolescents and AdultsTERMINATEDPHASE32006-022006-092006-09
NCT00300339Mixed Antagonist of Serotonin for Claudication Optimal TherapyCOMPLETEDPHASE22006-022007-122007-12
NCT00296179Ambien CR For Treatment Of Insomnia Associated With Depression When Used Concomitantly With LexaproCOMPLETEDPHASE42006-022007-06
NCT00296790Ambien CR vs. Placebo For Treatment Of Insomnia Associated With Anxiety When Used Concomitantly With Escitalopram (Lexapro)COMPLETEDPHASE42006-022007-02
NCT00494481E3 Breast Cancer Taxotere CombinationCOMPLETEDPHASE22006-012009-012007-06
NCT00267514Study to Demonstrate Equivalence of Sevelamer Carbonate Powder and Sevelamer HCl Tablets in Haemodialysis PatientsCOMPLETEDPHASE32006-012007-052007-03
NCT00681941An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On DialysisCOMPLETEDPHASE32006-012007-032007-01
NCT00268957Study to Compare Sevelamer Carbonate Powder to Sevelamer Hydrochloride Tablets in Patients With CKD on HemodialysisCOMPLETEDPHASE32006-012007-052007-03
NCT00445302Safety, Pharmacokinetics (PK), And Hematological Activity Of AMD3100 (Plerixafor) In Subjects With Renal ImpairmentCOMPLETEDPHASE12006-012007-082007-08
NCT00296829Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the ElderlyCOMPLETEDPHASE22006-012007-022007-02
NCT00258856Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®COMPLETEDPHASE22006-012007-112007-03
NCT00295165Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's DiseaseTERMINATEDPHASE32006-012006-102006-10
NCT00284141Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung AdenocarcinomaCOMPLETEDPHASE22006-012008-072008-07
NCT00288223Telithromycin in Acute Exacerbation of Chronic BronchitisTERMINATEDPHASE42006-012007-012007-01
NCT00280098Docetaxel in the Treatment of Hormone Refractory Prostate CancerCOMPLETEDPHASE42006-012007-10
NCT00288236Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO)COMPLETEDPHASE32006-012007-072007-07
NCT00315003TELI COM - Telithromycin in Children With Otitis MediaTERMINATEDPHASE32006-012006-072006-07
NCT00283790Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs PlaceboCOMPLETEDPHASE42006-012006-04
NCT00498797E3-Hormone Refractory Prostrate Cancer Taxotere CombinationCOMPLETEDPHASE22005-122008-092007-07
NCT00284128AVE7688 in Patients With Mild to Moderate Blood PressureCOMPLETEDPHASE2, PHASE32005-122008-032008-03
NCT00269477Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune®COMPLETEDPHASE22005-122007-122007-02
NCT00263042Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and OutcomesTERMINATEDPHASE32005-122009-042009-04
NCT00442169Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy AdultsCOMPLETEDPHASE22005-122009-042008-06
NCT00305188Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.COMPLETEDPHASE32005-122009-102009-10
NCT00268944Safety and Effectiveness Study of rhGAA in Patients With Advanced Late-Onset Pompe Disease Receiving Respiratory SupportCOMPLETEDPHASE32005-122007-062007-03
NCT00258011Study of Aldurazyme® Replacement Therapy in Patients With Mucopolysaccharidosis I (MPS I) DiseaseCOMPLETEDPHASE32005-122006-102006-10
NCT00311129Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHLCOMPLETEDPHASE22005-122007-072007-07
NCT00255021Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in ThailandCOMPLETEDPHASE42005-122009-012007-09
NCT00283062Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical ProstatectomyCOMPLETEDPHASE32005-122010-122010-12
NCT00830830TREAD-20 Extension - Treatment of Knee Pain Due to OsteoarthritisCOMPLETEDPHASE42005-122006-10
NCT00266747An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety DisorderCOMPLETEDPHASE32005-122007-012007-01
NCT00258908Immunogenicity and Safety of ADACEL™ as Fifth Dose in TaiwanCOMPLETEDPHASE32005-112006-082006-08
NCT00253968Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance InsomniaCOMPLETEDPHASE32005-112008-012008-01
NCT00258843Safety of Imovax Polio in Chinese Infants and ChildrenCOMPLETEDPHASE32005-112006-042006-02
NCT00255047Safety and Immune Response of Different Pediatric Combination Vaccines.COMPLETEDPHASE32005-112009-022008-07
NCT00314145A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAXCOMPLETEDPHASE32005-112006-112006-06
NCT00214461Safety, Tolerability, and Immunogenicity of a Clostridium Difficile Toxoid Vaccine in Healthy Elderly VolunteersCOMPLETEDPHASE12005-112006-022006-02
NCT00296803PROCLAIM: Study Examining Effects of Clopidogrel Compared to Placebo on Inflammation in Subjects With Metabolic SyndromeCOMPLETEDPHASE42005-112006-08
NCT00237445Study Comparing the Clinical Efficacy and Health Outcomes of Outpatients With Mild to Moderate Community-Acquired Pneumonia (CAP) Treated With Either Telithromycin Once Daily for 7 Days, or Azithromycin Once Daily for 5 DaysTERMINATEDPHASE42005-112006-092006-09
NCT00253903Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 YearCOMPLETEDPHASE32005-112008-092007-11
NCT00377000A Pilot, Multi-Center, Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels.COMPLETEDPHASE42005-112006-03
NCT00258817Phase IV Trial to Collect Safety Data and Sera in Healthy Children Given Fluzone VaccineCOMPLETEDPHASE42005-102007-082006-03
NCT00885105Evaluation of Responses to Fluzone® in Infants ≥ 6 Months of Age Who Did or Did Not Receive Fluzone® at 2 Months of AgeCOMPLETEDPHASE32005-102007-092006-01
NCT00361101A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic VirusCOMPLETEDPHASE12005-102010-042006-08
NCT00396331AMD3100 (Plerixafor) With G-CSF in Poor Mobilizing Adult Patients Who Previously Failed Hematopoietic Stem Cell (HSC) Collection/AttemptsCOMPLETEDPHASE22005-102009-122009-12
NCT00314132Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis.COMPLETEDPHASE32005-102006-112006-11
NCT00232310Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttErCOMPLETEDPHASE22005-102006-042006-04
NCT00254969Immunogenicity and Safety of Pentaxim in South African InfantsCOMPLETEDPHASE32005-102010-012008-05
NCT00271284Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic PatientsCOMPLETEDPHASE32005-102008-092008-09
NCT00272064ELEONOR STUDY: Insulin Glulisine in Type 2 Diabetes Mellitus.COMPLETEDPHASE32005-102008-052008-05
NCT00518427Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline GlargineCOMPLETEDPHASE42005-102008-032008-03
NCT00261092GEMOX: Oxaliplatin in Pancreatic CancerCOMPLETEDPHASE22005-10
NCT00258830Safety and Immunogenicity of the 2005-2006 Fluzone® VaccineCOMPLETEDPHASE42005-092007-032006-02
NCT00158600A Placebo-Controlled Study of Safety and Effectiveness of Myozyme (Alglucosidase Alfa) in Patients With Late-Onset Pompe DiseaseCOMPLETEDPHASE32005-092007-092007-09
NCT00258934Immunogenicity Study of the Influenza Vaccine in AdultsCOMPLETEDPHASE22005-092008-092008-06
NCT00258947Evaluation of Take and Safety of a Smallpox Vaccine in Healthy Young AdultsCOMPLETEDPHASE22005-092007-012006-12
NCT00265967Irbesartan in HypertensionCOMPLETEDPHASE42005-092007-02
NCT00335465Lantus Effect on Myocardial Glucose Metabolism in T2COMPLETEDPHASE42005-092008-062008-06
NCT00174720Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid.COMPLETEDPHASE32005-092007-022007-02
NCT00252330Efficacy and Safety of SR58611A in Patients With Major Depressive DisorderCOMPLETEDPHASE32005-092007-012007-01
NCT00855530Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive DisorderCOMPLETEDPHASE32005-092007-072007-07
NCT00252356Efficacy and Safety of SR58611A in Patients With Major Depressive DisorderCOMPLETEDPHASE32005-092007-052007-01
NCT00252343Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety DisorderCOMPLETEDPHASE32005-092007-022007-02
NCT00507091Phase I Irinotecan, 5-Fluorouracil and Leucovorin CombinationCOMPLETEDPHASE12005-082008-062006-05
NCT00499850Phase I FOLFOX CombinationCOMPLETEDPHASE12005-082008-042006-06
NCT00228176Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on RimonabantTERMINATEDPHASE32005-082009-042009-04
NCT00244257Safety Study of GMA161 in Patients With Idiopathic Thrombocytopenic Purpura (ITP)TERMINATEDPHASE12005-082008-072008-07
NCT00280605ALF-ONE : ALFuzosin ONcE DailyCOMPLETEDPHASE42005-082006-022006-02
NCT00135941Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2)COMPLETEDPHASE32005-082007-09
NCT00489190APIDRA Registration StudyCOMPLETEDPHASE42005-08
NCT00506051ZD6474(Vandetanib) + Alimta Combo StudyCOMPLETEDPHASE12005-072011-102006-05
NCT00123461Study of Safety and Efficacy of Doxercalciferol in Patients With Chronic Kidney Disease, Stage 3 or 4, and Secondary HyperparathyroidismCOMPLETEDPHASE42005-072007-102007-10
NCT00140621A Safety and Efficacy Study of Fabrazyme® Replacement Therapy in Patients With Cardiac Fabry DiseaseCOMPLETEDPHASE42005-072012-082012-08
NCT00125385Study of GC1008 in Patients With Idiopathic Pulmonary Fibrosis (IPF)COMPLETEDPHASE12005-072008-092008-09
NCT00466245Phase 2 Study of Safety, Tolerability, and Immunogenicity of Three Dose Levels of ACAM3000 Smallpox VaccineCOMPLETEDPHASE22005-072006-062006-06
NCT00127803Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult VolunteersCOMPLETEDPHASE12005-072006-032006-01
NCT00452907ACT MALI: Treatment of Malaria Based on Combination TherapiesCOMPLETEDPHASE42005-072007-062007-06
NCT00174733Efficacy of Ciclesonide Versus Placebo Administered Either as Once Daily or Twice Daily in Patients Treated Previously With an Inhaled CorticosteroidCOMPLETEDPHASE32005-072006-022006-02
NCT00264914Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionCOMPLETEDPHASE32005-072007-082007-08
NCT00137891Study Comparing Thyrogen Versus a Modified Release of Recombinant Human Thyroid Stimulating HormoneCOMPLETEDPHASE12005-062005-08
NCT00125879Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602COMPLETEDPHASE2, PHASE32005-062006-122006-06
NCT00232297Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnSCOMPLETEDPHASE22005-062007-022007-02
NCT00174785A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial FibrillationCOMPLETEDPHASE32005-062008-032008-03
NCT00174811Comparative Study to Evaluate the Efficacy and Safety of Telithromycin Given Once Daily Versus Cefuroxime Axetil Given Twice Daily in Children With Middle Ear InfectionsTERMINATEDPHASE32005-062006-062006-06
NCT00290992Rasburicase for HyperuricemiaCOMPLETEDPHASE22005-062006-042006-04
NCT00245674SOLIACS: Solian Solution in the Acute SettingCOMPLETEDPHASE42005-06
NCT00445796Arsucam® (Artesunate + Amiodaquine) Efficacy and TOLeranceCOMPLETEDPHASE42005-06
NCT00263003Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate HypertensionCOMPLETEDPHASE32005-06
NCT00292747Drotaverine in Dysmenorrhoea TreatmentTERMINATEDPHASE42005-05-252006-02-282006-02-28
NCT00206726Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)COMPLETEDPHASE22005-052008-042008-04
NCT00131352A Study of the Safety and Efficacy of Hylan G-F 20 (Synvisc) in Patients With Symptomatic Osteoarthritis of the KneeCOMPLETEDPHASE32005-052006-092006-09
NCT00319592A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVaxTM-JE and JE-VAXCOMPLETEDPHASE22005-052006-092006-09
NCT00174798MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.COMPLETEDPHASE22005-052006-052006-05
NCT00250653A Fifty-two-week Study to Evaluate the Safety of Saredutant in Adult and Elderly Patients With DepressionCOMPLETEDPHASE32005-052007-042007-04
NCT00258804Insulin Glargine During and After the Period of Fasting in RamadanCOMPLETEDPHASE42005-052006-022006-02
NCT00271323Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC PatientsTERMINATEDPHASE22005-052007-022007-02
NCT00424853ADVANCED Phase II Trial of Weekly vs 3 Weekly Docetaxel and Cisplatin Followed by Gemcitabine in Non-small-cell Lung Cancer (NSCLC)COMPLETEDPHASE22005-052008-082008-08
NCT00723086Japanese Study of the Combined Administration of Docetaxel With Prednisolone for Metastatic Hormone Refractory Prostate CancerCOMPLETEDPHASE22005-052008-092008-09
NCT00544180ROSPA - Record on Satisfaction of Patients With Actonel 35 mg Once a WeekTERMINATEDPHASE42005-052006-09
NCT00239967An International Study of Rimonabant in Dyslipidemia With AtheroGenic Risk In Abdominally Obese PatientsCOMPLETEDPHASE32005-052007-022007-02
NCT00274326DILIPO (DILutIonal HyPOnatremia)COMPLETEDPHASE32005-052007-072007-07
NCT00436371Amisulpride in Schizophrenic Acute Phase PatientsCOMPLETEDPHASE42005-052006-11
NCT00263016Docetaxel in Non Small Cell Lung Cancer (NSCLC)TERMINATEDPHASE22005-05
NCT00115570Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and AdolescentsCOMPLETEDPHASE32005-042006-112006-11
NCT00858468Safety and Immunogenicity Testing of Influenza Vaccine in Healthy Children 2 Months and 6 Months of AgeCOMPLETEDPHASE1, PHASE22005-042006-122006-06
NCT00174837TRACE: Tirapazamine-Radiation And Cisplatin EvaluationCOMPLETEDPHASE32005-042008-012008-01
NCT00395967AMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF AloneTERMINATEDPHASE22005-042006-082005-07
NCT00117689Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant RejectionCOMPLETEDPHASE22005-042007-122007-12
NCT00196794A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated DiarrheaCOMPLETEDPHASE32005-042007-08
NCT00777257Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap VaccineCOMPLETEDPHASE42005-042007-092007-03
NCT00250601An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With DepressionCOMPLETEDPHASE32005-042007-072007-07
NCT00250614An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With DepressionCOMPLETEDPHASE32005-042006-102006-10
NCT00272077Insulin Glargine in Type 2 Diabetes MellitusCOMPLETEDPHASE42005-042006-05
NCT00232258Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety StudyCOMPLETEDPHASE22005-042006-092006-09
NCT00283036APROVE : Irbesartan in HypertensionCOMPLETEDPHASE42005-04
NCT00272532EMINEM: Efficacy of Muscoril In NEck Myofascial SyndromesCOMPLETEDPHASE42005-04
NCT00258895Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®COMPLETEDPHASE32005-032007-042006-12
NCT00106509A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C.Difficile - Associated DiarrheaCOMPLETEDPHASE32005-032007-02
NCT00440648Cross-Over Study of Sevelamer Hydrochloride and Sevelamer CarbonateCOMPLETEDPHASE22005-032006-072006-03
NCT00436800Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal CarcinomaCOMPLETEDPHASE22005-032008-102008-10
NCT00257257Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic PatientsCOMPLETEDPHASE32005-032006-062006-06
NCT00174746Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent AsthmaCOMPLETEDPHASE22005-032005-112005-11
NCT00285025Study of the Effect of SR57667B in Patients With Alzheimer's DiseaseCOMPLETEDPHASE22005-032005-09
NCT00117650Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent ClaudicationCOMPLETEDPHASE22005-022010-032008-09
NCT00250939A Study of rhGAA in Patients With Late-Onset Pompe DiseaseCOMPLETEDPHASE22005-022006-112006-07
NCT00261105Telithromycin in Respiratory Tract InfectionsCOMPLETEDPHASE42005-022005-122005-10
NCT00129870CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal CancerTERMINATEDPHASE42005-022007-12
NCT00350038Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial FunctionsCOMPLETEDPHASE42005-022007-08
NCT00396266AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSFCOMPLETEDPHASE22005-012007-122007-12
NCT00103662Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma PatientsCOMPLETEDPHASE32005-012008-012006-10
NCT00103610Mobilization of Stem Cells With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma PatientsCOMPLETEDPHASE32005-012007-122006-07
NCT00271258Safety Study of Sodium Divalproate in Bipolar Disorder in AdolescentsCOMPLETEDPHASE32005-012007-01
NCT00397553Insulin Glulisine, Diabetes Mellitus Type 1COMPLETEDPHASE32005-012007-12
NCT00124332STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)COMPLETEDPHASE32005-012007-102007-10
NCT00454272Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic PatientsCOMPLETEDPHASE42005-012007-082007-08
NCT00292734STILDEP: Zolpidem in Depressive and Dysthimic PatientsCOMPLETEDPHASE42005-012006-06
NCT00256113An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With DepressionCOMPLETEDPHASE32004-122006-122006-12
NCT00252746ZD6474 Phase IIa Dose Finding Multicentre StudyCOMPLETEDPHASE22004-122007-012007-01
NCT00196755Study of Safety and Efficacy of Renagel® Compared With Calcium Acetate in Patients With Peritoneal DialysisCOMPLETEDPHASE32004-122006-042006-03
NCT00144781A Dose-optimization Study of Aldurazyme® (Laronidase) in Patients With Mucopolysaccharidosis I (MPS I) DiseaseCOMPLETEDPHASE42004-122006-012006-01
NCT00260351Immunogenicity and Safety of Verorab™ in Indian PopulationCOMPLETEDPHASE42004-122008-102008-08
NCT00643916Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of AgeCOMPLETEDPHASE22004-122007-102006-03
NCT00206661Safety and Efficacy Study in the Treatment of Pediatric Crohn's DiseaseTERMINATEDPHASE1, PHASE22004-122006-122006-12
NCT00233441Placebo Controlled Double-blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/FlutterCOMPLETEDPHASE2, PHASE32004-122006-052006-05
NCT00265993Enoxaparin in Acute Venous Thromboembolic DiseaseCOMPLETEDPHASE42004-122009-012009-01
NCT00917436Thiocolchicoside Injection and Capsule in Treatment of Acute Low Back PainCOMPLETEDPHASE42004-122005-072005-07
NCT00174642Opposing Step-by-step Insulin Reinforcement to Intensified StrategyCOMPLETEDPHASE32004-122008-12
NCT00431522Valproic Acid Sodium Salt in Bipolar DisorderCOMPLETEDPHASE42004-122006-102006-10
NCT00290979Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes MellitusCOMPLETEDPHASE32004-12
NCT00250627An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With DepressionCOMPLETEDPHASE32004-122006-122006-12
NCT00123565Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial InfarctionCOMPLETEDPHASE22004-122007-052007-05
NCT00098345Efficacy and Tolerability of ZD6474 in Patients With Thyroid CancerCOMPLETEDPHASE22004-112017-04-192008-02
NCT00074932Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe DiseaseCOMPLETEDNA2004-112006-122006-08
NCT00396383Treatment With AMD3100 (Plerixafor) in MM Patients to Mobilize PBCs For Collection and for TransplantationTERMINATEDPHASE22004-112007-052007-05
NCT00396201AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's DiseaseCOMPLETEDPHASE22004-112008-012006-10
NCT00229736A Study of AAV-hAADC-2 in Subjects With Parkinson's DiseaseCOMPLETEDPHASE12004-112013-032013-03
NCT00981630Study of Live Attenuated ChimeriVax™-Japanese Encephalitis VaccineCOMPLETEDPHASE22004-112007-112006-02
NCT00409357Dose Ranging Study of Alfuzosin in Patients With Lower Urinary Tract Symptoms Related to Benign Prostatic HyperplasiaCOMPLETEDPHASE22004-112005-082005-08
NCT00494338Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate CancerTERMINATEDPHASE22004-112005-042005-04
NCT00174668Insulin Glulisine in Diabetes Mellitus, Type 2COMPLETEDPHASE32004-112007-11
NCT00174694CHOOSE : Telithromycin, Acute Bacterial SinusitisCOMPLETEDPHASE42004-112005-12
NCT00239174A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese PatientsCOMPLETEDPHASE22004-112005-112005-11
NCT00310297Insulin Glulisine in Type 2 Diabetes MellitusCOMPLETEDPHASE12004-112004-12
NCT00130468TREAD-20: Trial of Hyalgan Three Injection-Regimen for the Treatment of Knee Pain Due to OsteoarthritisCOMPLETEDPHASE42004-112006-05
NCT00139295Comparison of Hylastan to Methylprednisolone Acetate in Patients With Symptomatic Osteoarthritis of the KneeCOMPLETEDPHASE32004-102007-09
NCT00831311Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean InfantsCOMPLETEDPHASE22004-102007-032005-11
NCT00772681Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx CarcinomaCOMPLETEDPHASE42004-102008-032008-03
NCT00132951KEYS: Study Comparing Clinical Health Outcomes of Telithromycin Versus Azithromycin in Outpatients With Community-acquired Lower Respiratory Tract InfectionsTERMINATEDPHASE42004-102006-092006-09
NCT00459004Japanese Dose-Response Study of Rimonabant in Obese PatientsCOMPLETEDPHASE22004-102006-042006-04
NCT00093275HP184 in Chronic Spinal Cord Injury SubjectsCOMPLETEDPHASE22004-102005-122005-12
NCT00831675Study of Safety and Immunogenicity of Fluzone® in Healthy ChildrenCOMPLETEDPHASE42004-092006-042006-04
NCT00322842Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma PatientsCOMPLETEDPHASE22004-092007-022007-02
NCT00206674Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's DiseaseCOMPLETEDPHASE32004-092006-062006-06
NCT00134563Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple SclerosisCOMPLETEDPHASE32004-092010-072010-07
NCT00268645Insulin Glargine in Type 2 DiabetesCOMPLETEDPHASE42004-09
NCT00174759CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial DiseaseCOMPLETEDPHASE32004-09
NCT00160030Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal CancerCOMPLETEDPHASE22004-092007-10
NCT00545337Glulisine + Lantus in Type I PatientsCOMPLETEDPHASE32004-092005-062005-06
NCT00546702Glulisine + Lantus in Type I PatientsCOMPLETEDPHASE32004-092005-022005-02
NCT00620100To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single AgentTERMINATEDPHASE22004-092005-042005-04
NCT00458718Efficacy and Safety of Rimonabant as an Aid to Smoking Cessation With or Without Nicotine PatchCOMPLETEDPHASE32004-092005-072005-07
NCT00094965Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal FunctionCOMPLETEDPHASE22004-092007-082007-08
NCT00133731The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary InterventionCOMPLETEDPHASE22004-092005-10
NCT00831987Safety and Immunogenicity of the World Health Organization (WHO) Formulation of the 2004-2005 Fluzone® VaccineCOMPLETEDPHASE42004-082006-022006-02
NCT00135083Variable Bolus Regimen 1-2-3 for Type 2 Diabetes MellitusCOMPLETEDPHASE32004-082007-11
NCT00135096Insulin Glulisine Administered Pre-meal Versus Post-meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal InsulinCOMPLETEDPHASE32004-082007-07
NCT00263055MASCOT : Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LVCOMPLETEDPHASE42004-082005-06
NCT00408135Japanese Study Evaluating Safety, Efficacy and Acceptability of Telithromycin in Children With InfectionsCOMPLETEDPHASE32004-082005-052005-05
NCT00481975Efficacy and Safety of Rimonabant on Weight Loss and Frequency of Binge Episodes in Obese PatientsCOMPLETEDPHASE32004-082005-082005-08
NCT00425243Efficacy and Safety of Zolpidem-MR Administered Over a Long Term Period as Needed for Insomnia (ZOLONG)COMPLETEDPHASE32004-082006-012006-01
NCT00087958Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine TreatmentCOMPLETEDPHASE22004-082009-042007-02
NCT00291005PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With PrednisoloneCOMPLETEDPHASE22004-08
NCT00264212AMISH : Aprovel for Management of Isolated Systolic HypertensionCOMPLETEDPHASE42004-08
NCT00086580Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) PatientsCOMPLETEDPHASE32004-072010-062010-06
NCT00206713Efficacy Study of Sargramostim in the Retreatment of Patients Who Have Crohn's Disease Who Have Previously Responded to Treatment With SargramostimTERMINATEDPHASE32004-072006-102006-10
NCT00144768A Study Investigating the Relationship Between the Development of Laronidase Antibody and Urinary GAG (Glycosaminoglycan) Levels in Aldurazyme® Treated PatientsCOMPLETEDPHASE42004-072007-052007-05
NCT00982137Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®)COMPLETEDPHASE22004-072007-032005-04
NCT00437463Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) InhibitorCOMPLETEDPHASE32004-072010-092010-09
NCT00358176Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal WomenCOMPLETEDPHASE32004-072007-032007-03
NCT00272012OPAL - Insulin Glulisine, Diabetes MellitusCOMPLETEDPHASE32004-072006-09
NCT00280618Oxaliplatin in Unresectable Hepatocellular CarcinomaCOMPLETEDPHASE22004-072006-11
NCT00325390Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment ElevationCOMPLETEDPHASE32004-07
NCT00461344Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast CancerTERMINATEDPHASE22004-072007-082005-06
NCT00924443A Study of Clofarabine in Older Patients With Acute Myeloid Leukemia (AML) for Whom Chemotherapy Is Not SuitableCOMPLETEDPHASE22004-062008-032006-06
NCT00185445Efficacy and Safety Study of Oral Fludarabine Phosphate in Combination With Mitoxantrone as First Line Treatment in Follicular NHLCOMPLETEDPHASE22004-062006-102006-10
NCT00268619FOCUS:Focus On Coronary Unstable SyndromesCOMPLETEDPHASE32004-062005-07
NCT00790101Risedronate vs Raloxifene in Hormone Replacement Therapy DiscontinuationTERMINATEDPHASE42004-062004-10
NCT01157871Dose-finding, Safety and Efficacy Study of NV1FGF in Patients With Intermittent ClaudicationCOMPLETEDPHASE22004-062005-082005-08
NCT00601835Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured TdCOMPLETEDPHASE42004-052005-072005-07
NCT00265369TEDDY: Spores of Bacillus Clausii in Acute Diarrhoea in ChildrenCOMPLETEDPHASE32004-05
NCT00277589LISA-study : Levothyroxin in Nodular GoiterCOMPLETEDPHASE42004-052008-122008-12
NCT00716924CASTLE (Clopidogrel And Serum Troponin Level Elevation)COMPLETEDPHASE32004-052006-02
NCT00481923Efficacy and Safety of Rimonabant With or Without Hypocaloric Diet in Obese PatientsCOMPLETEDPHASE32004-052005-042005-04
NCT00264927Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionCOMPLETEDPHASE32004-052007-092007-09
NCT00126009SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I PatientsCOMPLETEDPHASE22004-05
NCT00632216A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With OsteoporosisCOMPLETEDPHASE42004-052006-05
NCT00546676Ketek in CAP / AECB in Ambulatory Adult PatientsCOMPLETEDPHASE42004-052004-12
NCT00453908Alfuzosin Versus Placebo in Acute Urinary RetentionTERMINATEDPHASE32004-05
NCT00131300A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Shoulder OsteoarthritisCOMPLETEDPHASE32004-042006-02
NCT00322387Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma PatientsCOMPLETEDPHASE22004-042006-072006-07
NCT00079820Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in AdultsCOMPLETEDPHASE12004-042006-102006-10
NCT00280644Leflunomide in Rheumatoid ArthritisCOMPLETEDPHASE42004-04
NCT00135057Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal InsulinCOMPLETEDPHASE32004-042005-08
NCT00464256Comparison of Efficacy and Safety of Rimonabant 20mg/Day Versus Placebo in Smoking CessationCOMPLETEDPHASE32004-042004-112004-11
NCT00313885Efficacy and Safety of SR46349B in Patients With Sleep Disorders in FibromyalgiaCOMPLETEDPHASE22004-042005-062005-06
NCT00230178Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis SyndromeCOMPLETEDPHASE32004-042007-122007-12
NCT00311077Insulin Glulisine in Healthy Lean and Obese SubjectsCOMPLETEDPHASE12004-042004-10
NCT00297583Insulin Glulisine in Type 1 Diabetes MellitusCOMPLETEDPHASE12004-042004-05
NCT00501384Satavaptan Dose-Ranging Study in the Prevention of AscitesCOMPLETEDPHASE22004-042005-052005-05
NCT00501722Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic AscitesCOMPLETEDPHASE22004-042005-032005-03
NCT00081796Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast CancerCOMPLETEDPHASE32004-042006-092006-09
NCT00553020Assessment of Duration of Metabolic Effect of a Single Bolus of sc Injected Lantus Compared to NPH Insulin in Patients With Type 2 DiabetesCOMPLETEDPHASE42004-042005-07
NCT00501566Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic AscitesCOMPLETEDPHASE22004-042005-01
NCT00081900A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical CareTERMINATEDPHASE1, PHASE22004-032007-112007-07
NCT00088543Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell TransplantCOMPLETEDNA2004-032006-042006-04
NCT00322491Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma PatientsCOMPLETEDPHASE22004-032006-062006-06
NCT00181597Trilostane for Androgen-Independent Prostate CancerCOMPLETEDPHASE22004-032006-012006-01
NCT00130403OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal WomenCOMPLETEDPHASE42004-032007-03
NCT00360386ALBION "Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis"COMPLETEDPHASE22004-032005-022005-02
NCT00174772Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22004-032009-022009-02
NCT00638859Japanese Study Evaluating the Effects of Telithromycin in Children With Community-Acquired PneumoniaCOMPLETEDPHASE32004-032004-102004-10
NCT00087802Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE32004-032007-05
NCT00230217Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor MalignancyCOMPLETEDPHASE42004-032006-072006-07
NCT00285077Long-Term Safety Extension With SR57667B in Patients With Alzheimer's DiseaseCOMPLETEDPHASE22004-032006-112006-11
NCT00542165Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate HypertrophyCOMPLETEDPHASE42004-032004-12
NCT00071188ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22004-022007-102007-10
NCT00802867Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™COMPLETEDPHASE42004-022005-092005-06
NCT00777790Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in AdolescentsCOMPLETEDPHASE22004-022005-042004-04
NCT00268710Docetaxel in Hormone Refractory Prostate Cancer (HRPC)[Weekly or 3weekly TAX + Prednisone in HRPC]COMPLETEDPHASE22004-022006-032006-03
NCT00638534Japanese Study Evaluating the Effects of Telithromycin in Children With Acute Otitis MediaCOMPLETEDPHASE32004-022004-102004-10
NCT00331981Amisulpride in Schizophrenic PatientsCOMPLETEDPHASE42004-02
NCT00264173VALID : VAlproate Versus LIthium in Bipolar DisordersCOMPLETEDPHASE42004-022006-09
NCT00081497A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry DiseaseCOMPLETEDPHASE42004-012005-092005-09
NCT00772629Antibody Responses Following Meningococcal Tetravalent (A, C, Y, and W-135) Conjugate Vaccination in Healthy AdultsTERMINATEDPHASE22004-012004-042004-04
NCT00132938PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic BronchitisCOMPLETEDPHASE42004-012006-052006-05
NCT00077844Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE)COMPLETEDPHASE2, PHASE32004-012005-092005-09
NCT00254956Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent AsthmaCOMPLETEDPHASE32004-012005-062005-06
NCT00115375Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)COMPLETEDPHASE22004-012006-04
NCT00220272Study of the Effect of SR57667B on 18F-Dopa PET Imaging in Patients With Parkinson's DiseaseCOMPLETEDPHASE22004-012007-032007-03
NCT00609895The Incidence of Hypoglycemia in Insulin Glargine-Treated Subjects With Diabetes Mellitus Upon Switching Between Bedtime and Morning DosingCOMPLETEDPHASE42004-012004-08
NCT00453492Risedronate Sodium in Post Menopausal OsteoporosisCOMPLETEDPHASE42004-01
NCT00561964Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With MicroalbuminuriaCOMPLETEDPHASE32004-012005-07
NCT00368394Dose-Exposure-Response in Type 1 Diabetes MellitusCOMPLETEDPHASE12004-01
NCT00223938Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.TERMINATEDPHASE42003-12-302007-04-272007-04-27
NCT00078455Study of ILX651 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung CarcinomaCOMPLETEDPHASE22003-122005-08
NCT00077961Rituximab Plus CAMPATH in Patients With Relapsed/Refractory Low-Grade or Follicular, CD20-positive, B-cell NHLTERMINATEDPHASE1, PHASE22003-122006-02
NCT00113048Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic MalignanciesTERMINATEDPHASE12003-122005-09
NCT00930098A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic LeukaemiaCOMPLETEDPHASE22003-122007-07
NCT00847834Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese PopulationCOMPLETEDPHASE42003-122004-06
NCT00290927Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes MellitusCOMPLETEDPHASE32003-12
NCT00131326A Study of the Safety and Efficacy of Synvisc and Depo-Medrol in Patients With Osteoarthritis of the HipCOMPLETEDPHASE32003-112006-04
NCT00131768A Study of the Safety and Efficacy of Synvisc in Patients With Symptomatic Ankle OsteoarthritisCOMPLETEDPHASE32003-112006-02
NCT00071279SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein ThrombosisCOMPLETEDPHASE32003-112005-122005-12
NCT00637884A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy SymptomsCOMPLETEDPHASE42003-112004-02
NCT00132925An Efficacy and Safety Evaluation of Nasacort AQ in Children Ages 2-5 Years With Perennial Allergic RhinitisCOMPLETEDPHASE32003-112006-02
NCT00825058Efficacy and Safety of SR58611 Compared to Placebo and ParoxetineCOMPLETEDPHASE32003-112004-102004-05
NCT00104013Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's TypeCOMPLETEDPHASE32003-112007-112007-11
NCT00565162Insulin Glargine, INITIATE Metabolic and Economic Outcomes of LantusCOMPLETEDPHASE42003-112005-06
NCT0010364918-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's TypeCOMPLETEDPHASE32003-112007-102007-10
NCT00377273An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic KeratosesCOMPLETEDPHASE42003-112005-10
NCT00125827Study of Oral Clofarabine Administered Daily for 5 Days in Adult Patients With Refractory Solid TumorsCOMPLETEDPHASE12003-102006-022004-10
NCT00254917Assessment of the Immunogenicity and Safety of PENTAXIM™ in PhilippinesCOMPLETEDPHASE42003-102006-022006-02
NCT00772928Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™COMPLETEDPHASE32003-102006-112006-05
NCT00354939Insulin Analogue With Continuous Glucose Monitoring System (CGMS) MeasurementCOMPLETEDPHASE42003-102004-032004-03
NCT00263354Oxaliplatin in Gastric CancerCOMPLETEDPHASE22003-102006-072006-07
NCT00826852Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-TaxCOMPLETEDPHASE22003-102009-072009-07
NCT00617968GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast CancerCOMPLETEDPHASE22003-102005-06
NCT01053910Ramipril 10 mg/Day PreventionCOMPLETEDPHASE42003-102005-07
NCT00174863Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate CancerCOMPLETEDPHASE22003-102006-082006-08
NCT00637715Once Daily Given Alfuzosin in the Treatment of BPHCOMPLETEDPHASE42003-102004-12
NCT00549965Satisfaction and Compliance of Risedronate in PMOCOMPLETEDPHASE42003-10
NCT00549133Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing AtenololCOMPLETEDPHASE42003-102005-04
NCT00836953Study to Collect Sera for Immunogenicity Testing in Children Vaccinated With Fluzone®COMPLETEDPHASE42003-092004-072004-01
NCT00069862Iron Balance Study of DFO and GT56-252 in Patients With Transfusional Iron Overload Secondary to Beta-ThalassemiaCOMPLETEDPHASE1, PHASE22003-092005-11
NCT00703651Study of Inactivated, Split-Virion Influenza Vaccine Administered by Intradermal Route Versus Vaxigrip® in AdultsCOMPLETEDPHASE22003-092006-072006-05
NCT00070655Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS)COMPLETEDPHASE32003-092006-032006-03
NCT00637455Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight PersonnelCOMPLETEDPHASE42003-092005-01
NCT00772863Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian CancerCOMPLETEDPHASE22003-092008-06
NCT00630175Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary InsomniaCOMPLETEDPHASE32003-092004-022004-02
NCT00825019Efficacy and Safety of One Single Dose of SR58611 Compared to Placebo and ParoxetineCOMPLETEDPHASE32003-092004-122004-10
NCT00575913Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality StudyCOMPLETEDPHASE42003-092005-03
NCT00771849Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in ChildrenCOMPLETEDPHASE22003-082004-052004-03
NCT00068211Study of ILX651 in Patients With Inoperable Locally Advanced or Metastatic MelanomaCOMPLETEDPHASE22003-082006-01
NCT00078026An Investigation Into the Short Term Effect of APOMINE in Patients With Osteoporosis or Low Bone MassTERMINATEDPHASE1, PHASE22003-082004-12
NCT00069784The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention)COMPLETEDPHASE32003-082011-122011-12
NCT00077805PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)COMPLETEDPHASE42003-082006-07
NCT00268671Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN)COMPLETEDPHASE1, PHASE22003-082006-042006-04
NCT00835926A Study to Evaluate the Safety and Immune Responses to Fluzone® VaccinationCOMPLETEDPHASE42003-072003-092003-09
NCT00206596Study in Patients With Crohn's Disease Who Are Steroid Dependent, Despite Previous Unsuccessful Attempts to Reduce Steroids Due to Worsening of Crohn's DiseaseCOMPLETEDPHASE22003-072005-102005-10
NCT00174616CORE: Capecitabine, Oxaliplatin, Radiotherapy and ExcisionCOMPLETEDPHASE22003-072007-112007-11
NCT00243178Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)TERMINATEDPHASE32003-072005-092005-09
NCT00228150Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's DiseaseCOMPLETEDPHASE22003-072006-042006-04
NCT00651911Fasturtec TLS Treatment / ProphylysisCOMPLETEDPHASE42003-072004-07
NCT00562809The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild HypertensionCOMPLETEDPHASE42003-072004-08
NCT00249873Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)COMPLETEDPHASE32003-062009-032009-03
NCT00140608Efficacy of Seprapack Sinus Dressing Versus No Dressing in the Prevention of Intranasal Adhesions Following Sinus SurgeryTERMINATEDNA2003-062005-05
NCT00196716A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry DiseaseCOMPLETEDPHASE22003-062007-032006-04
NCT00089947A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant RejectionCOMPLETEDPHASE22003-062005-122005-12
NCT00249795Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)COMPLETEDPHASE32003-062009-082009-08
NCT00271271Efficacy Study of GEMOX Combination and Vinorelbine in NSCL PatientsCOMPLETEDPHASE22003-062006-10
NCT00267319FOCUS Fatigue Outcome in Copaxone USersCOMPLETEDPHASE42003-062006-10
NCT00311818Insulin Glargine in Type 2 Diabetes MellitusCOMPLETEDPHASE42003-062005-05
NCT00062803SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary EmbolismCOMPLETEDPHASE32003-062005-102005-10
NCT00476385Practicability and Acceptability of Stylomax® in ChildrenCOMPLETEDPHASE32003-062005-12
NCT00253955Study to Demonstrate the Clinical Efficacy of Levofloxacin in the Treatment of PneumoniaCOMPLETEDPHASE32003-062007-112007-05
NCT00642915Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil)COMPLETEDPHASE42003-062004-07
NCT00576368An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical PracticeCOMPLETEDPHASE42003-062004-04
NCT00059722This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.COMPLETEDPHASE22003-052007-06
NCT00066313ZD6474 in Treating Patients With Small Cell Lung CancerCOMPLETEDPHASE22003-052006-122006-12
NCT00067093Safety and Efficacy Trial Evaluating the Use of SR34006 in the Treatment of Deep Vein Thrombosis (DVT)COMPLETEDPHASE32003-052005-092005-09
NCT00563849Leflunomide + Methotrexate in Rheumatoid ArthritisCOMPLETEDPHASE42003-052004-08
NCT00763932Extension Study of Long-term Safety and Efficacy of Myozyme in Patients With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored Enzyme Replacement Therapy (ERT) StudiesCOMPLETEDPHASE22003-042006-072006-06
NCT00765414Extension Study of Long-term Safety and Efficacy of Myozyme for a Single Patient With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored ERT Studies.COMPLETEDPHASE22003-042006-082006-04
NCT00981175A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy AdultsCOMPLETEDPHASE22003-042008-022004-06
NCT00174564EXIBIT: Oxaliplatin in Biliary Tract CancerCOMPLETEDPHASE22003-042006-092006-09
NCT00174681Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 DiabetesCOMPLETEDPHASE42003-04
NCT00631579Rasburicase as a Uricolytic Therapy for Hyperuricemia in Patients With Leukemia or LymphomaCOMPLETEDPHASE22003-042004-062004-06
NCT00653302Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine)COMPLETEDPHASE42003-042005-102004-09
NCT00059280A Study of the Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe DiseaseCOMPLETEDPHASE2, PHASE32003-042005-092005-06
NCT00324376Study to Compare Once A Day Sevelamer Dosing With Three Times Per Day Sevelamer DosingCOMPLETEDPHASE22003-032004-05
NCT00772070Study of Reduced Dose of Menomune® in Children Who Previously Received Meningococcal Diphtheria Toxoid Conjugate VaccineCOMPLETEDPHASE22003-032004-052003-08
NCT00530556Insomnia and Daytime Function in OsteoarthritisCOMPLETEDPHASE42003-032004-062004-06
NCT00552370Glycemic Optimization Treatment StudyCOMPLETEDPHASE42003-032005-032005-03
NCT00563771Rasburicase for Treatment of Hyperuricemia in Children and Adolescence Patients With Tumor Lysis SyndromeCOMPLETEDPHASE42003-032004-01
NCT00277511Levofloxacin, Chronic Bacterial ProstatitisCOMPLETEDPHASE32003-03
NCT00539669TAX + Carboplatin or Cisplatin 1st Line Post-Surgery OvarianCOMPLETEDPHASE22003-03
NCT00053573rhGAA in Patients With Infantile-onset Glycogen Storage Disease-II (Pompe Disease)COMPLETEDPHASE1, PHASE22003-022006-112006-07
NCT00688883Fludara (Oral) Phase II Study for Indolent LymphomaCOMPLETEDPHASE22003-022004-082004-08
NCT00206700Open-label Trial of Leukine in Active Crohn's DiseaseTERMINATEDPHASE22003-022006-122006-12
NCT00637611Single-Center, Double-Blind, Randomized , Parallel Study Comparing Onset of Action, Efficacy & Safety of a Single-Dose of Fexofenadine HCl 180 mg vs Montelukast Na 10 mg & Placebo in Treating Seasonal Allergic Rhinitis Subjects in an Allergen Exposure UnitCOMPLETEDPHASE42003-022003-04
NCT00636870Fexofenadine (Allegra®) in Healthy Adults Who Have Been Identified as Slow Metabolizers for DesloratadineCOMPLETEDPHASE42003-022004-01
NCT00638118Fexofenadine HCl 180 mg, Montelukast Sodium 10 mg and Placebo in Suppression of Wheal and Flare Induced by Seasonal AllergenCOMPLETEDPHASE42003-022003-05
NCT00549068POWER Point of Care Effect on Satisfaction of TreatmentCOMPLETEDPHASE42003-022004-11
NCT00714961Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial InfarctionCOMPLETEDPHASE32003-022005-012005-01
NCT00564187Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical PracticeCOMPLETEDPHASE42003-022004-12
NCT00540891The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate ScoreCOMPLETEDPHASE32003-022004-10
NCT00051935A Study of the Safety and Pharmacokinetics of rhGAA in Siblings With Glycogen Storage Disease Type IICOMPLETEDPHASE22003-012003-102003-04
NCT00538018Telithromycin, Treating Adult Outpatients With Mild to Moderate Community-acquired Pneumonia (CAP) in High Bacterial Resistance AreasCOMPLETEDPHASE42003-012004-062004-06
NCT00357149Neoadjuvant Docetaxel Plus Cisplatin and 5-fluorouracil (TPF) Followed by Concomitant Chemoradiotherapy and Chemoradiotherapy Alone in Locally Advanced Squamous Cell Carcinoma of the Head and Neck Patients (SCCHNS)COMPLETEDPHASE22003-012008-02
NCT00273520TELICAST : Telithromycin in Acute Exacerbations of AsthmaCOMPLETEDPHASE32003-012004-052004-04
NCT00782041Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical CancerTERMINATEDPHASE22003-012003-08
NCT00637819Leflunomide in Systemic Lupus ErythematosusCOMPLETEDPHASE22003-012004-07
NCT00837824Severe Renal Disease Study in Fabry Patients Treated With FabrazymeTERMINATEDPHASE22002-122003-082003-08
NCT00051701Phase I/II Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkin's LymphomaTERMINATEDPHASE1, PHASE22002-122005-08
NCT00050778A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple SclerosisCOMPLETEDPHASE22002-122010-012007-09
NCT00261703Docetaxel in Head and Neck CancerCOMPLETEDPHASE2, PHASE32002-122010-072010-07
NCT00537563AMS VS MOXI Ketek vs Avelox in AMSCOMPLETEDPHASE32002-122003-092003-09
NCT00637585Fexofenadine HCl 180 mg, Desloratadine 5 mg and Placebo in Suppression of Wheal and Flare Induced by HistamineCOMPLETEDPHASE42002-122003-07
NCT00436293Taxotere + Cisplatin in Nasopharyngeal CarcinomaCOMPLETEDPHASE22002-122010-032010-03
NCT00353080Risedronate In The Prevention Of Osteoporosis In Osteopenic Postmenopausal WomenCOMPLETEDPHASE32002-122005-042005-04
NCT00648453Effect of Plavix on NO (Nitrogen Monoxide) Production of the Endothelial FunctionCOMPLETEDPHASE42002-122004-04
NCT00102128Study to Examine the Safety and Effectiveness of Implanted Skeletal Muscle Cells (Cells Removed From the Thigh Muscle) Into Scarred Areas of Heart Muscle After Heart Attack.TERMINATEDPHASE22002-112007-042007-04
NCT00050323Safety/Efficacy of a Vaccine Prepared From Dendritic Cells Combined With Tumor Cells to Treat Advanced Kidney CancerCOMPLETEDPHASE1, PHASE22002-112004-03
NCT00540709PUMP STUDY MDI Lantus/Lispro vs Continuous Insulin+LisproCOMPLETEDPHASE42002-112003-092003-09
NCT00538148Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPDCOMPLETEDPHASE42002-112004-092004-09
NCT00351091Risedronate in Postmenopausal Women With Low Bone DensityCOMPLETEDPHASE22002-112003-062003-06
NCT00272090Insulin Glargine in Type 1 Diabetes MellitusCOMPLETEDPHASE32002-112005-122005-12
NCT00547768Comparative Study Evaluating the Effects of Fexofenadine HCI 180 mg With Orange Juice Versus Placebo With Orange Juice in a Skin Wheal and Flare Challenge Model.COMPLETEDPHASE42002-112002-12
NCT00046501Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes AdolescentsCOMPLETEDPHASE32002-112005-02
NCT00464165Comparison of Efficacy and Safety of Rimonabant 5mg/Day or 20mg/Day Versus Placebo in Smoking CessationCOMPLETEDPHASE32002-112003-102003-10
NCT00399750TREE-2: Three Regimens of Eloxatin in Advanced Colorectal CancerCOMPLETEDPHASE22002-112005-06
NCT00459173Efficacy and Safety of Rimonabant as an Aid to Maintenance of Smoking CessationCOMPLETEDPHASE32002-112005-092005-09
NCT00611507A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric CancerCOMPLETEDPHASE22002-112004-04
NCT00576862Extension to Study HMR1964A/3011 in BelgiumCOMPLETEDPHASE42002-112004-04
NCT00539630TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHNCOMPLETEDPHASE32002-11
NCT00047840This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Non-small Cell Lung Cancer.COMPLETEDPHASE22002-102006-09
NCT00047788Efficacy Study of ZD6474 to Treat Multiple Myeloma CancerCOMPLETEDPHASE22002-102004-05
NCT00850603Safety and Immunogenicity of Intradermal Versus Subcutaneous Doses of Menomune®COMPLETEDPHASE42002-102004-112003-05
NCT00074958A Study of Fabrazyme in Pediatric Patients With Fabry DiseaseCOMPLETEDPHASE22002-102005-072005-05
NCT00146757A Study Evaluating the Safety and Pharmacokinetics of Aldurazyme® (Laronidase) in MPS I Patients Less Than 5 Years OldCOMPLETEDPHASE22002-102005-052005-05
NCT00050817Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)COMPLETEDPHASE32002-102005-08
NCT00353691Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32002-102004-11
NCT00094081Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck CancerCOMPLETEDPHASE32002-102006-092006-09
NCT00259363Oxaliplatin in Rectal CancerTERMINATEDPHASE1, PHASE22002-102006-06
NCT00077792Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)COMPLETEDPHASE32002-102006-122006-12
NCT00290953Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + EtoposideCOMPLETEDPHASE2, PHASE32002-102006-032006-03
NCT00633425Continuous Glucose Monitoring System (CGMS) in Type 2 Diabetic Patients Inadequately Controlled by Metformine Monotherapy; Analyze of Glycemic Profile Before and After Association of GlimepirideCOMPLETEDPHASE42002-102003-10
NCT0056322520 Week Bridging Study in Type II DMCOMPLETEDPHASE32002-102004-04
NCT00053508Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox VaccinationTERMINATEDPHASE22002-092003-092003-03
NCT00358228Comparison of the Efficacy and Safety of 2 Oral Doses of Rimonabant, 5 mg/Day or 20 mg/Day, Versus Placebo, as an Aid to Smoking Cessation (STRATUS US)COMPLETEDPHASE32002-092003-082003-08
NCT00402441Risedronate in the Prevention of Osteoporosis in Postmenopausal WomenCOMPLETEDPHASE42002-092004-062004-06
NCT00125840Clofarabine in Adult Patients With Advanced Solid TumorsCOMPLETEDPHASE12002-082007-08
NCT00697086European Study of Dronedarone in Atrial FibrillationCOMPLETEDPHASE32002-082004-062004-06
NCT00664144Rasburicase for the Treatment/Prevention of Hyperuricemia in Adult Patients With Relapsing Aggressive Non Hodgkin's LymphomaTERMINATEDPHASE22002-072005-012005-01
NCT00529750Effect of the Angiotensin II Receptor Antagonist Irbesartan on Biochemical and Functional Markers of Endothelial Dysfunction in Patients With HypertensionCOMPLETEDPHASE42002-072005-012005-01
NCT00425191Taxotere Combinations as First Line Therapy for Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer.COMPLETEDPHASE22002-072005-04
NCT00916097NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT)COMPLETEDPHASE22002-072005-112005-11
NCT00616694Impact of Vertebral Fracture Knowledge on Persistence in Subjects Taking Glucocorticoid TherapyCOMPLETEDPHASE42002-072004-12
NCT00272051XENOX - Evaluation of the Efficacy of Xaliproden in Reducing the Neurotoxicity of the Oxaliplatin + 5-FU/LV ChemotherapyCOMPLETEDPHASE32002-072004-05
NCT00798005Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease.COMPLETEDPHASE22002-062005-072005-07
NCT00288470A Double-blinded Evaluation of Safety and Efficacy of Hylaform and Hylaform Plus Compared to Zyplast.COMPLETEDNA2002-062003-08
NCT00696631European Trial of Dronedarone in Moderate to Severe Congestive Heart FailureTERMINATEDPHASE32002-062003-082003-01
NCT00077818Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE)COMPLETEDPHASE42002-062005-02
NCT00263029Preoperative Radiotherapy/ Oxaliplatin/ Capecitabine Treatment For Unresectable Locally-advanced Rectal CancerCOMPLETEDPHASE22002-062007-03
NCT00042341Phase II Study of Clofarabine in Pediatric Acute Lymphoblastic Leukemia (ALL)COMPLETEDPHASE22002-052006-01
NCT00034918This Study is to Assess the Efficacy and Safety of ZD6474 in Subjects With Metastatic Breast CancerCOMPLETEDPHASE22002-052003-11
NCT00042354Phase II Study of Clofarabine in Pediatric Acute Myelogenous Leukemia (AML) PatientsCOMPLETEDPHASE22002-052004-08
NCT00044889Phase II Study of Clofarabine in Adult Patients With Refractory or Relapsed Acute Myelogenous LeukemiaCOMPLETEDPHASE22002-052003-03
NCT0004615012 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.COMPLETEDPHASE32002-052002-12
NCT00390728Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial)COMPLETEDPHASE42002-042003-082003-08
NCT00399724A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar With Type 2 Diabetes MellitusCOMPLETEDPHASE42002-032003-082003-08
NCT00741897Fexofenadine Study On Filipino Children for The Relief of Perennial And Intermittent Allergic RhinitisCOMPLETEDPHASE42002-032003-12
NCT00368797Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive DiseaseCOMPLETEDPHASE22002-032005-042005-04
NCT00451971Objective Study in Rheumatoid ArthritisCOMPLETEDPHASE42002-03
NCT00044811Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent AsthmaCOMPLETEDPHASE32002-032003-102003-10
NCT00034294A Study of GT160-246 Versus Vancomycin in Patients With Clostridium Difficile-Associated DiarrheaCOMPLETEDPHASE22002-022003-07
NCT00077753EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged ImmobilizationCOMPLETEDPHASE42002-022007-022006-10
NCT00044824Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent AsthmaCOMPLETEDPHASE32002-022003-102003-10
NCT00045955Long-Term Safety Performance of Fexofenadine in AsthmaCOMPLETEDPHASE32002-022003-112003-11
NCT00348972Lantus in PrediabetesCOMPLETEDPHASE12002-02
NCT00228163Long Term Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With RelapsesCOMPLETEDPHASE22002-012015-012015-01
NCT00377624HUPS: Hyalgan Use in Painful ShoulderCOMPLETEDPHASE32002-012004-09
NCT01157143Gene Expression and Tolerability Study of NV1FGF in Patients With Peripheral Artery Occlusive Disease Planned to Undergo Major AmputationCOMPLETEDPHASE12002-012003-102003-10
NCT00196729Comparison of the Safety and Successful Ablation of Thyroid Remnant in Post-thyroidectomized Euthyroid Patients (i.e. Patients Administered Thyrogen) Versus Hypothyroid Patients (no Thyrogen) Following 131I AdministrationCOMPLETEDPHASE32001-122003-09
NCT00364858Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher DiseaseCOMPLETEDPHASE42001-122007-02
NCT00384215Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or MetforminCOMPLETEDPHASE42001-122005-02
NCT00290043Glulisine Pre- and PostmealCOMPLETEDPHASE12001-122002-03
NCT00783744Insulin Glargine Combination Therapies in Type II DiabeticsCOMPLETEDPHASE32001-122003-08
NCT00312208Docetaxel in Breast CancerCOMPLETEDPHASE32001-112013-102008-10
NCT00069888A Phase II Trial of Adjuvant Docetaxel in Patients At High Risk of Relapse Following ProstatectomyCOMPLETEDPHASE22001-112007-012007-01
NCT00046462Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other TreatmentCOMPLETEDPHASE32001-112004-122004-11
NCT00259376American-Australian-African Trial With Dronedarone in Patients With Atrial Fibrillation or Atrial Flutter for the Maintenance of Sinus RhythmCOMPLETEDPHASE32001-112003-092003-09
NCT00259428EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS)COMPLETEDPHASE32001-112003-082003-08
NCT00313937SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1COMPLETEDPHASE42001-112004-06
NCT0053725132 Week, Open, Randomized, 2 Way Cross Over Multicentre Trial to Compare Safety & Efficacy of Combination of HOE901 Insulin Analogue Once Daily at Bedtime + Lispro Insulin Before Meals vs NPH Insulin (Twice a Day) + Regular in Type 1 Diabetes MellitusCOMPLETEDPHASE32001-112004-02
NCT00258739Docetaxel in Non Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22001-102007-09
NCT00386061Rimonabant in Obesity Over a 2-Year Duration (RIO-Europe)COMPLETEDPHASE32001-102004-062004-06
NCT00029848Obese Patients With Type 2 DiabetesCOMPLETEDPHASE32001-102004-052004-05
NCT00029835Obese Patients With Untreated DyslipidemiasCOMPLETEDPHASE32001-092003-112003-11
NCT00029861Obese Patients With or Without Comorbidities (RIO-North America)COMPLETEDPHASE32001-082004-042004-04
NCT00043784SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary SyndromesCOMPLETEDPHASE32001-082005-02
NCT00032747Safety Study of Vasopressin V2 Receptor Antagonist on Patients With Severe Chronic Heart Failure (AQUAVIT).COMPLETEDPHASE22001-082003-02
NCT00046683Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic LeukemiaCOMPLETEDPHASE32001-072006-06
NCT01336751Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination TreatmentCOMPLETEDPHASE32001-072002-122002-12
NCT00521521Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck CancerCOMPLETEDPHASE22001-072006-05
NCT00403624Evaluation of the Neoadjuvant Treatment With Oxaliplatin -UFT- Radiotherapy in Rectal CancerCOMPLETEDPHASE1, PHASE22001-072005-112005-11
NCT00174629GILT Docetaxel - Non-Small Cell Lung CancerCOMPLETEDPHASE32001-062007-01
NCT00174824Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic PatientsCOMPLETEDPHASE42001-062007-042007-04
NCT00032734Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionCOMPLETEDPHASE22001-062003-07
NCT00046696A Study of NM-3 Administered Orally in Patients With Advanced Solid Tumors.COMPLETEDPHASE12001-052006-102006-10
NCT00146770Phase 3 Extension Study of the Safety and Efficacy of Aldurazyme® (Laronidase) in Mucopolysaccharidosis I (MPS I) PatientsCOMPLETEDPHASE32001-052005-032005-03
NCT00025896Safety and Efficacy of Recombinant Human Acid Alpha-Glucosidase in the Treatment of Classical Infantile Pompe DiseaseCOMPLETEDPHASE22001-052002-09
NCT00662870Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended VaccineCOMPLETEDPHASE32001-052004-012004-01
NCT00432315Docetaxel in Non Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22001-052009-102009-10
NCT00290030ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPHCOMPLETEDPHASE32001-052004-102004-10
NCT00029822Clinical Trial in Males With BPH (Enlarged Prostate)COMPLETEDPHASE32001-052005-03
NCT00044447Evaluate the Role of Adding Amaryl to Non-Insulin Dependent Diabetes Mellitus Patients Unresponsive to Maximum Dose Metformin & ThiazolidinedioneCOMPLETEDPHASE32001-052002-09
NCT00021255Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast CancerCOMPLETEDPHASE32001-042014-122014-12
NCT01487096Safety and Efficacy of Teriflunomide (HMR1726) in Multiple Sclerosis With RelapsesCOMPLETEDPHASE22001-042003-032003-03
NCT00324571Dialysis Clinical Outcomes Revisited (DCOR) TrialCOMPLETEDPHASE42001-032006-02
NCT00074984A Study of the Safety and Efficacy of Fabrazyme (Agalsidase Beta) as Compared to Placebo in Patients With Advanced Fabry DiseaseCOMPLETEDPHASE42001-022004-012004-01
NCT00358124Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination TherapyCOMPLETEDPHASE42001-012002-06
NCT00612495Endometrial Cancer - LOHP Alone and With 5FUCOMPLETEDPHASE22001-012005-03
NCT00542412CARE Canadian ALS Riluzole EvaluationCOMPLETEDPHASE42001-012004-12
NCT00912925Clinical Study of Aldurazyme in Patients With Mucopolysaccharidosis (MPS) ICOMPLETEDPHASE32000-122001-092001-09
NCT00611962Phase II Study of Oxaliplatine-Paclitaxel in Patients With Metastatic Germ Cell Tumor Refractory to CisplatinCOMPLETEDPHASE22000-122004-03
NCT00270348Effects of Ciclesonide MDI 50mg/Day and 200mg/Day (Ex-Valve) Once-Daily on Growth in Children With Mild Persistent AsthmaCOMPLETEDPHASE32000-122004-09
NCT00220311A Study to Confirm the Efficacy and Safety of Fludarabine Phosphate Administered in Untreated Chronic Lymphocytic Leukemia Patients With Anemia and/or ThrombocytopeniaCOMPLETEDPHASE42000-112005-092005-09
NCT00017550Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic SyndromeCOMPLETEDPHASE22000-092003-112003-11
NCT00819728Trial of Weekly Taxotere and Irinotecan (CPT-11) in Patients With Advanced Non-small Cell Lung CancerCOMPLETEDPHASE22000-062003-01
NCT00235300An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.COMPLETEDPHASE22000-052005-062003-04
NCT00325806Ramipril - HypertensionCOMPLETEDPHASE42000-052005-082005-08
NCT00611754Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and NeckCOMPLETEDPHASE22000-052003-02
NCT00259402Oxaliplatin in Esophagus Cancer (Advanced) 1st LineCOMPLETEDPHASE22000-022008-102008-10
NCT00653341Effect of Insulin Glargine in Insulin Naïve Subjects With Type 2 Diabetes on Oral Hypoglycemic Agent(s)COMPLETEDPHASE32000-012001-102001-10
NCT00277602Riluzole in Huntington's DiseaseCOMPLETEDPHASE31999-112004-072004-07
NCT00074971A Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry DiseaseCOMPLETEDPHASE31999-102004-12
NCT01755390A Dose Finding Study of XRP6258 in Patients With Advanced Solid TumorsCOMPLETEDPHASE11999-102002-102002-08
NCT00268632IMPACT Study (Improving Measurements of Persistence on "ACtonel" Treatment)COMPLETEDPHASE31999-082002-02
NCT01157156Safety and Tolerability of NV1FGF in Patients With Severe Peripheral Artery Occlusive DiseaseCOMPLETEDPHASE11999-062001-092001-09
NCT00273546Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck CancerCOMPLETEDPHASE31999-052006-022006-02
NCT00005645ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous TreatmentWITHDRAWNPHASE21999-05
NCT00004049SR-45023A in Treating Patients With Locally Advanced or Metastatic Solid TumorsCOMPLETEDPHASE11999-04
NCT02040636Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated PoliomyelitisCOMPLETEDPHASE21999-012000-052000-05
NCT00275210MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon CancerCOMPLETEDPHASE31998-102003-042003-04
NCT00290966Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric CancerCOMPLETEDPHASE2, PHASE31998-102003-05
NCT00003822SR-45023A in Treating Patients With Advanced Solid TumorsCOMPLETEDPHASE11998-08
NCT00130715Seprafilm in the Reduction of Incidence of Bowel Obstruction in General SurgeryCOMPLETEDNA1998-062003-08
NCT00174655BIG 02/98 Docetaxel - Breast CancerCOMPLETEDPHASE31998-062011-092011-09
NCT00401323Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaCOMPLETEDPHASE2, PHASE31998-012003-062003-06
NCT00003821Aminopterin in Treating Patients With Recurrent or Refractory Endometrial CancerWITHDRAWNPHASE21998-01
NCT00365131A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease.COMPLETEDPHASE41997-122004-07
NCT00174707Study of Docetaxel in Breast Cancer PatientsCOMPLETEDPHASE31997-122007-122007-12
NCT00452725Effect of MAXOMAT ® on the Growth of Small Children to NOONAN's SyndromeCOMPLETEDPHASE31997-102010-072010-07
NCT00226460Phase 2, Double-blind, Randomized, Controlled Multi-center Clinical Trial of the Safety and Efficacy of Transplanted Fetal Porcine Cells in Patients With Parkinson's Disease.COMPLETEDPHASE21997-082001-01
NCT00003713Chemotherapy in Treating Patients With Advanced or Metastatic Solid TumorsCOMPLETEDPHASE11997-08
NCT00688740Docetaxel in Node Positive Adjuvant Breast CancerCOMPLETEDPHASE31997-062010-012010-01
NCT00452491MAXOMAT ® in the Treatment of Severe Early Onset Intrauterine Growth Retardation on Pre-pubertal ChildrenCOMPLETEDPHASE31993-052010-042010-04
NCT00043706Safety, Tolerability, and Pharmacokinetics of CAT-192 (Human Anti-TGF-Beta1 Monoclonal Antibody) in Patients With Early Stage Diffuse Systemic SclerosisCOMPLETEDPHASE1, PHASE22003-09
NCT00082134Study of ILX651 in Patients With Hormone-Refractory Prostate Cancer Previously Treated With DocetaxelCOMPLETEDPHASE22005-12
NCT00396968AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDSWITHDRAWNPHASE1, PHASE2
NCT00002348A Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's LymphomaCOMPLETEDPHASE2